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ABSTRACT 
 
Assessment of Electrospinning as an In-House Fabrication Technique for Blood Vessel 
Mimic Cellular Scaffolding 
 
by 
 
Colby M. James 
 
 
Intravascular devices, such as stents, must be rigorously tested before they can be 
approved by the FDA.  This includes bench top in vitro testing to determine 
biocompatibility, and animal model testing to ensure safety and efficacy.  As an 
intermediate step, a blood vessel mimic (BVM) testing method has been developed that 
mimics the three dimensional structure of blood vessels using a perfusion bioreactor 
system, human derived endothelial cells, and a biocompatible polymer scaffold used to 
support growth of the blood vessel cells.  The focus of this thesis was to find an in-house 
fabrication method capable of making cellular scaffolding for use in the BVM.  Research 
was conducted based on three aims.  The first aim was to survey possible fabrication 
methods to choose a technique most appropriate for producing BVM scaffolding.  The 
second aim was to set up the selected fabrication method (electrospinning) in-house at 
Cal Poly and gain understanding of the process.  The third aim was to evaluate 
consistency of the technique. 
 v 
The work described in this thesis determined that electrospinning is a viable 
fabrication technique for producing scaffolding for BVM use.  Electrospun scaffolding is 
highly tailorable, and a structure that mimics the natural organization of nano sized 
collagen fibers is especially desirable when culturing endothelial cells.  An 
electrospinning apparatus was constructed in house and a series of trial experiments was 
conducted to better understand the electrospinning process.  A consistency study 
evaluated scaffold reproducibility between different spins and within individual spins 
while setting a baseline that can be used for comparison in future work aimed at 
electrospinning.  
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1.  INTRODUCTION 
 
 
Overview 
 
 
 The purpose of this thesis was to develop new scaffolds for growing tissue 
engineered blood vessels.  Specifically, the new scaffolds were intended to replace the 
existing scaffolding in an in vitro blood vessel mimic (BVM) system used to test 
intravascular devices.  This Introduction aims to explain the relevancy of the research 
conducted. 
 Before describing the specifics of the work, background information is required to 
understand the motivation for this work.  Therefore, this Introduction starts by explaining 
cardiovascular disease (CVD) in section 1, including the available treatments for CVD.  
The information in section 1 emphasizes the need for improved CVD treatment methods, 
which includes better device testing methods.  The BVM is such a testing method, and 
continued improvement to the system could make it invaluable in the device approval 
process. 
One avenue of CVD treatment, tissue engineered vascular grafts (TEVGs), is a 
promising new field of study that was used as the basis for the BVM.  In section 2, a 
review of TEVG research is included to introduce the available methods for creating 
blood vessels in a laboratory and the different types of scaffolding employed.  After 
TEVG information is presented, the BVM is explained in detail, including the current 
research being conducted to improve the system. 
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As the focus of this thesis was to explore alternative scaffolding for the BVM, 
section 3 introduces candidate fabrication methods to produce scaffolds for use in the 
BVM.   
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Cardiovascular Disease 
 
Statistics and Background Information 
 
 
Cardiovascular disease (CVD) is a class of diseases that affect the heart or blood 
vessels, and is the leading cause of death in the United States [1].  In 2006, CVD killed 
829,072 people, accounting for 34.2% of all deaths [2].  In 2009, CVD is expected to 
directly and indirectly cost the United States approximately $475.3 billion, and current 
health trends among Americans signal the potential for future devastation [3].  For 
example, statistics show a trend towards an increasingly overweight America, a key risk 
factor for CVD.  For children between the ages of 6 and 11 years, 17.5% were 
overweight in 2001-2004, in contrast to just 4.0% in 1971-1974.  For adolescents 12 to 17 
years of age in the same time periods, the prevalence of overweight individuals increased 
from 6.1% to 17.0% [4].  Also, diabetes mellitus, another key CVD risk factor, is an 
increasingly problematic disease in the United States [5].  In 2006, diabetes mellitus 
affected 10.6% of adults 20 years and older [6]. 
 
 
Atherosclerosis 
 
 
A major subset of patients with CVD suffer from atherosclerosis, a chronic, 
progressive, multifocal disease that affects the intimal layer of blood vessel walls through 
the formation of fatty plaques (Figure 1).  Generally, atherosclerosis targets large elastic 
arteries and medium to large muscular arteries, most often at points of branching, sharp 
curvatures, and bifurcations.  Advanced atherosclerotic plaques, or atheromatous plaques, 
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are composed of a central core of lipid and cholesterol crystals, as well as cells such as 
macrophages and smooth muscle cells (SMCs).  Necrotic debris, proteins, and 
degenerated blood cells are also contained in the plaque cores.  The core of the plaque is 
separated from the lumen of the blood vessel by a fibrous cap rich in collagen [7]. 
Atherosclerotic plaques are dangerous for several reasons.  First, they can block the 
vascular lumen, restricting blood flow distally.  Second, if the plaque is disrupted, a 
thrombus can form.  Third, the presence of plaques can degrade the contacting vascular 
wall, increasing the risk for aneurysm [8]. 
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Figure 1 - The progression of atherosclerosis from a healthy blood vessel (A) to the start 
(B) and development (C) of plaque formation.  Advanced plaque development results in 
significant vessel narrowing (D).  [American Heart Association, ?Cholesterol Media 
Library ? Atherosclerosis,? 2009 [9].] 
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Of all the diseases classified as atherosclerotic CVD, coronary artery disease 
(CAD), also known as ischemic heart disease (IHD), is the most problematic.  Not only is 
IHD the most common cause of myocardial ischemia and infarction, it is also the most 
serious, chronic, life-threatening illness in the United States [7].  One in every five deaths 
in the United States in 2005 was the result of CAD, and in 2009 it is estimated that 
785,000 Americans will suffer from a first coronary attack, while 470,000 will have a 
recurrent attack [6]. 
 
 
Cardiovascular Disease Treatment 
 
 
Percutaneous Transluminal Coronary Angioplasty 
 
 
Minimally invasive methods are available for the restoration of proper blood flow 
through coronary arteries.  One method termed percutaneous transluminal coronary 
angioplasty (PTCA), or balloon angioplasty, involves passing a long catheter from the 
femoral artery up the aorta to the openings of the coronary arteries, running a deflated 
balloon up the catheter, and inflating the balloon to compress against plaque deposits.  
PTCA widens the lumen, and increases blood flow through the vessel [10].  Plaque 
reduction occurs by compression, embolization, or redistribution of the plaque contents 
and by expansion of the vessel wall [8, 11].  PTCA success is limited by long term 
restenosis of the artery which is known to occur within the first four to six months in 30-
40% of patients.  Restenosis occurs due to fibrous tissue formation in the lumen, which is 
caused by excessive smooth muscle cell proliferation in response to angioplasty induced 
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injury [12].  In order to combat restenosis after PTCA, a majority of patients undergo a 
process known as stenting. 
 
Stents 
 
 
Stents are tube shaped cages or meshes most commonly made of 316 stainless 
steel or nickel titanium shape memory alloys that expand and support a larger, more 
uniform lumen (Figure 2).  Specifically, the role stents play as scaffolding in a blood 
vessel act to support the disrupted lumen and minimize thrombus formation [13].  
Stenting immediately after balloon angioplasty has been shown to be superior to 
angioplasty alone in several situations, including: blood vessels greater than 3mm in 
diameter, occluded vein grafts, recurring total occlusions, myocardial infarction, and in 
restenotic vessels following PTCA [14].  However, complications from stent implantation 
do arise.  Subacute stent thrombosis has occurred in 1 to 3% of patients within 7 to 10 
days after implantation, but has been virtually overcome by antiplatelet drugs [8].  A 
longer term complication called in-stent restenosis occurs among 50% of stented patients 
within 6 months of the procedure.  In-stent restenosis starts as damage to the intimal layer 
and stretching of the vessel wall, leading to a series of biological responses that results in 
luminal narrowing and restenosis from increased smooth muscle cell (SMC) migration 
and proliferation [15].  
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Figure 2 - Following percutaneous transluminal coronary angioplasty, a stent is used to 
prevent recoil of the luminal wall. [American Heart Association, ?What is a Stent?? 
2007 [16]]  
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Reduction of in-stent restenosis has been most successful with the introduction of 
drug-eluting stents.  Drug-eluting stents are coated with a polymer that can contain a 
variety of drugs that act to prevent SMC action, avoiding restenosis.  While the ultimate 
goal of any drug utilized in a drug-eluting stent is to prevent restenosis, the prevention 
pathway varies.  One example, sirolimus, prevents the degradation of p27kipl, a kinase 
inhibitor that plays an important role in regulating vascular SMC migration and 
proliferation [17].  Another drug called paclitaxel is a cytotoxic drug that suppresses 
SMC and endothelial cell (EC) migration and proliferation by disrupting microtubule 
action [18].  Drugs are released through diffusion or polymer degradation, both of which 
can be controlled through the engineering of specific polymer/drug systems. 
While drug-eluting stents beneficially inhibit in-stent restenosis, they may also 
disrupt EC activity, thus delaying arterial healing, and cause late thrombosis (any platelet 
rich thrombus occupying greater than 25% of the lumen after more that 30 days of 
implantation) [19].  Future drug-eluting stents seeking to alleviate the late thrombosis 
problem will require extensive preclinical testing, both in vitro and in vivo.  The BVM 
has potential to provide a physiologically accurate in vitro testing system. 
 
 
Heart Bypass 
 
 
Many ischemic patients have atherosclerotic constrictions or blockages in a few 
discrete locations along the artery, necessitating surgical intervention in the form of a 
heart bypass operation.  This involves bypassing blockages using a graft attached from 
the aorta to a site on the peripheral coronary artery beyond atherosclerotic plaque 
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blockages as shown in Figure 3 [20].  Grafts are mostly sections of subcutaneous vein 
from an arm or leg, which account for 400,000 bypass operations annually in the U.S. 
[21, 22].  These grafts, however, have a tendency to occlude over time due to accelerated 
atherosclerosis, resulting in 50% patency at 10 years [23].  Thus, there is an effort 
underway to engineer a suitable vascular graft for coronary artery applications. 
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Figure 3 - Bypass grafts restore blood flow to distal portions of arteries by circumventing 
blockages. [American Heart Association/American Stroke Association, ?Heart Attack 
Media Library ? Coronary Artery Bypass Grafting (CABG),? 2009 [24]] 
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Vascular Grafts 
 
 
 Grafting was introduced briefly in the preceding section during the discussion of 
coronary bypass procedures.  The autologous bypass veins are used as substitute conduits 
for blood to flow through, which is the general function of vascular grafts.  Although 
autologous vein grafting is the most prevalent grafting procedure, other synthetic and 
biological grafts have been developed.  The research on grafting is relevant to the work in 
this thesis as it was used to develop the BVM, and can be used to further improve the 
system.  Grafting research is described in the following section. 
 
 
Synthetic Vascular Grafts 
 
 
 As early as the beginning of the 20th century, researchers and doctors were 
conducting animal experiments to test the viability of vascular grafts constructed of many 
different materials, including aluminum, silver, glass, and Lucite tubes [8].  Currently, 
synthetic grafts are typically fabricated from poly(ethylene terephthalate) (Dacron) or 
expanded polytetrafluoroethylene (ePTFE) (Figure 4).  Both materials can be used to 
produce highly tailored grafts, varying not just length and diameter, but also porosity to 
promote healing and endothelialization.  In large diameter vessel applications (greater 
than 6 mm), where there is high flow and low resistance, synthetic grafts have a 90% 
patency rate at 5 to 10 years [25].  When used as small caliber arterial replacements 
(inner diameter less than 6 mm), they are prone to thrombus induction, embolism, and 
occlusion [26]. 
 13 
 
Figure 4 - Tubular geometry synthetic ePTFE with scanning electron micrograph of its 
microstructure (634x).  Nodes (blue arrow) run parallel to the long axis of the graft, while 
internodal fibers (red arrow) run in the circumferential direction. 
 
 
 
 
The mechanism behind synthetic graft failure involves the series of biological 
responses that occurs after implantation.  First, the luminal surfaces of implanted grafts 
become coated in a layer of plasma proteins consisting primarily of fibrinogen.  Second, 
this layer develops over time into a platelet-fibrin aggregate called the pseudointima.  
Finally, ECs cover this layer, thereby imitating the lumen of a native blood vessel and 
serving as a nonthrombogenic surface.  Due to the human body?s limited ability to 
endothelialize vascular grafts, this new intima, or neointima, is confluent only over a 15 
mm zone adjacent to the anastomosis, or site of sutured connection between the graft and 
native artery.  Thus, even after long term implantation, only the ends of implanted 
 14 
vascular grafts have endothelialized lumens while the inner lumen is covered by the 
platelet-fibrin pseudointima.  This inner layer may not adhere tenaciously to the graft, 
and may become dislodged, resulting in distal embolization or formation of a flap-valve 
that causes acute obstruction [8]. 
 
 
Biologic Vascular Grafts 
 
 
Grafts classified as biological are the result of natural fabrication within a living 
system and must be explanted from a donor.  No external fabrication techniques, such as 
the use of scaffolding for cellular support, are necessary.  Biological grafts can be 
classified as autografts, allografts, or xenografts.  Autografts come from the receiving 
individual, such as the sections of subcutaneous vein used for coronary bypass described 
earlier.  These are readily accepted by the host, eliciting little immunogenic or 
inflammatory response [20].  Allografts are donated from one individual to another of the 
same species.  Due to allelic variants of genes of the major histocompatibility complex, 
allografts run the risk of rejection by the host.  In the case that donor and recipient belong 
to different species, the graft is classified as a xenograft.  Rejection is high with 
xenografts due to maximal genetic disparity [27].  Autografts are the best choice for 
biological vascular grafts, but are in short supply due to a limited amount of self-
harvestable blood vessel conduit.  Around 60% of patients in need of bypass surgery do 
not have a vessel suitable for grafting [28]. One solution is to create autologous vascular 
grafts using techniques from the relatively new field of tissue engineering. 
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Tissue Engineered Vascular Grafts (TEVGs) 
 
 
A field still in its infancy, tissue engineering is the melding of biology, chemistry, 
physics, materials science, engineering, and many other disciplines, to design and build 
tissues and organs at least partially outside the body.  The goal of tissue engineering is 
the ability to start with cells from a host and transform them into an implantable construct 
that will improve the hosts quality of life by curing or alleviating the symptoms of a 
disease.  Figure 5 shows the typical steps necessary to create a tissue engineered implant.  
Tissues produced in this manner could eliminate the need for donors, as well as suppress 
the need for immunosuppressant therapy due to an autologous cell source [29, 30]. 
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Figure 5 - A typical tissue engineered implant starts with autologous cell sourcing (1).  
The explanted cells are expanded in vitro (2) and seeded onto a support scaffold (3).  
Further culturing of the seeded construct may include a variety of chemical and 
mechanical stimulation (3,4) to induce normal physiological cellular activity.  Finally, 
constructs are implanted into the host with the hope that immune response will be 
minimal (5). [Blitterswijk, ?The Central Tissue Engineering Paradigm,? 2008 [31]] 
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With respect to vascular grafts, tissue engineering may potentially replace 
synthetic materials, like ePTFE, in small diameter vessel applications.  The ideal graft 
would meet a long list of criteria, including: easy to handle, good suture retention, 
flexible and kink resistant, biocompatible, compliance matched to connecting artery, 
resistant to aneurysm, easily manufactured, economical, easily stored, and producible in 
many sizes [32]. 
 The basic strategy behind most attempts to produce tissue engineered vascular 
grafts (TEVGs) is to mimic the natural tri-layer structure and/or function of a blood 
vessel.  Figure 6 illustrates the tri-layer structure of native blood vessels, which TEVGs 
strive to at least partially replicate.  Different methods exist to attempt achieving this, 
from simple modification of ePTFE to building a completely biological graft.  Due to the 
focus of this thesis on vessel scaffolds, a review of these various methods is presented in 
the following sections. 
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Figure 6 - The three layered structure of a native blood vessel.  The intima consists of a 
single layer of blood contacting ECs that prevent platelet adhesion.  Below the intima lies 
a much thicker layer called the media comprised of multiple layers of SMCs as well as 
sheets of elastin and collagen occurring at regular intervals.  The pitch of these intervals 
is determined by vessel size and flow conditions [33].  The medial layer is largely 
responsible for blood vessel mechanical response to chemical signals, such as 
vasoconstriction and vasodilation, as well as mechanical integrity, such as resistance to 
bursting.  Composed largely of collagen and interspersed fibroblasts, the outer adventitia 
is a supportive connective tissue [1, 29]. 
 
 
 
Modified ePTFE Scaffolding 
 
 
 Endothelial cells comprising the intimal layer of blood vessels are known to 
inhibit thrombosis as well as act as an anticoagulant surface for blood flow [34].  With 
this in mind, researchers have produced small-diameter ePFTE vascular grafts with 
luminal endothelial linings in hopes to prevent thrombus induction, embolism, and 
occlusion.  This is a logical first step in the evolution of tissue engineered blood vessels 
since it involves simply altering the existing ePTFE grafts. 
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 Zilla et al developed and clinically applied an in vitro endothelialization 
procedure for ePTFE grafts.  Patients that required infrainguinal grafts but had unsuitable 
veins for grafting participated in the clinical study.  Autologous ECs were isolated from 
segments of the patients? cephalic, brachial, external jugular, or, if unsuitable as a conduit 
material, saphenous veins.  ECs were cultured until the required number of cells, 
approximately 16 x 106, was reached.  Sections of ePTFE were coated with a 
fibrinolytically inhibited fibrin glue to provide a surface for EC adherence.  ECs were 
seeded onto the luminal surface of the grafts and allowed to cultivate for approximately 6 
to 11 days to ensure maturation of the cytoskeleton for structural integrity before 
implantation [35]. 
A long term study from the same research group showed that patency rates for 
these endothelialized infrainguinal grafts at both 5 and 10 years improved compared to 
bare ePTFE grafts, and all retrieved samples had a confluent endothelium after 38.9 ± 
17.8 months [36].  However, while a confluent endothelium addresses part of the problem 
of vascular graft failure, the mechanical behavior of ePTFE is still vastly different from 
native artery.  Specifically, ePTFE has poor radial compliance.  Compliance in this case 
is vessel distension caused by increased blood pressure resulting in a temporary, 
reversible increase in diameter.  The inability of ePTFE vascular grafts to stretch in the 
radial direction has been shown to contribute to distal anastomotic intimal hyperplasia in 
vivo as a result of shear stress abnormalities [37].  Also, some functions of ECs are 
interrupted by a flow altering lack of radial compliance.  For example, ECs will produce 
various substances in response to shear stress and cyclic radial stretch, including 
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prostacyclins and nitric oxide, important substances in blood platelet aggregation and 
vasodilation, respectively [38]. 
Synthetic ePTFE graft material has another arguably disadvantageous property in 
that it is permanent.  ECs signal arterial remodeling in order to maintain a shear stress in 
most arteries of 15 dynes/cm2, but the non-degradable nature of ePTFE prevents this 
remodeling from occurring, resulting in non-ideal intimal shear stress [1, 39].  This has 
lead some researchers to avoid synthetic, non-biodegradable materials in the search for 
the ideal TEVG. 
 
 
Completely Biological TEVGs 
 
 
  By abstaining from using synthetic materials, L?Heureux et al hoped to produce a 
vascular graft that would be superior to any synthetic graft in three important ways.  First, 
an autologous, completely biological graft could be healed by the body.  Second, a 
biological matrix could be remodeled, as opposed to synthetic material that only 
degrades.  Finally, the absence of synthetic material could prevent foreign body reaction 
that results in inflammation and/or infection. 
 The result was a fused 3 layer biological construct similar to a native blood vessel 
consisting of the following: acellular inner membrane sodded with ECs to mimic the 
intima; middle layer of SMCs as a replacement for the media; and an outer layer of 
fibroblasts to act as the adventitia.  Histological examination of the lumen of the graft 
confirmed von Willebrand factor expression and acetylated-low density lipoprotein 
uptake characteristic of ECs [40, 41].  The middle ?media? layer stained positive for ?-
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smooth muscle actin, a SMC marker [42].  The outer adventitial layer contained vimentin 
and small fibers of elastin assembled in large circular arrays similar to native blood vessel 
adventitial layers.  Burst pressure of the engineered vessels reached a plateau of 2232 ± 
251 mmHg, compared to 1680 ± 307 mmHg for human saphenous vein.  While this 
ultimate strength is more than adequate, L?Heureux et al noted that compliance of the 
engineered biological grafts was much less than that of saphenous vein, a problem known 
to cause anastomotic intimal hyperplasia, resulting in decreased patency rates [43].  In 
vivo analysis in a canine model yielded a 50% patency rate at 7 days, even though the 
grafts were produced using human cells making them xenografts, which have severe 
problems maintaining patency.  The promising results from initial testing of biological 
TEVGs were tempered by the 3-month production time.  In cases where an alternate 
blood conduit is required immediately, these grafts would not be available [44]. 
 Another type of completely biological TEVG pioneered by Weinberg and Bell in 
1986 used scaffolding made from natural collagen type I, a component of the ECM.  The 
collagen scaffold was produced by denaturing bovine collagen, which was subsequently 
seeded with cultured bovine ECs, SMCs, and fibroblasts.  The resultant graft had 
inadequate burst strength (~325 mmHg) compared to native coronary artery (~5000 
mmHg) or saphenous vein (~2000 mmHg), necessitating the incorporation of a Dacron 
mesh sleeve for extra radial strength [45]. 
 To increase the mechanical properties of collagen based vascular grafts, Girton et 
al. subjected collagen gel constructs seeded with smooth muscle cells to glycation.  This 
is the nonenzymatic crosslinking of ECM proteins by reducing sugars.  Once crosslinked, 
the constructs showed a 16-fold increase in circumferential tensile stiffness.  Despite the 
 22 
similarity in compliance between these grafts and native arteries, the tensile strength and 
burst pressure still fell below the required values [46, 47]. 
 Completely biological TEVGs offer the advantage of easy incorporation into the 
host, but the long production time and lack of mechanical strength have led some 
researchers to pursue other avenues, including incorporation of synthetic, biodegradable 
polymers. 
   
 
Biodegradable Polymer TEVGs 
 
 
 One of the pervasive themes of extracellular (ECM ) based scaffolds, such as 
collagen, is their lack of mechanical strength.  Many research groups have focused on 
hybrid grafts, or those that incorporate a variety of synthetic materials for structural 
support and natural materials to interact with blood.  A majority of the synthetic 
structural support materials are biodegradable in hopes that remodeling processes within 
the body will eventually produce a true blood vessel, thus negating the need for synthetic 
support.  Based on this, research groups have pursued synthetic, biodegradable scaffolds 
that have sufficient mechanical strength, and other advantages over naturally derived 
scaffolding.  For example, degradation rate can be tailored in manufactured scaffolds.  
The body can use the scaffold as a guide for reconstruction, and by the time the healing 
process is complete, the scaffold can be completely degraded.  In addition, scaffold 
properties can be controlled, such as molecular and macroscopic structure, mechanical 
properties, and porosity.[29] 
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 Some degradable polyesters have been known for many years to be 
biocompatible, and as such provided a good starting point for TEVGs [48].  Mooney et al 
investigated the mechanical viability of spray treated polyglycolic acid (PGA) based 
tubular meshes for tissue engineering purposes in the mid 1990?s.  PGA meshes that were 
spray treated with a solution of poly(L-lactic acid) (PLLA) showed only a slight 
compression with the application of a 200 mN radial compressive force, a significant 
improvement on the performance of untreated PGA meshes, which were completely 
crushed by a force of 5 mN.  The study not only demonstrated the mechanical potential of 
biodegradable vascular scaffolding, but also showed a positive cellular response to the 
scaffolds by seeding SMCs and ECs on the lumen of a PLLA sprayed PGA mesh.[49] 
 Tissue engineered pulmonary artery grafts utilizing PGA/polyglactin copolymer 
scaffolds were produced by Shinoka et al. in 1998.  Autologous ECs, SMCs, and 
fibroblasts were expanded in culture, seeded onto the scaffolds, and cultured in vitro for 
seven days.  The finished grafts were used to replace 20 mm long x 15 mm diameter 
sections of pulmonary artery in lambs.  One control graft of unseeded PGA/polyglactin 
scaffolding was also implanted.  Results showed that all 7 cell-seeded grafts remained 
patent for up to 24 weeks, but the acellular polymer scaffold occluded due to thrombus 
formation.  Polymer scaffolds completely degraded by the 11th week, but the replacement 
tissue had insufficient burst strength to be used in high pressure systemic circulation [50]. 
 In 1999, Niklason et al used a PGA scaffold and a pulsatile bioreactor to conduct 
a study that looked more closely at the effects of culturing conditions in vitro.  Tubular 
PGA scaffolds were treated with sodium hydroxide to cause ester hydrolysis on the 
surface of the fibers, increasing hydrophilicity and cellular attachment.  SMCs were 
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seeded on the luminal surface and cultured under pulsatile and static conditions for 8 
weeks.  Histological examination revealed infiltration of SMCs into the wall of the PGA 
scaffold among the pulsed constructs, resulting in a smooth luminal surface suitable for 
EC seeding.  Static conditioned SMC constructs showed no infiltration and a luminal 
surface characterized by uneven polymer fragments, an unsuitable surface for EC 
seeding.  A layer of ECs was seeded on the lumen of pulsed constructs, followed by 
continuous perfusion of the vessel lumens for 3 days.  The final grafts showed a confluent 
endothelium expressing von Willebrand factor and platelet endothelial cell adhesion 
molecule.  They also attained a suitable burst strength at 2150 ± 709 mmHg, but a suture 
retention strength of 91 ± 26 g was still less than the strength of 273 ± 31 g reached by 
native arteries [51]. 
 The results from the studies presented in this section show how biodegradable 
polymer scaffolding has contributed to the field of TEVGs.  Grafts with mechanical 
properties more suited for implantation have been created, while immunogenic response 
has been minimized.  In addition, other scaffold properties can be controlled using 
synthetic, biodegradable polymers, including molecular properties and porosity.  Using a 
variety of techniques, it is possible to create grafts that continue to perform more and 
more like natural, human blood vessels. 
 
 
An Alternate Use for Established TEVG Techniques: Blood Vessel Mimic 
 
 
 The methods and research described in the preceding sections were focused on 
pursuing a TEVG for implantation into a human host.  However, TEVGs can potentially 
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serve an alternate purpose.  Inspired by these established techniques, the blood vessel 
mimic (BVM) creates TEVGs not for implantation, but for in vitro device testing.  The 
following section introduces the BVM and current research being conducted to make the 
system more physiologically accurate.  
 
 
Intermediate In Vitro Device Testing Using the BVM  
 
 
 Based on the challenges of animal studies, such as cost, lack of facilities and 
number of personnel required, and the leap that is made from in vitro static-culturing 
response to animal testing, a three dimensional BVM was developed to test intravascular 
devices in vitro.  Based on tissue engineered blood vessel techniques described earlier, 
the blood vessel mimic (BVM) provides a more efficient means of initial assessment in 
order to direct animal and clinical studies toward the most promising devices [52]. 
 The BVM system  (Figure 7) seeks to create a physiologically accurate 
environment for testing and evaluating intravascular devices prior to clinical trials.  At 
the start, the BVM consists of human ECs seeded on the luminal surface of an ePTFE 
support scaffold.  The system is placed in a perfusion bioreactor system, consisting of a 
peristaltic pump, gas permeable tubing, a chamber used as a media reservoir, and another 
chamber containing the BVM.  The perfusion bioreactor maintains flow of media through 
the BVM to cultivate the ECs until confluency, effectively making the luminal surface of 
the BVM similar to the luminal surface of a human blood vessel.  Once the ECs are 
confluent on the luminal surface of the ePTFE scaffold, a stent can be ?implanted? by 
way of the inlet port.  Media perfusion is resumed through the stented graft to encourage 
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EC proliferation and migration.  Removal of the grafts from the system and subsequent 
histological examination provides information on EC response to the implanted stent.  
Based on these results, the goal is that researchers can make a more informed decision on 
which products to move on to animal testing. 
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Figure 7 - Bioreactor system containing the Blood Vessel Mimic (BVM).  The BVM 
chamber (A) consists of three ports: luminal inlet port (B), luminal outlet port (C), and 
extraluminal outlet port (D).  The luminal inlet port allows media to flow into the system 
and implantation of stents.  The luminal outlet port allows media to flow out of the 
system.  The extraluminal outlet port, when unclamped and coupled with clamped 
luminal outlet and inlet ports, facilitates flow through the ePTFE vessel wall for cell 
sodding.  A separate reservoir is attached for easy media changing (E), and a peristaltic 
pump drives the flow of media through the system (F).  The entire bioreactor system is 
placed in an incubator at 37?C and 5% carbon dioxide. 
 
 
 
 The high throughput BVM is cost effective and expedient compared to 
preliminary animal testing.  Also, the effectiveness of animal models in intravascular 
device testing has been a concern for researchers, specifically the rate and extent of 
endothelialization [53].  An improved cost effective, high-throughput, physiologically 
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accurate BVM could help alleviate the dependency on expensive animal studies, and 
eventually provide a more appropriate testing environment for intravascular devices.  The 
following sections describe research aimed at making the BVM more cost effective and 
physiologically accurate, while maintaining the BVM?s ability to perform as a high-
thoughput testing environment. 
 
 
Pulsatile Flow and Shear Stress Optimization 
 
 
 Endothelial cells on the BVM  luminal surface are currently exposed to steady 
flow of low viscosity media.  This is not physiologically accurate, so media flow 
dynamics are being changed to more accurately imitate conditions found in native 
arteries.  Conditions of flow determine the differentiation path and properties of ECs, so 
it is important to recreate physiologic flow conditions as closely as possible.  To do this, 
the viscosity of the media must be changed to tune the shear stress experienced by the 
ECs to normal arterial shear stress. In addition, the steady flow should be replaced with a 
pulsating flow since this is what occurs in the body [29].  Altering the media viscosity 
and introducing pulsatile flow into the BVM system are currently under development 
[54]. 
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Bioreactor Redesign 
 
 
 A new BVM bioreactor is being designed for several reasons. First, installing and 
removing scaffolds from the BVM bioreactor is difficult, which causes operator 
frustration.  Also, the BVM must remain sterile at all times, and the difficulty of 
accessing the scaffolds makes maintaining sterility a challenge in itself.  A redesign of 
the system is necessary to make accessing the scaffolds more user-friendly and, thus, 
easier to maintain sterility [55].  Second, stents come in many shapes and sizes to fit the 
variations of coronary arteries, so the bioreactor should accommodate a BVM suitable for 
testing a wide range of stent sizes.  The current bioreactor limits testable stents to short, 
straight segments.  Finally, the bioreactor should be constructed of readily available, cost 
effective components so scale up is possible.  The current bioreactor vessel chambers are 
specially machined and not cost-effective, and should be replaced.  This work is currently 
underway [56].   
  
 
Cell Source and Sodding Procedure 
 
 
 In order to make the BVM more physiologically accurate, research on the cellular 
component of the system is also underway.  Currently, human microvessel endothelial 
cells (HMVECs) derived from liposuction fat are currently used to form the intima-like 
monolayer of ECs.  A more appropriate cell line sourced from large blood vessels is 
commercially available, and substitution of these large vessel cells for the HMVECs is 
under investigation.  In addition, the feasibility and development of protocols necessary 
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to construct a SMC/EC dual layer BVM is being researched.  The addition of a medial 
layer composed of SMCs adds physiological accuracy to the BVM. 
 
 
Physiologically Appropriate and Cost Effective Scaffolding 
 
 
 The BVM utilizes ePTFE because it is biocompatible, readily available, has 
adequate porosity, and does not degrade.  However, the mechanical properties and high 
cost of ePTFE make its use in the BVM less than optimal.  As mentioned in Section 
2.3.1, when implanted in vivo as a conduit, ePTFE tends to have poor long term patency 
due to its poor radial compliance.  But, since media is used in place of blood, intimal 
hyperplasia is not a concern.  The radial distension of vessels does, however, directly 
affect ECs in other ways.  The cyclic pumping of the cardiac cycle alters the shear stress 
imposed on endothelial cells, by both changing the fluid flow rate, and varying the caliber 
of the vessel.  Stress causes several endothelial cell reactions.  First, stress fibers of the 
actin cytoskeleton at the base of endothelial cells extend and align with the direction of 
shear stress, causing an elongated, cobblestone morphology.  Second, endothelial cells 
will produce various substances in response to shear stress and cyclic radial stretch, 
including prostacyclins and nitric oxide, important substances in blood platelet 
aggregation and vasodilation, respectively [57]. Third, endothelial cells signal arterial 
remodeling in order to maintain a shear stress in most arteries of 15 dynes/cm2 [1, 39]. If 
the goal is modifying the BVM to be as physiologically accurate as possible, including 
the response of endothelial cells to induced stress, then ePTFE must be replaced with a 
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more compliant scaffold.  The cost of any replacement scaffolding should be equal to or 
less than the current cost of ePTFE, which is currently priced at $10/cm. 
 As the purpose of this thesis is to explore more physiologically appropriate, in-
house fabricated scaffolding, a viable fabrication method for scaffold production based 
on established tissue engineering scaffold fabrication techniques must be identified.  The 
next section introduces and reviews possible fabrication methods that could produce 
appropriate scaffolding for the BVM.  Chapter 2 contains an evaluation of the fabrication 
methods for use in the BVM. 
 
 
Scaffolding for TEVGs 
 
Fibrous Non-woven Mesh Textiles 
 
 
 Micron-diameter fibers can be produced by extruding or gravity spinning a 
polymer solution or melt through a spinneret, followed by a drawing out process between 
a series of winders.  By collecting and compressing the fibers, a nonwoven textile 
scaffold is produced.  Depending on process parameters such as extrusion and drawing 
rate, scaffolds with varying fiber diameters and porosities are attainable [58, 59].  Early 
attempts at tissue engineering vascular grafts used non-woven mesh textile scaffolds 
made of polyurethane (PU) and PGA [49, 60, 61].  PGA mesh textiles have also provided 
scaffolding for tissue engineered cartilage [62]. 
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Solvent Casting and Particulate Leaching (SCPL) 
 
 
 Introduced by Mikos et al. in the early 1990s, solvent casting and particulate 
leaching (SCPL) produces scaffolds that are mechanically and morphologically tunable.  
In SCPL, salts are sieved to control for particle size and evenly distributed in a solution 
of dissolved polymer.  When the solvent evaporates the resulting solid polymer is 
impregnated with salt particles, which can be leached out using another solvent, usually 
high purity water.  The removal of the salt leaves a porous, degradable polymer scaffold, 
the pore size and percent porosity of which depend upon the amount of salt suspended in 
solution and the size of individual salt particles, determined by the sieving parameters 
[63].  SCPL scaffolds can be highly porous with pores large enough for complete cellular 
infiltration and vascularization.  For example, Mooney et al. used SCPL scaffolds made 
of PLLA to support the growth of hepatocytes and allow for vascularization in tissue 
engineered liver [64]. 
 
 
Thermally Induced Phase Separation (TIPS) 
 
 
 When a single homogenous polymer solution mixed at elevated temperatures is 
subsequently cooled, the solution converts into a two-phased system composed of 
domains of polymer-rich and polymer-poor regions.  Freeze drying of liquid-liquid 
phase-separated polymer solution produces microcellular structures as a result of solvent 
removal.  By controlling conditions such as polymer concentration, quenching route, 
quenching depth, solvent to non-solvent composition, and the presence of additives, the 
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final pore size distribution and interconnectivity can be tailored [65, 66]. A binary phase 
diagram is used to determine the solution concentration that results in spinoidal 
decomposition as shown in Figure 8.  More complicated methods of TIPS fabrication 
have been used as well; Dalton et al. produced poly(2-hydroxyethyl methacrylate-co-
methyl methacrylate) TIPS hydrogel tubes for in vivo nerve regeneration using a tertiary 
diagram of 2-hydroxyethyl methacrylate, methyl methacrylate, and water [66]. 
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Figure 8 - Typical binary phase diagram for a polymer in a solvent.  Quenching with too 
little polymer in solution results in disconnected microspheres of solidified polymer (A), 
while using a high concentration solution produces a porous macroscopic polymer matrix 
with no interconnecting pores (C).  By controlling quenching so that the polymer 
undergoes spinodal decomposition, a porous matrix with 100% pore interconnectivity is 
produced (B). 
 
 
If freezing occurs prior to liquid-liquid demixing, the polymer is expelled to the 
boundaries of the solvent crystallites, resulting in a solid-liquid phase separated polymer 
system.  Liu et al. demonstrated the variability of this technique using various solutions 
of polyurethane in 1,4-Dioxane frozen at different temperatures.  By keeping the 
concentration of the solution constant at 10% by weight polymer and freezing at 
temperatures ranging from -196 ?C to 0 ?C, scaffolds with pore sizes ranging from 4.7 ± 
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2.1 ?m to 70 ± 40 ?m were produced.  Conversely, using a constant freezing temperature 
of -80 ?C and varying solution concentration from 5% to 15% by weight polymer, 
scaffold pore architecture was affected in two ways.  First, lower concentrations (5% by 
weight polymer) produced pore sizes of 75 ± 29 ?m and higher concentrations (15% by 
weight polymer) resulted in 20 ± 9 ?m pores.  In addition, porosity was affected by 
varying solution concentration.  Lower concentrations yielded scaffolds with 51 ± 4% 
porosity, while higher concentration solutions created 10 ± 2% porosity scaffolds [67]. 
 
 
Solid Freeform Fabricated Scaffolds (SFF) 
 
 
 A high degree of control over the final structure of a scaffold is possible using 
solid freeform fabrication (SFF).  Several forms of SFF have been used to create 
scaffolds for tissue engineering, three of which are presented in this section and shown 
below in Figure 9. 
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Figure 9 - Equipment diagrams for three solid freeform fabrication methods.  All three 
systems construct three dimensional parts by fusing many two dimensional layers. 
 
 
Three-Dimensional Printing 
 
 
 Using various powders and a liquid binder, three dimensional printing builds 
constructs from the bottom up.  A three dimensional computer model is sliced into two 
dimensional layers, and each layer is built and fused with the previous layer by spraying 
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fresh powder with a binding agent [68].  Natural powdered materials have been used, 
such as cornstarch, dextran, and gelatin [69]. Synthetic polymers, like polycaprolactone, 
have also been used, but most biomaterials are not usually available in powder form and 
require processing [70]. A process called indirect three-dimensional printing involves 
creating scaffold molds using three dimensional printing, followed by solvent casting 
using a biopolymer.  Using this method, extra processing to manufacture powdered 
biomaterials is unnecessary, but complete removal of the powdered mold can be difficult 
[71]. 
 Resolution of three dimensional printing is limited in several ways.  First, the 
nozzle size and position controller introduce limits on particle placement.  Second, 
particle size limits the layer thickness to a minimum of 80-250 ?m.  Also, internal 
unbound powder is difficult to remove from porous parts, resulting in a lower bound on 
pore size [58, 72]. Kim et al. utilized three dimensional printing for macroscopic part 
construction, and coupled the technique with particulate leaching to introduce 
microporosity into the construct [73]. In this manner, the resolution limit of three-
dimensional printing was avoided while taking advantage of the macroscopic accuracy of 
the technique. 
 
 
Stereolithography 
 
 
 Stereolithography uses a focused ultraviolet laser that is scanned over a liquid 
bath of photopolymerizable polymer.  When the laser hits the bath, it causes low 
molecular weight monomers to chain react and polymerize at the laser-monomer 
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interface, resulting in a solid polymer.  By lowering the polymerized solid sections and 
striking the liquid on top with the laser, a construct is built layer by layer [74].  Since 
stereolithography requires a photopolymerizable polymer, the materials available for this 
process are limited [72].  In a similar fashion to indirect three-dimensional printing, 
stereolithogaphy has been used to produce scaffold molds, which were subsequently 
filled with powdered hydroxyapatite and sintered for bone scaffolding applications [75].  
A major limitation of stereolithography is that equipment required for this fabrication 
process is expensive [58]. 
  
 
Selective Laser Sintering 
 
 
 Similar to stereolithography, selective laser sintering (SLS) also uses a focused 
laser beam, but the beam?s function is not to polymerize.  The laser is selectively scanned 
over the surface of a powder, causing particles to locally melt and fuse together, creating 
a two dimensional cross section of a CAD designed part that can be built upon to create a 
three dimensional structure.  Tan et al. demonstrated the ability to incorporate the 
bioactive material hydroxyapatite into poly(etheretherketone) SLS processed scaffolds, 
an attractive fabrication technique for bone tissue engineering [76].  
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Electrospinning 
 
 
 The electrohydrodynamical phenomena known as electrospinning can be used to 
produce an interconnecting fiber network with fiber diameters ranging from millimeters 
to nanometers.  Electrospinning is based on the complex interplay between surface 
energy, rheology, and electrical charge.  The basic elements required for electrospinning 
are a polymer source, high voltage power supply, and grounded collector as shown below 
in Figure 10.  A high electric potential around 8,000 to 30,000 volts applied between the 
polymer solution being extruded through a metal syringe needle and the collector causes 
charge to build up in a polymeric droplet at the tip of the metal needle.  This charge 
creates a force large enough to overcome the surface tension of the solution causing the 
droplet to erupt towards the collector.  After eruption, the strand of polymer solution that 
extends from the needle tip to the collector is called a jet.  As it travels towards the 
collector, electrostatic forces within the jet cause physical reactions called bending 
instabilities that result in elongation of the fiber and solvent evaporation.  The result is a 
solid fiber network that takes the shape of the grounded collector [77]. 
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Figure 10 - A simple electrospinning apparatus.  Variable parameters include polymer 
solution concentration and injection rate, power supply setting, distance from polymer 
source to grounded collector (gap distance), and collector geometry. 
 
 
Still in its infancy, electrospinning is gaining popularity as a fabrication process 
for producing scaffolds with microstructures that mimic ECM.  The process is compatible 
with a number of materials, including synthetic biodegradable polymers like PGA, PLA, 
and PCL, and natural ECM components including collagen and elastin [32, 58, 78]. 
 
 
Scaffold Fabrication for the BVM  
 
 
 A variety of scaffold microstructures are possible using the techniques presented 
in the preceding sections.  Tubular scaffolds can be composed of a solid matrix with 
pores randomly suffused throughout (SCPL and TIPS), a solid matrix with carefully 
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controlled porous structure (SFF), or micro-fibers layered to form a macroscopic 
construct (Mesh textiles and electrospinning).  Chapter 2 will evaluate the candidate 
fabrication techniques, and their resultant microstructures, as replacements for ePTFE in 
the BVM. 
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Summary and Aims of this Thesis 
 
 
 Cardiovascular disease is the number one cause of mortality in the United States.  
There is a need to develop treatments for this epidemic, whether the treatments take the 
form of improved stent technology for revascularization or better conduits for bypass 
operations.  Using tissue engineering techniques, a blood vessel mimic was created to 
expedite the development of cardiovascular devices and therapies.  The current 
scaffolding used to support the growth, migration, and proliferation of endothelial cells 
on the lumen of the blood vessel mimic is expanded polytetrafluoroethylene, which 
exhibits a lack of radial compliance and cannot be modified in-house.  Thus, there exists 
a need to replace the expanded polytetrafluoroethylene with a more compliant scaffold 
that can be fabricated and modified in house. 
 The overall goal of this thesis was to pursue the replacement of the expanded 
polytetrafluoroethylene scaffolding used in the BVM.  To accomplish this goal, three 
aims were identified and pursued. First, methods for scaffold fabrication were compared 
and the most promising fabrication technique was selected to make scaffolds for use in 
the BVM.  Second, the apparatus for the chosen fabrication process was constructed.  
Third, the capabilities of the new system were evaluated.  Additionally, a preliminary 
proof of concept that the new fabricated scaffolds would support placement within a 
BVM bioreactor and subsequent cell deposition was performed. 
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2.  FABRICATION METHOD SELECTION AND ELECTROSPINNING 
 
 
Introduction 
 The end of Chapter 1 introduced various scaffold fabrication techniques that were 
candidates to replace commercially obtained ePTFE in the BVM.  The first section of 
Chapter 2 evaluates these techniques based on their appropriateness for use in the BVM.  
Criteria used for evaluation included: consistency and controllability, material 
compatibility, pore architecture, cost, and other special considerations.  Using a decision 
matrix, electrospinning was selected as the fabrication technique to pursue for BVM 
scaffold fabrication.  Section 2 will examine the process of electrospinning more closely 
by presenting a brief history, the physics involved, and some of the governing parameters 
of the fabrication technique.  Finally, section 3 concludes Chapter 2 by examining the 
electrospinning apparatus constructed in-house. 
 
 
 
 
Fabrication Method Selection 
 
 
 To choose the most appropriate method for BVM scaffold fabrication in-house at 
Cal Poly, candidate techniques were compared and a fabrication method was chosen 
using a decision matrix.  The decision matrix was based on both fabrication process and 
physical properties of scaffolds specific to the BVM.  The first aspect that methods were 
evaluated on was the controllability/reproducibility of the process.  Specifically, 
fabrication process inconsistencies were explored, such as resolution, final pore structure, 
and negative residual effects.  Second, fabrication methods were evaluated based on their 
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compatibility with a variety of materials; the more materials a process was compatible 
with, the higher it scored.  Third, pore architecture was evaluated.  In this case, pore 
architecture included pore size, percent porosity, and pore interconnectivity.  Fourth, 
monetary cost of each method was taken into consideration; the higher the cost of a 
fabrication method, the lower it scored in the decision matrix.  Finally, extra points were 
awarded to methods that had other desirable traits that did not fit into one of the first four 
evaluation criterion.  
 A table summarizing key features of all fabrication methods is provided (Table 1), 
followed by a discussion of each aspect. 
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Table 1 ? Summary of Candidate Scaffold Fabrication Methods 
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Controllable and Consistent Final Structure 
  
 
 Any fabrication method used for manufacturing scaffolds for the BVM must be 
consistent and controllable; the final product should be predictably reproducible.  For 
example, pore architecture and mechanical properties should be consistent between 
scaffolds that are produced using identical processes. 
 SCPL has the lowest rating in this category because interstitial pore size, or the 
size of pores not formed by salt particles, and wall thickness have been difficult to control 
[79].  In addition, in SCPL scaffolds thicker than 2mm it is difficult to completely 
remove the salt from the center of the scaffold [79].  TIPS utilizes spinodal 
decomposition to produce an interconnected porous network, but the exact architecture of 
the pores is uncontrollable [58].  While exact architecture is still random, electrospinning 
offers a slightly more predictable outcome in that fiber diameter size is controllable [78].  
In addition, fiber alignment is possible, as opposed to random orientation, both by 
collection using a grounded rotating drum or a dual ring collection system that alters the 
electromagnetic field around the collector [80, 81].  Fiber mesh fabrication is similar to 
electrospinning; fiber diameter is controllable and different collection methods can be 
used to generate scaffolds with varying geometry [82].  However, fiber mesh scaffolds 
exhibit random orientation and a lack of interconnecting structure, preventing them from 
load bearing applications [83]. 
 Solid freeform fabrication methods excel as controllable processes because the 
porous structure of scaffolding is planned using computer aided design software prior to 
fabrication [84].  However, the individual SFF methods are not equal in this category.  
For example, the resolution of three dimensional printing is limited in several ways.  
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First, the nozzle size and position controller introduce limits on particle placement.  
Second, powder particle size limits the layer thickness to a minimum of 80-250 ?m.  
Also, internal unbound powder is difficult to remove from porous parts, resulting in a 
lower bound on pore size [58, 72].  However, these shortcomings of three-dimensional 
printing have been alleviated; Kim et al. utilized three dimensional printing for 
macroscopic part construction, and coupled the technique with particulate leaching to 
introduce microporosity into the construct [75].  In this manner, the resolution limit of 
three-dimensional printing was avoided while taking advantage of the macroscopic 
accuracy of the technique.  Similar to three-dimensional printing, selective laser sintering 
also has a lower bound on resolution and pore size due to powder particle size [58]. 
While three-dimensional printing, stereolithography, and selective laser sintering 
all offer a high degree of control, stereolithography is especially controllable because it is 
not limited in resolution by powder particle size, and the use of a laser curing system is 
more accurate than the liquid binder spraying system used in three-dimensional printing.  
Heat transfer and unintentional polymerization in the polymer bath do, however, limit the 
resolution of stereolithography [74]. 
The relative scoring of these techniques with regard to consistency and 
controllability is provided in the decision matrix (Figure 11).  
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Compatible with a Variety of Materials 
 
 
 The ability to fabricate scaffolds using a multitude of materials imparts flexibility 
into the morphological and mechanical properties attainable for the BVM.  Any 
restrictions on the materials compatible with a particular fabrication method limit the 
possibilities for scaffold production, and these limited methods should be considered after 
more versatile methods. 
 Fiber mesh scaffold fabrication, SCPL, TIPS, and electrospinning are all 
compatible with the traditional polyester biomaterials poly(L-lactic acid), poly(glycolic 
acid), poly(caprolactone), and copolymers of these three [49, 63, 65, 80, 82, 85-90].  
Solution preparation for these methods usually involves an organic solvent, but 
electrospinning and fiber mesh fabrication by melt spinning are also possible using a 
polymer melt, obviating the need for a solvent [59, 91].   
 Of the SFF techniques, stereolithography is the most limited fabrication method 
since it requires photopolymerizable biomaterials.  Examples of these materials include 
polyethylene glycol acrylate, polyethylene glycol methacrylate, polyvinyl alcohol and 
modified polysaccharides [72].  For this reason, stereolithography scored the lowest on 
the decision matrix in the ?Material Selection? category.  Three dimensional printing and 
SLS both require powdered biomaterials, which include the traditional polyesters, and 
even powdered ECM [92, 93].  However, suitable powdered material requires processing, 
so three dimensional printing and SLS score lower than all other methods besides 
stereolithography [70].  Furthermore, SLS powders must also be controlled for particle 
size (more processing), so SLS scores lower than three dimensional printing [58].  
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The relative scoring of these techniques with regard to material compatibility is 
provided in the decision matrix (Figure 11).  
 
 
Pore Architecture 
 
 
 Matsuda et al. reported the ideal pore size for vascular graft scaffolding as 15 to 
80 ?m [94].  This pore size is meant to support cellular attachment and migration through 
a scaffold, as well as vascularization of the tissue.  BVM scaffolding is unique because 
there is no need for cellular infiltration into or vascularization of the scaffold.  The only 
requirement is the ability to support a monolayer of endothelial cells.  As a result, 
fabrication methods that result in macroporous structures, or pores that are larger than 50 
?m and suited to influence macroscopic tissue formation and vascularization, are not 
necessary.  Of interest are microporous structures (< 50 ?m) that affect cellular 
attachment, migration, and proliferation [29].  Specifically, a porous structure that 
prevents cellular infiltration while supporting a monolayer of ECs is desired. 
In addition to pore size, another structural property called porosity, or the total 
volume of a scaffold that pores occupy, plays a role in cellular development.  High 
porosities allow greater cellular infiltration and vascularization, as well as nutrient, waste, 
and oxygen transport.  An important aspect of porosity is pore interconnectivity. Without 
interconnectivity between adjacent pores, increasing porosity does not result in the 
aforementioned transport benefits since interconnectivity results in paths from the 
scaffolding matrix to the surface.  Also, pores that are not connected to any other pores 
are voids that lower the mechanical strength of scaffolds [58].  An ideal value for 
 50 
porosity in the BVM is unknown at this time, but fluid transfer from the lumen through 
the scaffold wall must be possible. 
For SCPL and TIPS, pore sizes of 5 to 600 ?m and porosity values of up to 90% 
have been reported [84, 95].  SCPL is rated lower than TIPS because SCPL results in a  
random dispersion of pores can result in incomplete pore interconnectivity [96].  When 
processed correctly, TIPS scaffolds go through spinoidal decomposition and achieve 
100% pore interconnectivity [95].  This interconnectivity would allow for media transfer 
through the BVM scaffold, while low pore sizes could prevent EC infiltration.  In 
addition, research has shown that porous structure integrity of TIPS scaffolds is superior 
to SCPL scaffolds.  Cao et al. compared poly(lactic-co-glycolic acid) (PLGA) scaffolds 
produced by both SCPL and TIPS by examining in vitro degradation.  In vitro immersion 
in an aqueous environment showed PLGA scaffolds produced by SCPL went through 
more pronounced changes in volume than TIPS scaffolds.  SCPL scaffolds lost about 
15% of their total mass by week six, whereas no noticeable mass loss was reported for 
TIPS scaffolds.  Morpholigically, TIPS scaffolds showed some deformation of their 
walls, but an overall porous and interconnected structure after 4 weeks of in vitro testing.  
The porous structure of SCPL scaffolds had completely collapsed by week 4 [79].  This 
lack of integrity translates to a SCPL score lower than TIPS on the decision matrix, 
however both methods score relatively well due to the pore sizes attainable. 
Non-woven fiber mesh textile scaffolds exhibit fiber sizes with lower bounds of 
approximately 10-20 ?m, allowing for a fully interconnected porous structure; however, 
the pore sizes (>100 ?m) are too large to prevent EC infiltration if used in the BVM [82, 
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97-99].  Due to the large pore size, non-woven fiber mesh fabrication scores the lowest 
on the decision matrix. 
Scaffolds composed of sub-micron electrospun fibers are of interest since they 
can be permeable or impermeable to cellular infiltration depending on material selection 
or fiber size.  Electrospun collagen scaffolds with submicron fiber diameters have been 
shown to promote cellular infiltration and vascularization, while biodegradable polyester 
electrospun scaffolds with similar fiber morphologies and porosities prevented any 
infiltration [100].  Electrospun PCL scaffolds fabricated with varying fiber diameters and 
evaluated for cellular infiltration showed a correlation between larger fiber size and 
greater cellular infiltration since larger fibers resulted in larger pore sizes [101].  Kwon et 
al. demonstrated that reducing fiber diameter to 0.5 to 1 ?m created an impermeable 
scaffold surface that supported EC migration, proliferation, and growth [102].  As stated 
at the beginning of this section, this type of scaffold architecture is attractive since it 
encourages the formation of a monolayer of ECs, so electrospinning scores the highest on 
the decision matrix in the ?Pore Architecture? category.  
As explained earlier, the resolution of solid freeform fabrication methods is 
limited; due to this resolution limitation, pore size and porosity are limited.  Three-
dimensional printing does not have the resolution required to produce pores smaller than 
100 microns, and even stereolithography can only achieve pore sizes as small as 20 
microns [58, 74, 84].  These pore sizes are too large for use in the BVM, but SFF 
techniques can be combined with other fabrication techniques, such as SCPL, to produce 
suitable BVM scaffolds.   
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The relative scoring of all techniques with regard to porosity is provided in the 
decision matrix (Figure 11). 
 
 
Cost 
 
 
 The goal of the BVM is a high throughput, low cost model for intravascular 
device testing, so BVM scaffolding should be inexpensive to fabricate.  Methods of 
fabrication were evaluated for cost based primarily on the cost of required equipment.  
For example, fiber mesh scaffold fabrication requires an infusion system, a spinneret, and 
a collector.  In contrast, stereolithography requires more expensive equipment such as a 
laser, a computer control system, and a photopolymer receptacle [58].  Since the exact 
cost of each fabrication method is ultimately dependent upon the specific system used, 
methods were evaluated for cost relative to other methods. 
 The relative scoring of these techniques with regard to cost is provided in 
the decision matrix (Figure 11).  
 
 
Other 
 
 
 There are special aspects of certain fabrication methods that are important to 
consider when deciding on a final BVM scaffold fabrication method.  SCPL and TIPS 
both have the advantage of being simple compared to all other methods, and due to their 
simplicity both were awarded extra points [58, 84].  As mentioned in the Introduction, an 
 53 
important feature of electrospun fibers is their mimicry of the ECM.  Sub-micron fibers 
are beneficial for cell deposition and proliferation, similar to the function collagen plays 
in the ECM [103].  Also, the ability of electrospun scaffolds with small fiber diameters to 
act as an impermeable sieve to cells allows the creation of a BVM with a monolayer of 
EC on the scaffold surface.  Preventing EC infiltration saves cells and time, important 
inputs in the high throughput BVM.  For these benefits, electrospinning was given 
several extra points in the decision matrix (Figure 11). 
 
 
Decision Matrix and Fabrication Method Choice 
 
 
The summary of all candidate fabrication methods presented in Table 1 was used 
to help generate the decision matrix shown in Figure 11.  Both consistent/controllable 
final structure and pore architecture were considered paramount for BVM scaffolding, so 
there criteria were rated on a scale of 1 to 10, where a score of 1 was the worst and 10 the 
best.  A method that is uncontrollable and completely inconsistent, and produces 
scaffolds with no porous structure would receive a score of 1 in both categories.  Material 
selection and cost were rated on a scale of 1 to 5, with a score of 1 again corresponding to 
a technique inappropriate for BVM scaffolding and 5 with techniques that are desirable 
for BVM scaffolding fabrication.  Extra points were awarded in the ?Other? category for 
fabrication methods with desirable characteristics that did not fit in other categories.  
Scores were awarded based on personal opinion.
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Figure 11 ? The decision matrix used to determine the most desirable fabrication technique for 
producing BVM scaffolds was generated using the summary information shown in Table 1.
 55 
 According to the decision matrix, electrospinning emerged as the fabrication 
choice for BVM scaffolding.  This technique is inexpensive and can be performed in-
house at Cal Poly, and the resulting scaffolding can be made of many materials.  By 
changing process parameters, fibrous scaffolds with fiber diameters ranging from tens of 
microns to hundreds of nanometers can be consistently fabricated.  In addition, 
electrospun fibrous scaffolding can mimic the natural structure of ECM, and prevent EC 
infiltration into BVM scaffolding walls while supporting an endothelial monolayer on the 
lumen.  The next section will introduce electrospinning in more detail.
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Electrospinning Fundamentals 
 
 
Brief History of Electrospinning 
 
 
 In the late 19th century, Lord Rayleigh noticed disturbances in liquids placed in 
electric fields.  Later, liquids were observed to discharge in reaction to excess charge 
after metals had been tested for discharge based on their point geometry and material 
composition, and it was found that point discharge characteristics are independent of the 
kind of metal [104].  It was observed that eruption of liquid from a drop of water 
occurred when charged using a high potential.  Using glycerine in order to observe the 
effects of increased viscosity, threads formed from the drop surface and extended 15 mm 
toward ground before breaking up into individual droplets [105].  In 1934, the process of 
electrospinning was patented, but work pioneering the fundamentals behind the 
phenomenon did not begin until the 1960s with the work of Sir Geoffrey Taylor [106].  
Taylor furthered the understanding of electrified liquid jets with his calculation of the 
conical shape of the droplet where a jet may originate [107].  Interest in the process of 
electrospinning to produce nano and micro fibers, and to explain and quantify 
electrospinning phenomena, has only been seriously pursued since the 1990s [108]. 
 The following sections explain the dynamic electrospinning process, and look at 
four key parameters in the electrospinning process: applied voltage, solution 
concentration, volumetric flow rate, and gap distance. 
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Jet Dynamics 
 
 
 A droplet of polymeric solution from which a jet originates is stable largely due to 
surface tension.  When subjected to an electric field, ions form within the droplet and 
distribute on the surface.  This creates a repulsive force, and results in a droplet in the 
shape of a characteristic Taylor cone [107].  If the force is large enough, surface tension 
is overcome and a jet erupts from the droplet.  After a jet is established, ions carry excess 
electrical charge away from droplet, resulting in fewer surface charges on the droplet than 
the polymer jet.  Radial components of the Coulomb forces cause these ions to move to 
the surface of the jet, while the repulsive Coulomb forces between charges of like sign on 
the jet surface work against viscoelastic stress and cause jet elongation and thinning.  The 
surface charge density of the jet increases as it moves away from the drop, eventually 
causing a bending perturbation (Figure 12).  The bending perturbation grows outwards 
radially, resulting in an erratic, whipping jet known as a bending instability [78]. 
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Figure 12 - When surface charge density is large enough, charges will interact to cause 
the jet to move slightly off its axis, a feature known as a bending perturbation.  The bent 
section is forced downward and outward (FDownward), as well as upward (FUpward) and 
outward (FResultant) by charges above and below the region, respectively.  Due this 
repulsive Coulomb force, the bending perturbation grows, later becoming a three 
dimensional bending instability. [Fig. 5 from Reneker, D.H. et al.. ?Electrospinning jets 
and polymer nanofibers.? 2008 [78]] 
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 A bending instability is a growing, perturbed path of charged jet that forms as a 
three-dimensional coil carried downstream.  Continued forces from Coulomb repulsion 
causes the coil to increase in diameter as it travels further from the droplet, allowing the 
jet to elongate by large factors in a small region of space.  Surface charge density 
continues to increase as the jet approaches the collector, resulting in a second bending 
perturbation and subsequent bending instability within the first coil.  Smaller diameter 
bending instabilities form in this manner until the jet strikes the collector, or solidifies 
into a fiber.  Without the large amount of elongation in a small space that takes place 
because of the bending instabilities, kinetic energy would be required to keep the leading 
sections of the jet ahead of the following sections.  Instead, the electrical energy is used 
by the jet to elongate, decrease in diameter, and increase in surface area per unit mass of 
solution (Figure 13) [109].  
 60 
 
Figure 13 ? The path of an electrospinning jet is complicated, but not random.  The first 
bending instability coils outward, forming a conical flow path.  The second bending 
instability follows the coiled path of the first, coiling around its instantaneous path of 
travel.  The third bending instability forms in the same manner, coiling around the path of 
travel of the second bending instability, and also outward with the trajectory of the first 
bending instability. [Fig. 6 from Reneker, D.H. et al., ?Electrospinning jets and polymer 
nanofibers.? 2008 [78]] 
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Magnitude of the Applied Potential 
 
 
 As stated previously, at a low applied potential difference, surface charges and 
surface tension on a droplet act against each other, distorting the shape of the droplet into 
the characteristic Taylor cone.  Above a critical voltage, surface tension is overcome and 
a jet forms. With a low viscosity solution, the jet breaks apart into micro droplets due to 
surface tension, resulting in the process of electrospraying.  If the solution has a 
sufficiently high viscosity, the jet does not break apart and electrospinning results [110].   
 When electrospinning voltage is varied, but all other variables are kept constant, 
the surface charge density on the polymer jet changes, which affects the final morphology 
of the electrospun fibers.  Deitzel et al. found that above a certain potential difference 
between the needle and collector, bead defects began to form rapidly [111].  This is 
attributed to the capillary instability of polymer jets; surface tension within the cylindrical 
jet drives the formation of spheres, which have less surface free energy per unit volume 
than cylinders.  Excess surface charges carried with the jet create a strong elongational 
flow, and may either stabilize or destabilize the capillary instability [112].  This means 
either increasing or decreasing the magnitude of the applied voltage can decrease bead 
defect density, depending on the electrospinning system.  Bead defects are repeated at 
intervals, and the fibers that connect adjacent beads decrease in diameter as the bead 
density increases (Figure 14). 
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Figure 14 ? Capillary instabilities drove the formation of a bead-dominated electrospun 
fiber mat with small diameter connecting fibers (left, 243X).  Increasing the applied 
voltage decreased the bead defect density and increased the diameter of the connecting 
fibers (right, 256X). 
 
 
Polymer Solution Concentration 
 
 
 Surface tension and viscosity are directly related to polymer solution 
concentration (Figure 15).  This means solution concentration has a significant influence 
on the electrospinning process.  Low viscosity solutions show surface tension as the 
dominating factor, and concentrations below a threshold value will result in drops instead 
of fibers.  Higher concentrations that result in solutions with high viscosities can cause 
processing problems; polymer solution flow to the needle tip becomes difficult to control, 
and the cohesive nature of the viscoelastic solution resists jet elongation [111]. 
There is a range of concentrations that produces solutions with appropriate 
viscosity for fiber formation and easy processing.  Variation of solution concentration 
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within this range causes variation in final fiber morphology.  A power law relationship 
exists between fiber diameter and solution concentration, with higher concentrations 
correlating to larger fiber diameters [101, 111].  This is because higher solution 
concentration leads to higher viscosity, which resists jet elongation and thinning.  The 
exact exponent of the power relationship depends on the polymer/solvent system used in 
the electrospinning process [109].  
  
 
 
Figure 15 ? Increasing polymer concentration causes a simultaneous decrease in surface 
tension (red) and increase in viscosity (blue). [Fig. 6 from Deitzel et al., ?The effect of 
processing variables on the morphology of electrospun nanofibers and textiles.? 2001 
[111]] 
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Flow Rate Dependency 
 
 
 Volumetric flow of polymer solution into a charged Taylor cone affects the 
electrospinning process in two ways.  First, the rate must be tuned so that a stable Taylor 
cone is formed.  A low flow rate results in the formation of a vacuum in the needle, 
causing the Taylor cone to disappear and temporarily stop the electrospinning process.  
Conversely, high flow rates cause build up of solution at the needle tip.  Second, as flow 
rate increases, surface charge density decreases.  The rate of charge withdrawl into the 
solution is dependent upon the residence time of ions in contact with the needle, and at 
higher flow rates solution spends less time in contact with the needle [113].  Since 
surface charge density is the driving force behind electrospinning, and flow rate directly 
affects surface charge density, flow rate is an important parameter in the process. 
 
 
Gap Distance 
 
 
 Thompson et al. showed that distance from the charged Taylor cone to the 
collector and final fiber diameter follow a negative power relationship [114].  The 
increase in distance allowed bending instabilities and whipping action to elongate and 
decrease the diameter of the polymer jet.  However, gap distances that are too great have 
negative results.  Gap distance shares a negative exponential relationship with surface 
charge density, so when gap distance increases, surface charge density drops [113].  As 
distance between the charged solution and collector increases, the magnitude of the 
electric field between the two decreases, resulting in the formation of fewer charged ions.  
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This can cause the jet to fail to collect on the grounded collector, or introduce bead 
defects into collected fibers. 
 
 
The Electrospinning Apparatus 
 
 
 Following selection of electrospinning as the best technique to pursue in-house 
fabrication of BVM scaffolding, the next aim of this work was to implement the new 
method.  Previously, to the best of our knowledge, no electrospinning systems or research 
had been pursued on the Cal Poly campus.  An electrospinning device was constructed 
piece-wise from components supplied by various companies.  The final configured 
system is illustrated below in Figure 16.  The following sections describe the function of 
each component. 
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Figure 16 ? The electrospinning apparatus incorporates a high voltage power supply (A),  
a rotating/translating mandrel collection system (B) with dual speed control box (C), a 
syringe pump for polymer solution infusion (D), an external power supply (E), a dual 
switch array (F), an AC/DC power converter, and an isolation chamber (H). 
 
 
High Voltage Power Supply 
 
 
 The driving force behind the electrospinning phenomenon is a high potential 
difference between a polymer solution and a collection system.  A K7-30R high voltage 
power supply, from Matsusada Precision Inc., provided this driving force.  The K7-30R 
is capable of output voltages from 0 to 30,000 V at a current of 250 ?A with a ripple of 
only 150 mV.  The output voltage is controlled via an external power supply amplifier 
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ranging from 0 to 10 V, which will be explained later.  The polarity of the K7-30R is 
reversible, however the feature was unnecessary for the application presented in this 
thesis. 
 
 
Fiber Collection System 
 To produce tubular geometries of electrospun fibers, a rotating/translating 
mandrel collection system is used.  Machined and assembled by Custom Design and 
Fabrication (Richmond, Virginia), the collector has speed controls for rotation and 
translation of the metallic mandrel where the fibers are collected, as well as adjustable 
pitch for the swing arms (Figure 17).  By rotating continuously in one direction and 
translating back forth over a set distance, the electrospun fiber builds up a tubular 
geometry on the mandrel.    
 
 
 
Figure 17 ? Mandrel angular velocity (?mandrel) and translational velocity (vtranslation) were 
adjusted on the speed control box.  The translation distance (xtranslation) was set on a swing 
arm wheel attached to the collector. 
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Polymer Infusion System 
 
 
 High precision infusion of polymer into the electrospinning apparatus is 
performed with a KD Scientific Model 100 syringe pump, syringes, and metallic needles.  
The lead from the high voltage power source is attached to the needle while ground is 
connected to the collector (Figure 18).  As the polymer solution is pushed through the 
needle by the syringe pump at a controlled volumetric rate, the high potential difference 
between the needle and collector causes ion formation in the polymer solution, leading to 
the formation of a Taylor cone and subsequent polymer jet, as described earlier.  
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Figure 18 ? Polymer solution was injected through the needle from the syringe by force 
from the syringe pump (left).  The high voltage and grounding leads (red and green wires, 
respectively) from the high voltage power supply provided the electrostatic force 
necessary for electrospinning to occur. 
 
 
External Power Supply 
 
 
 The K7-30R high voltage power supply requires a separate DC power supply with 
a 1 to 10 V range to act as an amplifier for high voltage output.  The amplifying factor is 
3000.  This means a setting of 3 V on the external power supply correlates to a high 
voltage output of 9,000 V.  A Heathkit IP-2718 DC power supply provides the 
amplification. 
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Electrical Supply 
 
 
 Power from the laboratory where the electrospinner is housed comes from a wall 
receptacle at around 110 VAC.  Since the K7-30R high voltage power supply requires 24 
VDC at 1.3 A, a Kele PS5R-SC AC/DC transformer is used to convert the power.  A two 
switch array was also built to control power input into the high voltage power supply.  
One switch provides the K7-30R with 24 VDC at 1.3 A, and the other starts the high 
voltage output. 
 
 
Containment Chamber 
 
 
 Electrospun fibers have a tendency to settle not only on the collection surface, but 
also on any other surrounding surfaces because the fiber motion during bending 
instabilities is erratic.  To prevent material build up on the surrounding surfaces in the 
fume hood, a containment chamber was constructed using 1/8? and 1/4? thick transparent 
acrylic sheets.  The collector sits within the containment chamber, and the necessary 
wires pass through a small opening cut out of the corner of the front panel.  The front 
panel is attached only with adhesive tape, making it removable to allow access to the 
collector.  A small hole was drilled in the left wall panel to slide the needle through and 
into the chamber.  Four 1/4? diameter holes were drilled into the top of the back panel to 
allow solvent vapor to escape the containment chamber.  The entire chamber is placed in 
a fume hood to safely remove solvent vapor from the electrospinning process. 
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 Following successful construction of the electrospinning apparatus, the next step 
of this project was to use the system to create tubular polymer scaffolds. 
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3.  ELECTROSPINNING TRIAL EXPERIMENTS 
 
Introduction 
 
 
Chapter 2 explained how electrospinning may be an appropriate scaffold 
fabrication technique for use in the BVM.  The aim of the work in this chapter was to use 
the newly constructed electrospinning system to create polymer tubes through a series of 
Spin experiments.  The Spin experiments presented in this chapter served two important 
functions.  First, these experiments provided experience with and understanding of the in-
house electrospinning apparatus.  This included getting familiar with the various process 
parameters and how they affected the electrospun cylindrical constructs.  Second, the 
Spin series was used to determine an electrospinning protocol for a particular polymer, 
P(LLA-CL), that resulted in continuous, uniform fibers with diameters as close to the 
nanoscale as possible.  The resulting protocol was implemented for consistency studies 
that will be described in the next chapter. 
 
 
Methods and Results 
 
 
Methods and results from each Spin will be presented in the following manner; 
the purpose behind the experiment is explained, process parameters are specified, 
observations made during the process are given, microstructural construct images are 
included, and an explanation behind the resulting structure is provided.  Polymer 
solutions for all experiments in the Spin series varied in concentration, but the process for 
mixing and using it followed the Solution Mixing Protocol (see Appendix B).  The 
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selected polymer in all cases was P(LLA-CL) with a monomer to monomer molar ratio of 
90:10 (L-lactic acid to caprolactone) obtained from Lakeshore Biomaterials 
(Birmingham, Alabama).  This particular polymer was selected due to advice from Dr. 
Gene Boland (Tissue Genesis, Inc., Honolulu, HI; currently at Cardiovascular Innovation 
Institute, Louisville, KY) asserting that P(LLA-CL) was simple to electrospin and 
degradation rates could be tailored by changing the monomer to monomer molar ratio.  
The selected solvent in all cases was chloroform (99.8% min., BDH), also recommended 
by Dr. Boland based on its effectiveness and low cost.  All constructs were spun (see 
Appendix C), immediately removed from the collector, allowed to sit in a desiccator for 
24 hours, sputter coated with gold, and examined using a scanning electron microscope 
(SEM).  The interior surface (surface that contacted the mandrel collector) of all 
constructs was examined, and some constructs had other surfaces (exterior or cross-
sectional) examined as well.  All SEM pictures were taken at random locations on the 
indicated scaffold surfaces. 
Probable explanations are presented for the variations noticed between spins, but 
flawless theoretical explanation was not the purpose of the Spin series.  It is simply 
worthwhile to use knowledge gained from literature to try to explain the science behind 
changes in morphology. 
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Spin #1     
 
 
Purpose: 
 
These initial process parameters were recommended by Dr. Gene Boland.   
 
SOLUTION:    5.3% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18G needle 
APPLIED VOLTAGE: 16.5 kV 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
The solution droplet originating at the needle tip grew over time until it was a 1 cm long 
cylindrical shaped mass hanging vertically from the needle tip. 
 
SEM Imaging: 
 
 
Figure 19 ? The interior surface of the cylindrical scaffold from Spin #1 shows beads 
that are 15 to 20 ?m in diameter (black lines) and fibers that connect the beads with 
diameters of hundreds of nanometers to several microns (black arrows). (1013x) 
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Spin #1 resulted in bead-on-fiber defects with a large ratio of polymer contained 
in the beads.  As shown in Figure 19, the fiber diameters ranged in size from hundreds of 
nanometers to several microns.  Spherical bead diameters were an order of magnitude 
larger than fiber diameters.  Some of the beads flattened, which likely resulted from 
insufficient solvent evaporation upon striking the collector. 
 
 
 
 
Spin #2 
 
 
Purpose: 
 
This experiment looked at the effects of decreasing gap distance on the 
electrospinning product.  The decrease in gap distance should have increased the electric 
field strength between needle tip and collector, and also restricted the space available for 
polymer jet bending instability formation. 
SOLUTION:    5.3% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18G needle 
APPLIED VOLTAGE: 16.5 kV 
GAP DISTANCE:  5 in 
 
 
Process Observations: 
 
After 1.6 ml of solution had been spun, the droplet had formed a partially 
solidified polymer mass stretching the needle tip to within 1 in of the collector.  The 
process was stopped, the mass was removed, and then the process was restarted.   
The stretched mass returned after 2.3 ml of solution had been spun, but the 
process was not stopped. 
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The Taylor cone had moved away from the needle tip by approximately 1 cm by 
the end of the process. 
Cross-sectional thickness of the product from Spin #2 was greater than Spin #1. 
 
SEM Imaging: 
 
 
Figure 20 ? The interior surface of Spin #2 appeared to be a fused, solid surface with 
very little porosity and no visible fibers. (56x) 
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Figure 21 ? The exterior surface of Spin #2 was comprised of a bead-on-fiber defect 
morphology. (346x) 
 
 
 
 
Looking at the interior surface of Spin #2 (Figure 20), the nearly flat surface 
could have been caused by electrosprayed droplets fusing together on the collector 
surface, indicating an incorrect accelerating voltage or low solution concentration.  The 
flat, fused surface could also have been caused by electrospinning of either uniform fibers 
or bead-on-fiber fibers that did not reach the bending instability phase that causes 
extensive solvent evaporation, thus resulting in viscous fibers that fused together on 
contacting the collector surface.   
The outside surface of Spin #3 (Figure 21), however, shows the same bead-on-
fiber morphology as Spin #1 (Figure 19).  This is strange behavior, but may be explained 
by the movement of the Taylor cone away from the needle tip.  Since the solution had to 
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travel 1 cm in open air before erupting through the Taylor cone, evaporation of the 
solvent could have caused an increase in solution concentration.  If the process started out 
as electrospraying, an increase in solution concentration would explain why the process 
ended as electrospinning.  If the process was electrospinning throughout, an unintended 
change in concentration could have changed the distance the jet had to travel before the 
start of bending instabilities, resulting in solidified fibers that did not fuse together. 
For electrospun BVM scaffolding, the interior surface should be composed of 
continuous fibers free of bead defects [89].  Further Spin experiments attempted to 
fabricate continuous fiber scaffolds. 
 
 
 
 
Spin #3 
 
 
Purpose:  
 
The gap distance of Spin #3 was changed to 15 in to examine the effects of 
increased gap distance.  This should have weakened the electric field while allowing 
more room for bending instabilities to form. 
SOLUTION:    5.3% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18G needle 
APPLIED VOLTAGE: 16.5 kV 
GAP DISTANCE:  15 in 
 
 
Process Observations: 
 
The Taylor cone stayed close to the needle tip the entire time, but a silken thread 
of polymer 1 in long formed and was hanging from the needle tip by the end of the 
process. 
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There was noticeable build up on the containment chamber walls. 
Cross-sectional thickness of this spin was less than Spin #1. 
 
SEM Imaging: 
 
 
Figure 22 ? The interior surface of Spin #3 shows a bead-on-fiber morphology with bead 
diameters (black lines) similar to those of Spin #1 (Figure 19).  Fiber diameters do not 
appear to rise above 1 micron. (1886x)  
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Figure 23 ? A cross-sectional view of Spin #3 shows a structure formed predominately 
of beads. 
 
 
 
 
The interior surface of Spin #3 (Figure 22) showed fewer flattened beads than 
Spin #1, but the bead-on-fiber morphology remained the same.  The bead connecting 
fibers may have slightly smaller diameters, indicating continued elongation made 
possible by the increase in gap distance.  The reduction in the appearance of flattened 
beads is probably due to the extra distance the jet had to travel.  Most of the beads had 
enough time to have the solvent completely diffuse out.  Only the larger beads deformed 
upon impact with the collector because not all the solvent was able to diffuse out.   
A cross-sectional examination of this spin (Figure 23) reveals a consistent 
structure throughout, as opposed to the drastic difference seen in the structure of Spin #2.  
This may be explained by the location of the Taylor cone.  Since the Taylor cone stayed 
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close to the needle tip, the solution concentration stayed constant, resulting in a uniform 
structure.  The cross-sectional thickness was also less, indicating that less solution ended 
up actually striking the collector.  Akin to this, the walls of the containment chamber had 
noticeable build up on them.  Two explanations for the build up on the chamber walls are 
probable.  First, the decrease in the electric field may explain this; surface charge causes 
jet elongation and bending instability, but the electric field attracts the jet towards the 
collector.  A weaker field may have caused the jet to stray from the needle-to-collector 
path and strike other surfaces, including the containment chamber walls.  Second, the 
deviation of the jet from the straight line path from needle tip to collector caused by the 
expanding radius of the conical bending instabilities may have increased to the point that 
the jet struck the chamber walls before reaching the collector. 
The formation of silken threads on the needle tip were probably the result of the 
electrospinning process stopping and starting intermittently as a consequence of the 
increased gap distance.  The extra distance the jet had to travel might have allowed more 
opportunities for the jet to break apart between the beads, stopping the electrospinning 
process for a short time.  Silken fibers would be the remnants of broken jets.   
 
 
 
 
Spin #4     
 
 
Purpose: 
 
Generally, decreasing the applied voltage should decrease the surface charge 
density on the polymer jet, decreasing elongational flow and affecting capillary instability 
in either a positive (decrease in the occurrence of beads) or negative (increase in the 
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occurrence of beads) manner.  The purpose of this experiment was to decrease the 
applied voltage to observe if bead defect density increased or decreased.  The needle was 
also changed to a smaller internal diameter for the remainder of the Spins. 
SOLUTION:    5.3% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 27G needle 
APPLIED VOLTAGE: 13 kV 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
After 2.0 ml of solution had been spun, the polymer mass had formed again and 
the Taylor cone and jet were based at the tip of the mass.  The needle was not cleaned. 
 
SEM Imaging:  
 
 
Figure 24 ? This interior surface image of Spin #4 shows a bead-on-fiber morphology 
similar to the interior surface of Spin #1 (Figure 19).  Black lines show designate the 
diameter of selected beads, while black arrows mark the diameter of selected fibers. 
(989x) 
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Figure 25 ? Bead defect density significantly decreased on the exterior surface of Spin 
#4 compared to the interior surface (Figure 24) as shown above.  This structure was 
observed on the exterior of Spin #2 as well (Figure 21). (329x) 
 
 
 
The main purpose of Spin #4 was to test the effects of decreasing the applied 
voltage, but since the needle size was changed from 18G to 27G as well, the results are 
mostly inconclusive.  The smaller needle diameter was used in subsequent spins, so more 
conclusions can be made from later experiments. 
The lumen of this construct looks similar to that of Spin #1, with a large amount 
of polymer contained in bead defects connected by small diameter fibers (Figure 24).  
During the electrospinning process, the Taylor cone moved away from the needle tip, 
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which may explain the fiber dominated exterior surface of the construct (Figure 25) in the 
same manner as Spin #2 (Figure 21). 
 
 
 
 
Spin #5 
 
 
Purpose: 
 
This experiment attempted to increase the applied voltage to observe the effects on the 
final morphology of the construct. 
 
SOLUTION:    5.3% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 27G needle 
APPLIED VOLTAGE: 25 kV 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
Shortly after the process was started the external amplifying power supply started 
making a clicking noise.  The process was stopped immediately. 
The external amplifying power supply was examined to discover what 
malfunctioned.  The fuse was not blown, but the output would not change from 30 V (the 
max output of the power supply).  This means the voltage regulating device within the 
power supply was damaged.  An alternate external amplifying source would need to be 
obtained. 
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Spin #6 
 
 
Purpose: 
 
A temporary external amplifying power source was located that provided a set 
voltage of 5 V at 1.5 A, equating to a high output voltage of 15 kV.  Until another 
variable external power supply could be located, the series of experiments looking at 
varying applied voltage was put on hold.  Spin #6 experiment looked at the effect of 
increasing the solution concentration. 
 
SOLUTION:    7.8% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 27 gauge needle 
APPLIED VOLTAGE: 15 kV (channel set at 5 V, 1.5 A) 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
The droplet grew downward as the process continued until it reached 2 cm long, 
at which time 3 ml of solution had been used and the process ended.  The Taylor cone 
was located near the needle tip during the entire process. 
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SEM Imaging: 
 
 
Figure 26 ? Continuous fibers were present on the interior surface of Spin #6 shown 
above, but fiber diameter appears to be distributed over a range (<1 to 5 ?m) as indicated 
by the measured fibers (black lines and arrows).  Periodic large-diameter sections 
characteristic of capillary instability are present as well (top left). (769x) 
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Figure 27 ? The exterior surface of Spin #6 appeared similar to the interior surface 
(Figure 26), but fiber diameter distribution was tighter.  The thick sections characteristic 
of capillary instability were still present (top middle).  The diameters of three random 
fibers are shown above (black lines). (1315x) 
 
 
 
 
With this experiment, continuous fiber morphology was achieved for the first 
time.  This success was likely due to the increase in solution concentration.  The variation 
in fiber diameter seen on the interior surface (Figure 26) might have been due to jet 
behavior at start-up, prior to the formation of a completely stable jet.  On the exterior 
surface (Figure 27), fiber diameter is more uniform, indicating that the jet had changed 
somehow by the end of the process.  Both surfaces have periodic larger diameter sections 
of fiber indicative of capillary instability.   
Since the external power source had to be switched, the applied voltage was 
varied in addition to the solution concentration.  But, although inconclusive due to the 
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variation in applied voltage, this experiment demonstrated the probable importance of 
solution concentration on the final structure of the P(LLA-CL) electrospun constructs.   
 
 
 
 
Spin #7 
 
 
Purpose: 
 
Since Spin #6 resulted in continuous fibers with a small defect presence, the 
effects of an even higher polymer weight percentage solution were investigated in Spin 
#7. 
SOLUTION:    10.1% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 27/18* gauge 
needle 
APPLIED VOLTAGE: 15 kV (channel set at 5 V, 1.5 A) 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
Similar to the previous spin, the droplet grew while the Taylor cone stayed near 
the needle tip. 
The droplet grew faster during this spin. 
*After 1.25 ml of solution had been spun, the syringe pump?s release switch 
engaged, indicating the pump could not provide enough force to feed the solution through 
the needle. 
*The 27 gauge needle was replaced with an 18 gauge needle. 
The droplet did not grow after the needle was replaced, and the spin finished 
without complications. 
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SEM Imaging: 
 
 
Figure 28 ? Spin #7 appeared to have greater variation among fiber diameters than Spin 
#6 (Figure 26).  Several of the larger fibers were measured (black lines), but sub-micron 
fibers were prevalent as well. (773x) 
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Figure 29 ? Variation of fiber diameter decreased by the end of the process, evidenced 
by this figure showing the exterior surface of Spin #7.  Three random fiber diameters are 
shown above (black lines).  Sub-micron fibers were not present on the exterior surface. 
(1321x) 
 
 
 
 
Similar to Spin #6, the interior surface of Spin #7 contained fibers with varying 
diameters (Figure 28).  At first approximation, it appears that the variation of fiber 
diameter was greater than that of Spin #6 (Figure 26).  It also appears that fiber diameter 
on the interior surface stayed the same between Spins #6 and #7.  Increasing the solution 
concentration should have increased the average fiber diameter, but in this case it resulted 
in a larger distribution of fiber sizes.  This result went unexplained in terms of 
controllable variables.  Other undocumented variables could have been responsible such 
as temperature, humidity, and age of the polymer solution.   
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An unexpected complication with the syringe pump and needle required a switch 
to a larger diameter needle during the process.  This lead to the unintended discovery that 
switching to a larger needle may have produced more uniform fibers with slightly larger 
fiber diameters on the exterior surface (Figure 29).   
 
 
 
 
Spin #8 
 
 
Purpose: 
 
With previous spins, it was discovered that increasing the solution concentration 
resulted in continuous fibers.  Also, increased viscosity caused by the increase in solution 
concentration restricted the needle size to 18G.  This experiment tested a solution 
concentration in between the concentrations used in Spin #6 and #7 while using the larger 
diameter needle to see if variability of fiber diameter could be reduced.   
 
SOLUTION:    9.0% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18 gauge needle 
APPLIED VOLTAGE: 15 kV (channel set at 5 V, 1.5 A) 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
Using a flashlight, it was possible to see the onset of the first bending instability 
approximately 4 inches from the needle tip. 
By the end of the process, a small mass of polymer was hanging from the needle 
tip, but the Taylor cone never shifted position. 
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SEM Analysis: 
 
  
Figure 30 ? Fiber diameters from the interior surface of Spin #8 varied (black lines), but 
the distribution appeared tighter than the interior surfaces of Spin #6 (Figure 26) and Spin 
#7 (Figure 28). (700x) 
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Figure 31 ? The exterior surface of Spin #8 showed continuous fibers with slightly 
smaller diameters (black lines) than those of the interior surface. (688x)   
 
 
 
 
The interior surface of Spin #8 was composed of uniform fibers with less 
variation in diameter (Figure 30), similar to that of the exterior surface of Spin #7.  
Average fiber diameter looked to have decreased slightly by the end of the process, 
although this observation was a first approximation based on the appearance of the 
exterior surface image (Figure 31).  This structure was deemed appropriate for the 
consistency study, although the fiber size was larger than desired.  Further experiments 
were conducted in an attempt to reduce fiber diameter. 
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Spin #9 
 
 
Purpose: 
 
Continuous fibers were first produced after increasing the solution concentration and 
switching to an external power source set at 5 V, 1.5 A.  The current from the alternate 
external power source increased from approximately 0.2 A in early experiments to 1.5 A 
for experiments that yielded fibrous structures, so it may have been this equipment switch 
that resulted in a fibrous structure as opposed to the increase in solution concentration.  
Spin #9 recreated Spin #1 using the new external amplifying power source to see if a 
fibrous structure resulted. 
SOLUTION:    5.3% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18 gauge needle 
APPLIED VOLTAGE: 15 kV (channel set at 5 V, 1.5 A) 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
No complications were observed during this spin. 
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SEM Analysis: 
 
 
Figure 32 ? Bead-on-fiber defects were still present on the interior surface of Spin #9 
despite using the alternate external power source. (1032x) 
 
The external power source was simply an amplifier used to control the output 
from the high voltage power source, and this was accomplished by varying voltage, not 
current.  In other words, the current from the external source should have had no effect on 
the final morphology of the construct.  The interior surface of the construct from this trial 
(Figure 32) consists of a similar bead-on-fiber morphology as Spin #1 (Figure 19).  From 
this experiment, it was concluded that increasing solution concentration resulted in a 
continuous fiber morphology, not the change in external amplifying power source. 
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Spin #10 
 
 
Purpose: 
 
By increasing the gap distance on Spin #6, it appeared that bead-connecting fibers 
had decreased in diameter.  This experiment followed Spin #6, but gap distance was 
increased in an attempt to decrease fiber diameter. 
SOLUTION:    7.8% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18 gauge needle 
APPLIED VOLTAGE: 15 kV (channel set at 5 V, 1.5 A) 
GAP DISTANCE:  15 in 
 
 
Process Observations: 
 
There were no complications during the spin, including no build up of polymer on 
the needle tip. 
After the spin, a large amount of polymer coated the containment chamber walls 
and the plastic frame of the collector. 
SEM sample preparation was more difficult than normal because the constructs 
tore easily. 
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SEM Analysis: 
 
 
Figure 33 ? As expected, increasing the gap distance decreased the average diameter of 
the fibers on the interior surface of Spin #10 (black lines). (688x) 
 
 
 
 
Although thinner fibers resulted from increasing the gap distance (Figure 33), less 
fiber collected on the mandrel, resulting in fragile constructs that tended to rip apart 
during SEM sample preparation.  A more robust construct might be produced by allowing 
the process to continue until 6 ml of polymer solution is spun.  The tradeoff is the 
increased time and expense associated with scaffold production.  Therefore, increased 
gap distance was not pursued as a method of reducing the average fiber diameter.   
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Spin #11 
 
 
Purpose: 
 
This experiment explored a completely new set of parameters used by X.M. Mo et al 
[89].  Fibers with diameters around 600 nanometers were fabricated with these 
parameters, which more closely mimics the size of ECM collagen. 
 
 
SOLUTION:    5.3% by weight P(LLA-CL) in chloroform 
FLOW RATE:   2 ml/hr (3 ml of solution used) through 27 gauge needle 
APPLIED VOLTAGE: 12 kV  
GAP DISTANCE:  15 in 
 
 
Process Observations: 
 
The process had to be stopped several times so the needle tip could be cleaned 
due to polymer build up.  Cleaning was necessary because no Taylor cone issued from 
the mass of polymer at the needle tip. 
 
 
 
 
 
 
 
 
 
 
 
 
 99 
SEM Analysis: 
 
 
Figure 34 ? The interior surface of Spin #11 was almost completely void of fibers.  The 
process appears to have been electrospraying, not electrospinning. (1035x) 
 
 
 
 
Attempting to recreate the experiment performed by Mo et al. failed to produce a 
uniform fiber morphology (Figure 34).  The familiar bead-on-fiber morphology resulted, 
with the beads less densely packed than in past experiments.  There are several reasons 
this experiment failed to recreate electrospun fibers made by Mo et al.  First, the polymer 
used in the established study was 75:25 P(LLA-CL), and despite its similarity to the 
90:10 P(LLA-CL) used in the Spin series, the 75:25 required different parameters for a 
successful spin.  Second, the 75:25 P(LLA-CL) was dissolved in acetone, not chloroform.  
Different solvents have inherently different properties, which will affect the final 
structure of electrospun constructs.  Third, a flat, aluminum collector was used by Mo et 
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al. instead of a rotating mandrel.  The electric fields created by collectors varies based on 
their geometry, and influences jet dynamics. 
Results from this spin were disappointing, so later experiments were conducted 
that altered the parameters used in Spin #8 in order to fabricate continuous fiber scaffolds 
while trying to mimimize fiber diameter. 
 
 
 
 
Spin #12 
 
 
Purpose: 
 
This experiment was the start of a series of trials that attempted to find the lowest 
solution concentration that would result in a continuous fiber morphology.  In this 
manner, fiber size could theoretically be decreased and P(LLA-CL) resin could be 
conserved during future studies.  Spin #6 with a lower solution concentration was the 
basis for this experiment. 
 
SOLUTION:    7.0% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18 gauge needle 
APPLIED VOLTAGE: 15 kV 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
No complications were observed during the process. 
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SEM Analysis:  
 
 
Figure 35 ? The interior surface of Spin #12 consisted of a bead-on-fiber morphology 
with most of the beads slightly elongated. (464x) 
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Figure 36 ? Overall structure changed by the exterior surface of Spin #12 to a more 
fibrous morphology.  Beads are still present, but comprise much less of the structure than 
the interior surface (Figure 35). (244x) 
 
 
 
 
Spin #6, which used a solution concentration of 7.8% by weight polymer, resulted 
in continuous fibers (Figure 26), but this spin, which used a 7.0% solution, did not 
(Figure 35).  This revealed that for this particular set of parameters (gap distance, applied 
voltage, flow rate, and needle size) there was a threshold solution concentration that 
would increase viscosity and decrease surface tension enough that continuous electrospun 
fibers would result.  The next logical step in the process was to increase the solution 
concentration slightly to find this threshold concentration.   
Similar to earlier trial experiments, the exterior structure was more fibrous than 
the interior (Figure 36).  No movement of the Taylor cone was noted during the spinning 
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process, so there was another variable at work that caused the structure to change.  The 
interior structure may have had a greater presence of bead-on-fiber defects because it was 
created directly after the jet was formed.  At this time, the full potential of the applied 
voltage to create surface charges may not have been realized.  The lack of surface charge 
could have allowed capillary instability to cause the jet to form the bead-on-fiber 
structure. 
 
 
 
 
Spin #13 
 
 
Purpose: 
 
Solution concentration was increased slightly in an attempt to find the threshold 
concentration that would produce a continuous fiber morphology. 
 
SOLUTION:    7.4% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18 gauge needle 
APPLIED VOLTAGE: 15 kV 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
No complications were observed during the process. 
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SEM Analysis: 
 
 
Figure 37 ? The beads elongated on the interior surface of Spin #13 as compared to Spin 
#12 (Figure 35), but continuous fibers were not produced. (484x) 
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Figure 38 ? The exterior surface of Spin #13 also showed a bead-on-fiber morphology. 
(481x) 
 
 
 
 
The increased solution concentration of this trial resulted in a more fibrous 
structure, but bead defects were still present (Figure 37).  Interestingly, the exterior 
surface morphology was the same as that of the interior surface (Figure 38).  This was 
different behavior than Spin #12, and may be explained by a slightly different start-up 
procedure that resulted in quicker establishment of a fully charged jet.  Specifically, the 
electrospinning apparatus was supplied with power, the external amplifier, and the high 
voltage power supply were all turned on within 5 seconds of each other.  In past 
experiments, no attempt was made to start the process in this manner. 
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Spin #14 
 
 
Purpose: 
 
Spin #14 tested a slightly increased solution concentration to continue the search 
for a threshold concentration. 
SOLUTION:    7.6% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18 gauge needle 
APPLIED VOLTAGE: 15 kV 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
Polymer built up at the needle tip at the beginning of the spin.  The process was 
stopped after 0.5 ml was spun, the needle was cleaned, and the process was restarted. 
 
SEM Analysis: 
 
 
Figure 39 ? Beads on the interior surface of Spin #14 were elongated similar to those on 
the interior surface of Spin #13 (Figure 37). (470x) 
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Figure 40 ? The exterior surface of Spin #14 consisted of uniform fibers. (489x) 
 
 
 
 
 
Bead defects on the interior surface of this trial elongated slightly compared to 
Spin #13 (Figure 39).   By the end of the process, the morphology was again different 
from the interior surface (Figure 40), similar to Spin #12 (Figure 36).  Since the exact 
start-up procedure was not recorded for this or any previous experiment, it cannot be 
determined if start-up sequence played a role in the change in structure.  For the 
consistency study, the start-up procedure was the same for all spins to eliminate this as a 
source of variability. 
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Spin #15 
 
 
Purpose: 
 
By this time, enough trials had been conducted that the electrospinning process 
was familiar.  Although nano-sized uniform fibers were not produced, a suitable structure 
for the consistency study had been fabricated (Spin #8).  This experiment was a repeat of 
Spin #8 with a set start-up procedure. 
SOLUTION:    9.0% by weight P(LLA-CL) in chloroform 
FLOW RATE:   6 ml/hr (3 ml of solution used) through 18 gauge needle 
APPLIED VOLTAGE: 15 kV (channel set at 5 V, 1.5 A) 
GAP DISTANCE:  10 in 
 
 
Process Observations: 
 
After 1.7 ml of solution had been spun, polymer build-up started to appear and 
hang from the needle tip, but the Taylor cone appeared unaffected.  The needle tip was 
not cleaned because the consistency study protocol called for an uninterrupted process, 
and this spin was used as a consistency study trial.   
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SEM Analysis: 
 
 
Figure 41 ? Fiber diameter sizes from the interior surface of Spin #15 (black lines) were 
similar to sizes seen from Spin #8 (Figure 30). (682x) 
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Figure 42 ? Fiber size on the exterior surface of Spin #15 was slightly smaller than 
interior surface fibers. 
 
 
 
 
Implementing an electrospinning start-up protocol produced an interior surface 
with less variability in fiber diameter (Figure 41).  However, fiber sizes on the interior 
surface were slightly larger than fiber sizes on the exterior surface (Figure 42).  The 
reason for this morphological discrepancy is unknown, but somehow the process changed 
from the start to the finish of the spin.  Exploring this phenomenon was not the purpose 
of this work, and the interior surface of Spin #15 was appropriate for the consistency 
study. 
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Discussion 
 
 
 Overall, these 15 trial spins met the goals stated at the beginning of this chapter.  
After gaining an understanding for how electrospinning parameters affect fiber 
morphology, a protocol was established to fabricate scaffolds composed of continuous 
diameter fibers (see Appendix C).  The trial spins explored parameters such as applied 
voltage, solution concentration, gap distance, and needle size.  In general it was noted 
that concentration of the P(LLA-CL) solution had the most effect on fiber diameter; the 
higher the concentration, the larger the fiber diameter would be.  In addition, below a 
certain solution concentration (~7% by weight 90:10 P(LLA-CL) in chloroform), the 
process becomes more like electrospraying than electrospinning.  Increasing the applied 
voltage appeared to slightly decrease the average fiber diameter, as did decreasing the 
needle diameter.  Increasing gap distance also resulted in a decrease in fiber diameter, but 
less polymer collected on the grounded mandrel. 
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4.  ELECTROSPINNING CONSISTENCY STUDY 
 
 
Introduction 
 
 
In order for electrospun scaffolds to be a viable replacement for ePTFE, they must 
meet qualifications which include the following: biologically acceptable, mechanically 
appropriate, lower cost than ePTFE, and producible in a high throughput manner.  The 
fourth qualification, high throughput, involves the speed and ease with which the 
scaffolds are produced.  In the case of the electrospun scaffolds, in-house production 
allows for quick manufacturing time and the process itself is relatively simple.  However, 
high throughput scaffolds are inappropriate if there is not at least some level of 
consistency between scaffolds produced with the same controllable parameters.  It is with 
this in mind that the same spinning parameters were used to manufacture multiple 
scaffolds to establish consistency data.  Consistency was examined by looking at fiber 
diameter size, wall thickness, and Young?s modulus of individual spins.  Porosity testing 
was initially intended, but lack of a suitable method dictated that no porosity data be 
included in consistency evaluations.  See Appendix D for the method originally intended 
to collect porosity measurement. 
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Methods 
 
 
Electrospinning Parameters for the Consistency Study 
 
 
 All consistency study scaffolds were fabricated using the electrospinning 
parameters shown below and the electrospinning protocol in Appendix C.  A total of 11 
spins were performed using this protocol.   
 
Polymer:  9.0wt% P(LLA-CL) in chloroform 
Feed Rate:  6ml/hr, using a total of 3ml per spin 
Needle:  18 gauge, beveled, blunt (BD 305180) 
Gap:   10 in 
Voltage:  15000V (external source set to 5V) 
Translate: Distance set at 16cm, speed set at 2 
Rotate:  Speed set at 6 
 
 
 After fabrication, scaffolds were placed in a desiccator for at least 24 hours to 
remove residual solvent.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 114 
Sampling Method 
 
 
 After desiccation, all spins were sectioned as shown below (Figure 43).  Sections 
were cut while the scaffold was on the mandrel using a No. 11 razor blade. 
 
 
 
Figure 43 - Individual scaffolds fabricated in the consistency study were all sectioned for 
examination in a similar manner.  Section A represented the area of the scaffold furthest 
away from the collector?s rotation motor, while section D was always the area of the 
scaffold closest to the collector?s rotation motor. 
 
 
 
 
Fiber Measurement 
 
 
 The diameter of electrospun fibers can be used to characterize the electrospinning 
process [80], and this study used fiber diameter to evaluate the morphological 
consistency of the in-house electrospinning process. 
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Fiber Measurement Method 
 
 
 For each scaffold, fiber diameter measurement sections A, B, C, and D (Figure 
43) were mounted with luminal surfaces up on SEM sample stages using adhesive 
graphite tape and sputter coated with gold using a Pelco Model 3 Sputter Coater.  All 
sections were imaged using an FEI Model 200 Scanning Electron Microscope at 
approximately 700x magnification.  Three random locations were selected on each 
section and imaged for fiber diameter analysis.  To choose the fibers to be measured, a 
fixed fiber selection mask was applied to each image, resulting in 9 measurements per 
image (Figure 44).  This resulted in 27 fiber diameter measurements per section, and 108 
measurements per scaffold.  Measurements were made using ImageJ 1.41o image 
analysis software (National Institutes of Health, USA).  All images and collected fiber 
size measurements are compiled in Appendix E.  
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Figure 44 ? All fiber diameter measurement images appeared similar to this figure.  The 
nine circles were the fixed fiber selection mask used to pick individual fibers to measure.  
Fibers closest to the center of the circles had their diameters measured and recorded for 
analysis. 
 
 
Thickness Measurement 
 
 
 Scaffold wall thickness was also measured to evaluate the consistency of the 
electrospinning process.  Wall thickness is important because different thicknesses equate 
to different mechanical responses; thicker scaffolds will be less compliant than scaffolds 
with thinner walls.  In addition, accurate tensile testing requires careful measurement of 
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sample wall thickness.  Values for sample thickness were obtained from cross-sectional 
images of the cylindrical scaffolds by the method described in the next section. 
 
 
Thickness Measurement Method 
 
 
 Each scaffold was measured for thickness at 6 different locations (Figure 45).  
Samples were prepared in the same manner as the fiber measurement samples, including 
mounting on SEM stages and sputter coating with gold.  The FEI Model 200 Scanning 
Electron Microscope was used to capture images of wall thickness at approximately 20x 
magnification (Figure 46).  Twelve thickness measurements were made for each image at 
locations corresponding to numbers on a clock (1 o?clock, 2 o?clock, etc.) using the 
ImageJ 1.41o image analysis software.  All images and collected thickness measurements 
are compiled in Appendix F. 
 
 
 
Figure 45 ? Six cross-sectional surface thicknesses were measured (A1, B1, B2, C1, C2, 
and D1).  Tensile testing sample thicknesses were calculated by averaging the thicknesses 
of the cross sectional surfaces on either end of the tensile testing sample. 
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Figure 46 - All images acquired for cross-sectional thickness analysis appeared similar to 
this picture.  Thickness measurements (t) were made perpendicularly from the interior 
surface to the exterior surface of each scaffold at 12 separate locations. 
 
 
 
Tensile Testing 
 
 
 Uniaxial tensile testing was performed on the consistency study spins to evaluate 
the similarity of the mechanical responses.  Young?s modulus was the property 
investigated for two reasons.  First, Young?s modulus is easily obtained from a stress 
versus strain plot.  Second, in a pulsing BVM system, compliant scaffolding would 
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ideally stretch circumferentially, then return to its original dimensions.  This denotes 
stress in the linear elastic region of the scaffolding material, characterized by Young?s 
modulus.  Thus, it is Young?s modulus, not other parameters such as ultimate tensile 
strength that is of interest in this study. 
 Accurate tensile testing requires careful measurement of sample thickness.  Since 
cross-sectional thicknesses of the consistency spins varied, individually estimating the 
thickness for each tensile testing sample was necessary, as opposed to using an average 
value pooled from all thickness measurements.  By averaging the two thicknesses 
measured at the ends of each tensile testing sample, an estimate for thickness appropriate 
for calculating stress in the tensile testing sample was obtained.  For example, thickness 
for the tensile testing sample between sections A and B was calculated as the average 
thickness between cross-sections A1 and B1. 
 
 
Tensile Testing Methods 
 
 
 An Instron In-Spec 2200 benchtop tensile tester was used to test all tensile testing 
samples at a pulling speed of 5.6 mm/min.  Samples were cut into two rectangular sheets 
for testing in both the longitudinal and circumferential directions, resulting in six tests per 
scaffold.  Each of the tensile testing samples was measured for width and gauge length 
prior to testing.  Using the measured dimensions (thickness, width, and gauge length), 
collected data (pulling force and extension), and a Microsoft Excel macro program, stress 
versus strain plots were generated.  The aforementioned Excel macro was created to 
automatically convert all tensile testing inputs into stress versus strain data, plot the data, 
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isolate the linear elastic region of the plot, and calculate Young?s modulus.  All tensile 
testing figures are contained in Appendix G. 
 
 
Results 
 
 
Results and Statistical Analysis of Fiber Diameter 
 
 
 Fiber diameter data was analyzed using Minitab 15 statistical analysis software, 
and the figures and tests presented in this section were generated by the same program.  
The data did not form a normal distribution, but a majority of the fibers had diameters 
between 6 and 9 microns (Figure 47).  Boxplots are shown that summarize the data based 
on each of the 11 scaffolds and 4 sections sampled on each scaffold (Figure 48).  A one-
way analysis of variance (ANOVA) test was also performed to test for statistical 
difference between the spins, with a Tukey?s method of comparison test to highlight the 
differences between individual tests (Figure 49).  Table 2 shows P-value results for 
intrascaffold ANOVA testing which indicate the scaffolds that had significantly different 
fiber diameters at the different sections tested (P > 0.05).  Appendix H contains the full 
intrascaffold ANOVA test results. 
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Figure 47 ? A histogram of all 1188 data points shows that the average fiber diameter 
was 7.12 ?m with a standard deviation of 2.159 ?m.  A normal distribution curve with the 
same mean and standard deviation (7.12 and 2.159, respectively) is superimposed on the 
image. 
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Figure 48 ? Boxplots of all fiber diameter measurements separated into individual spins 
and sections provide a summary of the data.  An asterisk indicates an outlier, the vertical 
lines show the non-outlier data range, and the rectangle on each line represents the 
interquartile range of each data set.  The horizontal line through each interquartile range 
box marks the median of each data set. 
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Figure 49 ? An analysis of variance model comparing fiber diameter between spins (top) 
indicated that at least one spin was significantly different from the rest (P < 0.05).  
Tukey?s method of comparison was used to generate 95% confidence intervals for 
individual spins (bottom).  The confidence intervals can be used to determine which spins 
were significantly different from each other.  For example, the confidence interval of spin 
3 does not overlap the confidence interval of spin 9, so the fiber diameter of the two is 
statistically different. 
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Table 2 ? Intrascaffold ANOVA Results  
SPIN P-VALUE 
1 0.741 
2 0.219 
3 0.336 
4 0.439 
5 0.047 
6 0.503 
7 0.344 
8 0.287 
9 0.490 
10 0.450 
11 0.028 
 
 
 
 Statistical analysis of fiber diameter indicates that differences in fiber diameter 
did exist between individual spins.  In addition, intrascaffold ANOVA testing revealed 
that the sections imaged for Spin 5 and Spin 11 contained fibers of statistically different 
diameter (Table 2).   
  
 
Results and Statistical Analysis of Scaffold Wall Thickness 
 
 
 Wall thickness data was analyzed in the same manner as fiber diameter.  ANOVA 
testing using Minitab 15 showed that wall thickness between spins varied, with thinner 
walls produced for the first 4 spins than the remaining 7 (Figure 51).  Wall thickness 
along the length of scaffolds (or intrascaffold wall thickness) was tested using one-way 
ANOVA testing.  A table of P-values is not provided since the only spin with statistically 
similar wall thickness data was Spin #10.  All 11 intrascaffold wall thickness ANOVA 
tests can be found in Appendix I. 
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Figure 50 ? A boxplot of the cross-sectional thickness data gathered shows how 
thickness varied.  An asterisk indicates an outlier, the vertical lines show the non-outlier 
data range, and the rectangle on each line represents the interquartile range of each data 
set.  The horizontal line through each interquartile range box marks the median of each 
data set. 
 
 126 
 
Figure 51 ? The ANOVA results comparing scaffold wall thickness between Spins 
indicates that thickness varied from spin to spin. 
 
 
 
Results and Statistical Analysis of Tensile Testing 
 
 
 Minitab 15 was also used to analyze tensile testing data and generate all figures.  
A histogram of all recorded values for Young?s modulus shows a range of values from 2 
to 17 MPa (Figure 52).  An ANOVA test of Young?s modulus data versus spin number 
indicates that despite the wide range of the data, all consistency spins produced scaffolds 
that were mechanically similar (Figure 53). 
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Figure 52 ? The range of the data shown in this histogram of Young?s modulus values 
yielded a mean value of 8.1 MPa with a standard deviation of 4.2 MPa. 
 
 
 
Figure 53 ? An ANOVA analysis of Young?s Modulus (E) based on individual spins 
suggested that all scaffolds were statistically similar (P > 0.05).  This analysis does not 
take into account the effects of testing section (AB, BC, and CD) or sample orientation 
(longitudinal or radial pull). 
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 To better understand what affected the Young?s modulus values, several other 
ANOVA tests were performed.  An ANOVA test of Young?s modulus versus sample 
section showed that different sections had no effect on mechanical properties (Figure 54).  
Sample orientation, however, had a clear effect on Young?s modulus values (Figure 55).   
 
 
 
Figure 54 ? The large P-value from this ANOVA test of Young?s Modulus (E) versus 
testing section (AB, BC, and CD) indicates that separate sections from all scaffolds were 
statistically similar. 
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Figure 55 ? The wide range of the tensile testing data was caused by mixing data from 
both testing directions (longitudinal and radial) as indicated by this ANOVA test of 
Young?s modulus (E) versus sample direction (orientation).  The P-value is essentially 
zero, meaning that sample orientation had a definite effect on the tensile testing data. 
 
 
 
Discussion and Conclusions 
 
 
 The goal of the consistency study was to evaluate the reproducibility of the 
electrospinning process.  In summary: 
? Fiber diameter between scaffolds was inconsistent, but the data indicates a 
majority of fiber sizes between 6 and 9 microns.  The reason behind the 
variation in fiber diameter among certain consistency spins is unknown.  
Variation in fiber diameter has been shown to decrease with decreasing 
solution concentration, though below the threshold solution concentration, the 
process ceases to be electrospinning and become electrospraying [89, 115].  
By lowering the concentration of the P(LLA-CL) solution, as well as adjusting 
other electrospinning parameters, variation in fiber diameter can be reduced. 
 130 
? Within individual scaffolds, fiber diameter was consistent, except in the cases 
of Spin #5 and Spin #11.  This indicates that fiber diameter across the length 
of the tubular P(LLA-CL) scaffolds is mostly consistent.  Improved 
electrospinning technique and equipment set-up may increase the intrascaffold 
consistency. 
? Wall thickness was inconsistent between spins; thickness values ranged from 
0.4 mm to 1.2 mm.  Sample preparation may have contributed to the 
inconsistent data gathered in this study. 
? Wall thickness within individual scaffolds was also inconsistent in all but one 
scaffold (Spin #10).  This is believed to have been caused by areas of lower 
resistance along the length of the grounded mandrel, resulting in preferential 
fiber collection sites. 
? Pooled together, all the data obtained from tensile testing suggests no 
statistical difference in the mechanical response between consistency spins.  
However, when the data is examined based on sample orientation, a surprising 
result emerges.  Since the polymer collector is a rotating drum, and this 
rotation should produce a scaffold composed of circumferentially aligned 
fibers, it is natural to assume that the scaffold would be mechanically 
anisotropic with a higher Young?s modulus in the radial direction.  The results 
from this study, however, suggest that the scaffolds were actually stiffer in the 
longitudinal direction.  The first possible reason for this is that fibers 
somehow managed to align themselves longitudinally, not circumferentially.  
Examination of the SEM images used to gather fiber diameter data showed 
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that this was probably not the case.  Rather than having one clear direction of 
fiber orientation, the fibers appeared to be randomly oriented, as if they had 
been collected on a flat sheet collector.  Thus, the probable reason for the 
discrepancy between data collected from longitudinal pulls and radial pulls 
lies in the testing method.  Specifically, when radial samples were loaded into 
the tensile tester, they had to be unfurled to create flat sheets.  This unfurling 
action caused internal stresses that severed the connections between many 
fibers, resulting in a weaker material than the longitudinal samples. 
 
Despite the indicated difference in fiber diameter and wall thickness between 
scaffolds, mechanical testing data indicated the scaffolds were all the same.  These results 
are counterintuitive since structure (in this case fiber diameter) determines properties 
(Young?s modulus).  In other words, scaffolds with different fiber diameters should have 
different values for Young?s modulus. 
In conclusion, the question of whether or not electrospinning is a reproducible 
process in-house at Cal Poly (and thus applicable to the BVM system) has a mixed 
answer.  Morphologically, the process has thus-far proven statistically inconsistent; 
however, mechanically, the process is statistically consistent.  In addition, preliminary 
cell viability testing on the electrospun P(LLA-CL) scaffolding has shown promising 
results (see Appendix J).  With further experimentation into changing parameters such as 
solution concentration, accelerating voltage, solution flow rate, gap distance, and needle 
size, scaffolds with tighter fiber diameter, wall thickness, and Young?s modulus 
distributions can be produced.  The data presented in this thesis provides a benchmark for 
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comparison for future in-house electrospinning research.  With further research and 
improvements to the process, electrospinning should provide appropriate scaffolding for 
the BVM. 
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5.  DISCUSSION AND FUTURE WORK 
 
Summary 
 
 
This thesis describes work completed to improve the existing in vitro blood vessel 
mimic (BVM) system used to test and evaluate intravascular devices - specifically, the 
need to improve the scaffolding used to support the attachment, proliferation, migration, 
and growth of endothelial cells.  This thesis hypothesized that more appropriate 
scaffolding could be manufactured in-house using an established fabrication technique 
without increasing scaffolding cost.  Research was conducted in two phases.  First, using 
peer reviewed literature to identify and evaluate established candidate fabrication 
techniques, a method for scaffold production was chosen for further research. The 
selection was based on a list of criteria which included: process consistency, pore 
architecture and microstructure, material compatibility, cost, and BVM -specific benefits.  
This first phase of research was presented in Chapter 2, and results led to the selection of 
electrospinning as the fabrication method to pursue.  The second phase of research tested 
the hypothesis that the chosen fabrication method (electrospinning) could produce high-
throughput scaffolding with consistent morphology and mechanical properties.  Chapter 3 
presented the series of electrospinning trial experiments used to obtain a basic 
understanding of the electrospinning process and arrive at a set of fabrication process 
parameters used to evaluate scaffold consistency.  By using the same set of 
electrospinning parameters to produce multiple scaffolds and examining the structural 
morphology and mechanical properties of each, process consistency was evaluated.  
Chapter 4 presented the methods used to gather the consistency data, as well as the 
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resulting statistical analysis of the data.  This work determined that electrospinning is a 
viable fabrication technique for producing scaffolding for BVM use.  Results from the 
consistency study showed that average diameter of the microfibers composing the 11 
electrospun scaffolds was not statistically similar from scaffold to scaffold, but fibers 
from the same scaffold were.  Scaffold wall thickness proved to be inconsistent both 
between scaffolds and within the same scaffold.  Mechanical response in the form of 
Young?s modulus indicated that the 11 scaffolds were statistically similar.  Results from 
the consistency study set a baseline that could be used for comparison in future work 
aimed at electrospinning BVM scaffolding. 
 
 
Electrospun Scaffolds: Novel Alternatives in the Blood Vessel Mimic System 
 
 
 Tissue engineering was introduced in Chapter 1 of this thesis as a means to 
potentially replace synthetic materials, like ePTFE, in small diameter vessel applications.  
Methods used to create small caliber blood vessels using tissue engineering vary widely 
including various cell sodding procedures, culturing conditions, and scaffolding (see 
Chapter 1, Section 2).  Using established techniques from past research, a blood vessel 
mimic (BVM) was previously developed.  The system utilizes ePTFE as scaffolding, a 
popular material in large diameter blood vessel replacements.  Much research has been 
conducted on ePTFE and its effectiveness in various applications in the human body.  In 
the case of the BVM, ePTFE is not necessarily the ideal scaffolding; high cost, lack of 
radial compliance, and necessary out-of-house production are all reasons that scaffolding 
in the BVM could be optimized. 
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 With this need in mind, electrospinning was pursued as a possible scaffold 
fabrication method for replacing ePTFE.  Electrospinning has been studied on both a 
physical phenomenon front and as a method for producing tissue engineering scaffolding.  
In the case of tissue engineering, the nanoscale fibrous structures that are possible 
through electrospinning mimic the collagen rich ECM of native blood vessels, and as 
such may prove to be the scaffolding of choice in future tissue engineered blood vessels.  
This work was unique in that it did not attempt to produce an implantable tissue 
engineered blood vessel, as many other groups strive to do [32, 77, 116-123] .  Rather, 
electrospun scaffolding was studied as a method for creating in-vitro blood vessel models 
never meant to be implanted into hosts.  For this reason, the consistency and scalability of 
electrospinning techniques was the primary focus, which is a unique contribution to the 
tissue engineering and electrospinning field.  
Ultimately, electrospun scaffolding was implemented in the BVM system in a 
small, preliminary study, and results indicated that cells could adhere to P(LLA-CL) 
scaffolds in the BVM (see Appendix J).  The future work necessary to produce 
electrospun scaffolding that can be successfully implemented in the BVM is described in 
the next section. 
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Future Work 
 
 
Improved Consistency: Further Exploration of Process Parameters 
 
 
 Experimental data on fiber morphology, wall thickness, and mechanical 
properties of the electrospun P(LLA-CL) was analyzed to set a base line for the 
consistency of the in-house electrospinning process.  Information obtained on the initial 
consistency of the electrospinning process is not meant to be used as a finishing point.  
Rather, further research should be conducted and the elctrospinning apparatus modified 
as needed to increase the consistency of the resulting constructs. Improving consistency 
may involve many aspects of the electrospinning process, including: making more precise 
measurements (such gap distance and amount of solution used), exploring other variables 
in the process (solution feed rate, needle geometry, temperature, humidity, time in 
solution, and collector to power source resistance), and experimenting with alternate 
equipment (power supply, collector, and containment chamber).  It may also prove 
worthwhile to repeat the experiments presented in this thesis to determine if operator skill 
played a role in the consistency of the electrospinning process.  
 
 
Design of Experiment 
 
 
 After an electrospinning procedure has been developed that results in desirable 
scaffolds with respect to microstructure and mechanical properties, process parameters 
for that specific system should be evaluated using a design of experiment (DOE).  A 
DOE would simplify the process of understanding how the electrospinning process 
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parameters affect the final scaffold structure and mechanical properties.  Other 
electrospinning systems have been characterized in this manner, including P(LLA-CL) 
[89].  A good example of a DOE comes from work by Thompson et al.  An in depth 
analysis of 13 process parameters was performed for several polymer systems to 
determine which treatments had the most effect on final fiber diameter [114].  While an 
analysis of 13 parameters may be excessive for electrospun BVM scaffolding, a DOE 
involving 5 or 6 primary parameters for the in-house electrospinning system would make 
it easier to tailor scaffolds to desired specifications in the future. 
 
 
Improving the Electrospinning Apparatus 
 
 
Power Supply 
 
 
 The driving force behind the electrospinning process is electrostatic repulsion 
produced by a high voltage power supply [77].  The current power supply consists of 
both a high voltage power converter (Matsusada K7-30R) and an external amplifying unit 
(Heathkit IP-2718).  During the trial spin series of experiments, the external amplifier 
broke when turned past 6 volts due to the amount of current being drawn through it.  This 
limits the accelerating voltage possible to 18 kV.  As future scaffolding may require 
higher accelerating voltages, a replacement power supply may be necessary.  A 
replacement power supply should be a self contained power converter and amplification 
unit with a voltage output meter and, possibly, a current output meter.  The output current 
should be kept as low as possible to minimize the hazardousness of the electrospinning 
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process, but the output voltage possible should be at least 30 kV to allow for a variety of 
possible electrospun constructs.  A good replacement would be ES30R-5W from Gamma 
High Voltage Research, or the CZE1000R from Spellman High Voltage. 
 
 
Containment Chamber 
 
 
 Minimizing the influence of external electromagnetic fields and grounded 
surfaces is important in the electrospinning process in order to generate consistent jet 
dynamics between spins and to ensure that the jet strikes the collector surface [124].  
With this in mind, the containment chamber could be improved.  For example, the access 
panel should seal better to prevent perturbation of the jet.  Also, research has shown that 
carefully oriented electrodes can influence jet dynamics [81, 125]; a new containment 
chamber could incorporate a series of electrodes designed to influence the jet in flight, 
the orientation of collected fibers, or both. 
 
 
Characterization of Constructs 
 
 
Alternate Techniques 
 
 
Alternate testing methods may also improve the validity and accuracy of a 
consistency rating for these particular constructs without changing any aspect of the 
process.  Consider, for example, a process such as mercury porosimetry, which is based 
on the principle that the pressure required for a non-wetting liquid like mercury to 
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overcome liquid surface tension and be forced into pores is indicative of pore size [126].  
Mercury porosimetry could be used to find a value for average pore size of electropsun 
scaffolds, and also to compare the pressures required to completely infiltrate all pores.  
Statistical analysis of these pressures is another method that could be used to evaluate 
consistency.  
 
 
 
 
Improved Tensile Testing 
 
 
 As explained in the Chapter 4, tensile testing samples were rectangular sheets cut 
from the tubular constructs.  In retrospect, using rectangular samples probably 
contributed to a lack of precision in the mechanical testing data for several reasons.  First, 
while thickness measurements were carefully conducted using SEM analysis, width 
measurements of the sample were obtained using a simple ruler with an accuracy of ± 
1mm.  Second, the action of unfolding the electrospun constructs into rectangular sheets 
appeared to disrupt the cohesive structure of the construct matrix.  The flattening of 
tubular samples results in a compressive force on the exterior surface of the constructs 
and a tensile force on the interior surface.  These opposing forces most likely caused 
separation of fibers in the constructs below the midpoint of the thickness.  The effect was 
more pronounced in radially-oriented samples because the amount of unrolling needed to 
produce a flat, rectangular tensile testing sample was much greater than that of 
longitudinally oriented samples.  In the future, rectangular samples should not be used for 
tensile testing mainly due to the probable damage done to electrospun constructs during 
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sample preparation.  Rather, tensile tests should be conducted on unaltered tubular 
samples (Figure 56). 
 
 
 
Figure 56 ? One possible tensile testing alternative to rectangular samples.  A custom 
fixture would be constructed that uses two small rods to pull the electrospun tubular 
construct apart. 
 
 
Improved Thickness Measurement 
 
 
 Sample preparation methods used for wall thickness samples involved an excess 
of contact with the scaffold.  Accidental pressure from contact with the scaffold could 
have decreased the true cross-sectional thickness.  This problem seems probable due to 
the lower values for wall thickness gathered from earlier spins; at this stage, sample 
preparation was not as refined as in later spins.  To alleviate this problem, alternate 
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thickness measurement techniques should be explored.  Ideally, thickness could be 
quickly measured with the scaffold still on the mandrel using a method like ultrasonic 
imaging.  This would not only save time and increase the accuracy of wall thickness data, 
but the thickness at any point along the scaffold length could be easily obtained. 
 
 
Physiologically Accurate Fiber Production 
 
 
 Although this work successfully produced fibers with micron-scale cross-
sectional diameters, electrospinning is capable of producing nanoscale fibers.  Literature 
indicates that nanoscale fibers may be ideal for cell incorporation since they mimic the 
natural structure of the ECM [89, 123].  The parameters necessary to electrospin fibers 
that mirror the size of collagen is not discrete; small fibers may be produced by changing 
electrospinning process parameters while using the same polymer, or by experimenting 
with different polymers [80, 87, 111, 125, 127, 128].  Future work should focus on both 
approaches in order to build a library of available scaffolds for use in the BVM.  In 
addition, incorporation of biomacromolecules such as collagen and elastin is an avenue 
worth exploring that might improve the physiological appropriateness of electrospun 
scaffolding for the BVM [122, 129]. 
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Conclusion 
 
 
 This thesis has identified, created, and utilized a new fabrication technique for 
creating blood vessel mimic scaffolding that can potentially replace ePTFE.  As the goal 
of the BVM is to provide an in-vitro intravascular device testing environment as similar 
to native human blood vessel as possible, highly tailorable scaffolding is desirable in 
order to produce blood vessel mimics with various geometries and mechanical properties.  
Information presented here is meant as a starting point for future research that seeks to 
improve the in-house electrospinning process and its role in the BVM.  Electrospinning 
as a scaffold fabrication technique has the potential to produce consistent, tailorable, and 
inexpensive constructs made in-house for use in the BVM. 
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APPENDIX A: LIST OF ABBREVIATIONS 
 
 
 
ANOVA ? Analysis of Variance 
BVM ? Blood Vessel Mimic 
CAD ? Computer Aided Design 
CAD ? Coronary Artery Disease 
CVD ? Cardiovascular Disease 
DOE ? Design of Experiment 
EC ? Endothelial Cell 
ECM ? Extracellular Matrix 
ePTFE ? Expanded Polytetrafluoroethylene 
FDA ? Food and Drug Administration 
HMVECS ? Human Microvessel Endothelial Cells 
IHD ? Ischemic Heart Disease 
P(LLA-CL) ? Poly(L-Lactic-co-Caprolactone) 
PCL ? Polycaprolactone 
PGA ? Polyglycolic Acid 
PLGA ? Poly(Lactic-co-Glycolic Acid) 
PLLA ? Poly(L-Lactic Acid) 
PTCA ? Percutaneous Transluminal Coronary Angioplasty 
PU ? Polyurethane 
SCPL ? Solvent Casting Particulate Leaching 
SEM ? Scanning Electron Microscope 
SFF- Solid Freeform Fabrication 
SLS ? Selective Laser Sintering 
SMC ? Smooth Muscle Cell 
TEVG ? Tissue Engineered Vascular Graft 
TIPS ? Thermally Induced Phase Separation 
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APPENDIX B: MIXING P(LLA-CL) SOLUTIONS FOR ELECTROSPINNING 
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Materials/Equipment Vendor Part Number Quantity 
Poly(L?lactide-co-caprolactone) [P(LLA-CL)] 
(90:10) Monomer Mole % L-Lactide:Caprolactone  
Lakeshore 
Biomaterials 90:10 LCL 11E 50 grams 
Chloroform, extra dry, water <50ppm, stabilized Fisher Scientific, Inc 326820010 1 Liter 
10 ml Syringe, Luer-Lok tip BD 309604 100/Pack 
Blunt Fill Needle, 18G 1½ (1.2 mm x 40 mm) BD 305180 100/Pack 
Analytical Balance Acculab ALC-80.4 1 
Orbital Shaker FinePCR SH130 1 
Vaccum-Pressure Pipette Aid Drummond Scientific Co. P-80991 1 
Serological Pipet 5 x 1/10 ml VWR International 53283-706 NA 
Clear Glass Vial 20 ml VWR International 15900-002 72/CS 
 
 
1.) Put on safety gloves. (WARNING: Chloroform can have serious side-effects if it 
comes in contact with skin, eyes or is inhaled or swallowed.  Target organs to be effected 
are kidneys, heart, central nervous system, liver, eyes, reproductive system and skin.  
Always open chloroform in a hood and wear protective clothing!!) 
 
2.) Remove the P(LLA-CL) resin (Figure B1) from the freezer and 
allow it to sit at room temperature for at least 10 minutes.  This 
prevents condensation on the resin when exposed to the air, 
reducing the amount of atmospheric degradation.  
 
 
3.) While the resin is warming, calculate the weight percent polymer of the finished 
solution based on quantity P(LLA-CL) being used.  See below for this calculation. 
 a.  Polymer solutions are quantified by weight percent polymer (WPP), and there 
are two components to the solution: P(LLA-CL) and chloroform. The polymer 
Figure B1 ? 90:10 P(LLA-
CL) resin from Lakeshore 
Biomaterials. 
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can be weighed directly, but the chloroform must be converted from volume 
to mass using density (1.48 g/ml). 
 



+
=
ba
aWPP 100  
 
    where: 
     a = mass of polymer (g) 
     b = mass of solvent (g) 
 
Consider: 1.10 g of P(LLA-CL) is dissolved in 8 ml of chloroform (1.48 
g/ml), the weight percent polymer of the solution would be calculated as 
follows: 
 
[ ]
%50.8
94.12
10.1100
/48.1810.1
10.1100
=




=




+
=
WPP
g
gWPP
mlgmlg
gWPP
 
 
Conversely, by rearranging the equation, the mass of polymer required for a 
specific WPP solution can be determined. 
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4.) Weigh out the P(LLA-CL) and put it in a 20ml glass vial (Figure 
B2).  Set the vial aside for now and return the P(LLA-CL) resin to the 
freezer. 
 
 
 
 
 
5.) Retrieve the chloroform (Figure B3) from the hazardous chemical 
cabinet and place it in a fume hood immediately. 
 
 
 
 
 
6.) Acquire a disposable glass pipette and the pipette aid (Figure B4).  
Pipette the required volume of chloroform from your calculations into 
the scintillation vial with the P(LLA-CL). Immediately cap both the 
scintillation vial and chloroform container to prevent evaporation of 
chloroform. 
 
7.) Properly label the solution vial with the WPP, date, and your initials. 
 
Figure B2 ? A glass 
scintillation vial used to 
mix and store solutions. 
Figure B3 ? A bottle 
of chloroform. 
Figure B4 ? A pipette 
aid used to pipette 
solvent. 
 164 
8.) Wrap the labeled vial in aluminum foil. Prohibiting light exposure can prevent 
solution degradation. 
 
9.) Place the vial on an orbital shake table (Figure B5).  Secure the 
vial using tape to ensure the vial will not tip over when mixing.  
Set the shake table speed to 3 revolutions per second. 
 
 
 
10.) Allow the P(LLA-CL) solution to mix for 24 hours. After mixing is complete, the 
solution is usable for up to 48 hours.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B5 ? The orbital 
shake table used to mix 
solutions. 
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APPENDIX C: ELECTROSPINNING PROTOCOL 
 
 
 
 
 
 
 
WARNING: This process requires extremely high voltages! Always wear shoes, gloves, 
and be mindful of what you are touching. To use the electrospinner, you must be 
trained by a qualified user and cleared by an appropriate faculty member. 
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1.) Put on gloves gloves. 
 
2.) Prepare to clean the polymer collector (Figure C1) by 
getting paper towels and isopropal alcohol. 
 
 
 
 
3.) Unplug the green ground wire from the collector (Figure 
C2).  
 
 
 
 
 
4.) Unplug the yellow power wire from the DC motor control 
box (Figure C3).  
 
 
 
 
 
 
Figure C1 ? Collector for the 
electrospinning apparatus. 
Figure C2 ? Ground input 
for the collector is located to 
the right of the engine casing. 
Figure C3 ? The yellow 
power wire connects into the 
rear panel of the motor 
control box. 
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5.) Clean debris from previous spins using isopropyl alcohol. 
Stray polymer preferentially builds up on exposed metal, 
wires, and motor casings, but polymer build-up can occur 
anywhere on the collector, even the side not facing the 
electrified needle (Figure C4).  
 
6.) Replace the collector in the containment chamber and reconnect the ground and power 
wires. 
 
7.) Plug in all equipment (syringe pump, main power, external power supply, and DC 
motor control box). 
 
8.) Using a multimeter, check the resistance between the 
ground connection and the aluminum mandrel (Figure C5). 
Verify that there is some conductivity.  
 
 
 
 
9.) Attach the desired needle to a 10ml syringe (Figure C6).  
 
 
 
Figure C4 ? Polymer 
fiber build up on the 
collector. 
Figure C5 ? If resistance 
between the mandrel and the 
ground connection is too 
high, electrospinning will not 
occur. 
Figure C6 ? A variety of 
needles can be attached to the 
10ml syringes. 18 and 27 
gauge needles are shown 
above. 
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10.) In the fume hood, pull just over the desired amount of 
polymer solution into the syringe (Figure C7). The solution 
may be very thick, so this could take some time. Make sure 
there is no air in the syringe.  
 
 
 
 
11.) Put the needle through the small hole drilled in the 
containment chamber and set the syringe into the syringe 
pump (Figure C8).  
 
 
 
 
12.) Hang the exposed metal of the red high voltage wire on 
the needle inside the containment chamber (Figure C9).  
 
 
 
 
 
 
Figure C7 ? Loading 
polymer solution into a 
syringe. 
Figure C8 ? The syringe 
should sit on the syringe 
pump while the needle enters 
the containment chamber via 
the access hole. 
Figure C9 ? The high 
voltage wire hangs on the 
needle inside the containment 
chamber to reduce the risk of 
shock. 
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13.) Position the polymer collector in the containment 
chamber so that the mandrel and needle tip are at the 
desired gap distance apart and perpendicular to each other 
(Figure C10). The ground wire input should face away 
from the needle. 
 
 
14.) Place the front window onto the containment chamber 
(Figure C11). The bottom corners are cut off the front 
window to allow the wires access into the containment 
chamber.  
 
 
 
15.) Switch on the syringe pump and enter the desired settings (ie ? syringe, volume, flow 
rate, etc.). If you previously used the electrospinner and want to run with the same 
syringe pump settings (and no one else had used the apparatus since), there is no need 
to make any changes to the syringe pump programming. 
 
Syringe pump instructions should be located in a cabinet close to the electrospinner if 
you need instructions on how to operate it. 
 
Figure C10 ? The correct 
alignment of the needle and 
collector is necessary to 
ensure a uniform spin. 
Figure C11 ? The front panel 
must be secure prior to 
electrospinning. 
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16.) Turn on the ?Rotate? and ?Slide? functions of the 
collector at the DC motor control box (Figure C12).  The 
speed at which the mandrel rotates and translates can be 
adjusted here.  
 
 
17.) Turn on the external power source and set it at the 
desired voltage (0-10 V), then turn the power source off 
(Figure C13).  
 
 
 
 
 
18.) Press the ?Run? button on the syringe pump. The solution is now being slowly 
pushed through the needle.  
 
19.) When a droplet forms on the end of the needle, the process is ready to begin. The 
following three steps should be performed in order, as quickly as possible. 
 
 
 
 
Figure C12 ? The DC motor 
control box. 
Figure C13? The external 
power source that acts as an 
amplifier control for the high 
voltage power converter. 
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20.) Turn on the ?Main Power? (Figure C14). Power is on if 
the light on the AC/DC power converter turns green.  
 
 
 
 
21.) Turn on the external source. 
 
 
22.) Be ready to turn the ?HV? on. Look at the droplet on the 
end of the syringe, and turn ?HV? on (Figure C15). The 
droplet should disappear.  
 
 
 
 
23.) Look and listen for any problems with the equipment. If you hear clicking 
coming from either of the power supplies, stop the process immediately. 
 
24.) Observe the process for the entire spin. The aluminum mandrel should slowly start to 
become coated with polymer, turning it white. 
 
Figure C14 ? The main 
power switch is located on 
the left side of power control 
switch box (red arrow). 
Figure C15 ? The HV switch 
is located on the right side of 
the power control switch box 
(red arrow). 
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25.) When the desired amount of solution has been spun, the process should be shut down 
as follows: 
a.) Press the ?Run/Stop? button on the syringe pump to stop the pump. Turn off 
the syringe pump.  
b.) Turn the ?HV? switch to off. 
c.) Turn off the external power supply. 
d.) Turn ?Main Power? off. 
e.) Turn off ?Rotate? and ?Slide? for the collector. 
 
26.) Allow the evaporated solvent to leak out of the containment chamber for a few 
minutes. 
 
27.) Remove the front window of the containment chamber and detach the coated 
mandrel from the collector. 
 
28.) Touch the red high voltage wire to the green ground wire to remove residual charge. 
 
29.) Using gauze, gently twist the scaffold to break it loose from the mandrel. The 
scaffold should now easily slide off the mandrel. Finished scaffolds should be stored 
in a desiccator. 
 
30.) Unplug all equipment. 
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31.) Remove the syringe and needle from the syringe pump and dispose of properly, and 
close the hood. 
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APPENDIX D:  HIGH CONTRAST SURFACE POROSIMETRY 
 
 
Introduction 
 
 
 Porosity, as referred to in this thesis, is defined as the percent space not occupied 
by electrospun fibers.  Porosity is normally reported in terms of void space in a volume, 
but appropriate methodology for gathering volumetric data was not available.  The 
method developed instead measured the percent void space on the surface of samples.  
This method, intended to collect surface porosity data on the electrospun P(LLA-CL) 
scaffolds, was named high contrast surface porosimetry. 
 
 
Method 
 
 
 The same sampled sections that were used to take fiber diameter measurement 
images were used to capture porosity images.  The FEI Model 200 Scanning Electron 
Microscope was also used for imaging.  Voltage bias on the Everhart-Thornley electron 
detector was set to -200 V.  This prevented detection of lower energy electrons from sub-
surface fibers while highlighting the surface fibers.  Contrast and brightness were 
adjusted on the SEM until surface fibers were clearly defined (Figure D1).  High contrast 
images were then converted black and white images using the ?Threshold? command in 
ImageTool V3.0 image analysis software (The University of Texas Health Science Center 
in San Antonio) (Figure D2).  Finally, percent white/void space was calculated using the 
?Count White/Black Pixels? command in ImageTool.  The value for white pixels 
represented the percent surface void space. 
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Figure D1? A high contrast, backscattered electron image taken using the FEI Model 200 
Scanning Electron Microscope.  Surface fibers are highlighted, while subsurface fiber 
presence is minimized. (149x) 
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Figure D2 ? The ?Threshold? command in ImageTool converts all pixels into either 
white or black.  Whether a pixel translates to white or black depends on a user controlled 
threshold scale. 
 
 
 
 
Conclusion 
 
 
 No results are reported due to concerns that the method is prone to operator 
subjectivity during two important steps.  First, when capturing the image using the SEM, 
contrast and brightness are controlled by the operator.  Since it is difficult to set these 
parameters the same for every image, this is a source of error.  Second, the ?Threshold? 
command is also operator controlled.  Although the threshold was adjusted until it 
appeared that only solid fibers were highlighted, this method still depended on operator 
opinion.  After these two concerns were raised, it was decided that gathering porosity 
data in this matter would not give accurate results, and so the method was abandoned. 
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 Although as of now the method has the issues mentioned above, future 
improvements may make it an acceptable method for quickly gathering surface porosity 
data. 
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APPENDIX E: FIBER DIAMETER MEASUREMENTS 
 
 
Introduction 
 
 
 As stated in Chapter 4, fiber diameters were measured using a combination of 
SEM images and the Image J software.  Using the program?s line length measurement 
tool (ANALYZE > MEASURE), the scale bar on all images was measured.  This length 
corresponded to 50 microns on all images.  The sample selection mask was then used to 
measure 9 separate fiber thicknesses.  A simple calculation was then used in Microsoft 
Excel to convert the collected fiber thicknesses into fiber diameter in microns.  In the data 
shown below, entries under Diameter are in microns.  All other values are unitless. 
 
microns
S
tD 50•


=  
  Where:  D is fiber diameter in microns 
    t is fiber thickness measured on Image J 
    S is length of the scale bar measured on Image J 
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SPIN 1        
         
Section A1   
Scale Bar: 50 microns is 2.792 
    
Sample Length Diameter  
1 0.343 6.14  
2 0.226 4.05  
3 0.393 7.04  
4 0.459 8.22  
5 0.441 7.90  
6 0.347 6.21  
7 0.42 7.52  
8 0.509 9.12  
9 0.452 8.09  
    
 
         
         
         
Section A2   
Scale Bar: 50 microns is 2.834 
    
Sample Length Diameter  
1 0.488 8.61  
2 0.458 8.08  
3 0.251 4.43  
4 0.444 7.83  
5 0.237 4.18  
6 0.506 8.93  
7 0.4 7.06  
8 0.483 8.52  
9 0.409 7.22  
    
 
         
         
         
Section A3   
Scale Bar: 50 microns is 2.834 
    
Sample Length Diameter  
1 0.253 4.46  
2 0.284 5.01  
3 0.4 7.06  
4 0.496 8.75  
5 0.479 8.45  
6 0.446 7.87  
7 0.427 7.53  
8 0.497 8.77  
9 0.131 2.31  
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Section B1   
Scale Bar: 50 microns is 2.807 
    
Sample Length Diameter  
1 0.427 7.61  
2 0.428 7.62  
3 0.457 8.14  
4 0.439 7.82  
5 0.138 2.46  
6 0.168 2.99  
7 0.352 6.27  
8 0.174 3.10  
9 0.432 7.70  
    
 
         
         
         
Section B2   
Scale Bar: 50 microns is 2.958 
    
Sample Length Diameter  
1 0.471 7.96  
2 0.154 2.60  
3 0.241 4.07  
4 0.262 4.43  
5 0.512 8.65  
6 0.41 6.93  
7 0.409 6.91  
8 0.218 3.68  
9 0.741 12.53  
    
 
         
         
         
Section B3   
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.34 5.88  
2 0.401 6.94  
3 0.416 7.20  
4 0.416 7.20  
5 0.448 7.75  
6 0.418 7.23  
7 0.448 7.75  
8 0.464 8.03  
9 0.214 3.70  
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Section C1   
Scale Bar: 50 microns is 2.862 
    
Sample Length Diameter  
1 0.427 7.46  
2 0.437 7.63  
3 0.421 7.35  
4 0.179 3.13  
5 0.471 8.23  
6 0.478 8.35  
7 0.113 1.97  
8 0.798 13.94  
9 0.402 7.02  
    
 
         
         
         
Section C2   
Scale Bar: 50 microns is 2.834 
    
Sample Length Diameter  
1 0.441 7.78  
2 0.224 3.95  
3 0.379 6.69  
4 0.151 2.66  
5 0.244 4.30  
6 0.414 7.30  
7 0.394 6.95  
8 0.406 7.16  
9 0.41 7.23  
    
 
         
         
         
Section C3   
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.372 6.47  
2 0.166 2.89  
3 0.425 7.39  
4 0.346 6.02  
5 0.424 7.37  
6 0.418 7.27  
7 0.394 6.85  
8 0.517 8.99  
9 0.294 5.11  
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Section D1   
Scale Bar: 50 microns is 2.972 
    
Sample Length Diameter  
1 0.21 3.53  
2 0.485 8.16  
3 0.396 6.66  
4 0.654 11.00  
5 0.504 8.48  
6 0.358 6.02  
7 0.175 2.94  
8 0.557 9.37  
9 0.439 7.39  
    
 
         
         
         
Section D2   
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.335 5.83  
2 0.181 3.15  
3 0.437 7.60  
4 0.127 2.21  
5 0.432 7.51  
6 0.138 2.40  
7 0.461 8.02  
8 0.179 3.11  
9 0.263 4.57  
    
 
         
         
         
Section D3   
Scale Bar: 50 microns is 3.027 
    
Sample Length Diameter  
1 0.641 10.59  
2 0.322 5.32  
3 0.14 2.31  
4 0.338 5.58  
5 0.381 6.29  
6 0.507 8.37  
7 0.478 7.90  
8 0.878 14.50  
9 0.124 2.05  
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SPIN 2        
         
Section A1  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.346 5.96  
2 0.392 6.75  
3 0.487 8.39  
4 0.338 5.82  
5 0.473 8.15  
6 0.453 7.80  
7 0.195 3.36  
8 0.462 7.96  
9 0.4 6.89  
    
 
         
         
         
Section A2  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.44 7.54  
2 0.348 5.97  
3 0.418 7.16  
4 0.531 9.10  
5 0.424 7.27  
6 0.357 6.12  
7 0.489 8.38  
8 0.372 6.38  
9 0.468 8.02  
    
 
         
         
         
Section A3  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.386 6.62  
2 0.187 3.21  
3 0.345 5.91  
4 0.195 3.34  
5 0.467 8.00  
6 0.275 4.71  
7 0.443 7.59  
8 0.245 4.20  
9 0.418 7.16  
    
 
 184 
Section B1  
Scale Bar: 50 microns is 2.93 
    
Sample Length Diameter  
1 0.184 3.14  
2 0.337 5.75  
3 0.391 6.67  
4 0.358 6.11  
5 0.376 6.42  
6 0.376 6.42  
7 0.361 6.16  
8 0.381 6.50  
9 0.358 6.11  
    
 
         
         
         
Section B2  
Scale Bar: 50 microns is 2.958 
    
Sample Length Diameter  
1 0.751 12.69  
2 0.241 4.07  
3 0.405 6.85  
4 0.317 5.36  
5 0.439 7.42  
6 0.157 2.65  
7 0.406 6.86  
8 0.394 6.66  
9 0.387 6.54  
    
 
         
         
         
Section B3  
Scale Bar: 50 microns is 2.862 
    
Sample Length Diameter  
1 0.44 7.69  
2 0.384 6.71  
3 0.427 7.46  
4 0.118 2.06  
5 0.294 5.14  
6 0.282 4.93  
7 0.206 3.60  
8 0.267 4.66  
9 0.428 7.48  
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Section C1  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.431 7.46  
2 0.427 7.39  
3 0.196 3.39  
4 0.461 7.98  
5 0.443 7.67  
6 0.388 6.72  
7 0.388 6.72  
8 0.482 8.34  
9 0.45 7.79  
    
 
         
         
         
Section C2  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.428 7.41  
2 0.453 7.84  
3 0.677 11.72  
4 0.203 3.51  
5 0.372 6.44  
6 0.675 11.68  
7 0.406 7.03  
8 0.394 6.82  
9 0.193 3.34  
    
 
         
         
         
Section C3  
Scale Bar: 50 microns is 3.027 
    
Sample Length Diameter  
1 0.497 8.21  
2 0.477 7.88  
3 0.43 7.10  
4 0.402 6.64  
5 0.748 12.36  
6 0.2 3.30  
7 0.374 6.18  
8 0.138 2.28  
9 0.37 6.11  
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Section D1  
Scale Bar: 50 microns is 3.013 
    
Sample Length Diameter  
1 0.388 6.44  
2 0.394 6.54  
3 0.37 6.14  
4 0.352 5.84  
5 0.087 1.44  
6 0.427 7.09  
7 0.378 6.27  
8 0.471 7.82  
9 0.482 8.00  
    
 
         
         
         
Section D2  
Scale Bar: 50 microns is 3.068 
    
Sample Length Diameter  
1 0.451 7.35  
2 0.258 4.20  
3 0.442 7.20  
4 0.43 7.01  
5 0.44 7.17  
6 0.422 6.88  
7 0.418 6.81  
8 0.4 6.52  
9 0.527 8.59  
    
 
         
         
         
Section D3  
Scale Bar: 50 microns is 2.944 
    
Sample Length Diameter  
1 0.187 3.18  
2 0.148 2.51  
3 0.418 7.10  
4 0.336 5.71  
5 0.357 6.06  
6 0.196 3.33  
7 0.448 7.61  
8 0.331 5.62  
9 0.351 5.96  
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SPIN 3        
         
Section A1  
Scale Bar: 50 microns is 2.999 
    
Sample Length Diameter  
1 0.406 6.77  
2 0.403 6.72  
3 0.414 6.90  
4 0.51 8.50  
5 0.418 6.97  
6 0.406 6.77  
7 0.448 7.47  
8 0.399 6.65  
9 0.464 7.74  
    
 
         
         
         
Section A2  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.44 7.54  
2 0.427 7.32  
3 0.385 6.60  
4 0.454 7.78  
5 0.434 7.44  
6 0.424 7.27  
7 0.443 7.59  
8 0.318 5.45  
9 0.492 8.43  
    
 
         
         
         
Section A3  
Scale Bar: 50 microns is 2.972 
    
Sample Length Diameter  
1 0.385 6.48  
2 0.405 6.81  
3 0.379 6.38  
4 0.292 4.91  
5 0.34 5.72  
6 0.44 7.40  
7 0.425 7.15  
8 0.418 7.03  
9 0.535 9.00  
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Section B1  
Scale Bar: 50 microns is 2.999 
    
Sample Length Diameter  
1 0.467 7.79  
2 0.37 6.17  
3 0.439 7.32  
4 0.431 7.19  
5 0.523 8.72  
6 0.389 6.49  
7 0.367 6.12  
8 0.418 6.97  
9 0.44 7.34  
    
 
         
         
         
Section B2  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.435 7.46  
2 0.51 8.74  
3 0.416 7.13  
4 0.468 8.02  
5 0.422 7.23  
6 0.473 8.11  
7 0.494 8.47  
8 0.427 7.32  
9 0.449 7.70  
    
 
         
         
         
Section B3  
Scale Bar: 50 microns is 2.862 
    
Sample Length Diameter  
1 0.418 7.30  
2 0.457 7.98  
3 0.438 7.65  
4 0.358 6.25  
5 0.391 6.83  
6 0.396 6.92  
7 0.37 6.46  
8 0.413 7.22  
9 0.457 7.98  
    
 
         
         
 189 
Section C1  
Scale Bar: 50 microns is 2.999 
    
Sample Length Diameter  
1 0.448 7.47  
2 0.492 8.20  
3 0.427 7.12  
4 0.338 5.64  
5 0.382 6.37  
6 0.407 6.79  
7 0.138 2.30  
8 0.444 7.40  
9 0.486 8.10  
    
 
         
         
         
Section C2  
Scale Bar: 50 microns is 2.862 
    
Sample Length Diameter  
1 0.263 4.59  
2 0.502 8.77  
3 0.374 6.53  
4 0.399 6.97  
5 0.296 5.17  
6 0.401 7.01  
7 0.286 5.00  
8 0.455 7.95  
9 0.127 2.22  
    
 
         
         
         
Section C3  
Scale Bar: 50 microns is 2.834 
    
Sample Length Diameter  
1 0.41 7.23  
2 0.347 6.12  
3 0.379 6.69  
4 0.376 6.63  
5 0.354 6.25  
6 0.372 6.56  
7 0.409 7.22  
8 0.361 6.37  
9 0.359 6.33  
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Section D1  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.41 7.06  
2 0.346 5.96  
3 0.088 1.52  
4 0.069 1.19  
5 0.392 6.75  
6 0.374 6.44  
7 0.696 11.99  
8 0.105 1.81  
9 0.424 7.30  
    
 
         
         
         
Section D2  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.474 8.20  
2 0.36 6.23  
3 0.388 6.72  
4 0.474 8.20  
5 0.074 1.28  
6 0.389 6.73  
7 0.157 2.72  
8 0.388 6.72  
9 0.376 6.51  
    
 
         
         
         
Section D3  
Scale Bar: 50 microns is 2.944 
    
Sample Length Diameter  
1 0.113 1.92  
2 0.251 4.26  
3 0.364 6.18  
4 0.911 15.47  
5 1.092 18.55  
6 0.381 6.47  
7 0.415 7.05  
8 0.39 6.62  
9 0.381 6.47  
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SPIN 4        
         
Section A1  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.387 6.70  
2 0.481 8.32  
3 0.319 5.52  
4 0.486 8.41  
5 0.38 6.58  
6 0.453 7.84  
7 0.489 8.46  
8 0.481 8.32  
9 0.501 8.67  
    
 
         
         
         
Section A2  
Scale Bar: 50 microns is 2.93 
    
Sample Length Diameter  
1 0.492 8.40  
2 0.479 8.17  
3 0.506 8.63  
4 0.461 7.87  
5 0.496 8.46  
6 0.409 6.98  
7 0.464 7.92  
8 0.462 7.88  
9 0.511 8.72  
    
 
         
         
         
Section A3  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.358 6.20  
2 0.482 8.34  
3 0.489 8.46  
4 0.486 8.41  
5 0.486 8.41  
6 0.443 7.67  
7 0.497 8.60  
8 0.462 8.00  
9 0.458 7.93  
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Section B1  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.08 1.38  
2 0.466 8.07  
3 0.477 8.26  
4 0.363 6.28  
5 0.672 11.63  
6 0.461 7.98  
7 0.333 5.76  
8 0.353 6.11  
9 0.462 8.00  
    
 
         
         
         
Section B2  
Scale Bar: 50 microns is 2.834 
    
Sample Length Diameter  
1 0.4 7.06  
2 0.518 9.14  
3 0.443 7.82  
4 0.419 7.39  
5 0.496 8.75  
6 0.47 8.29  
7 0.516 9.10  
8 0.444 7.83  
9 0.496 8.75  
    
 
         
         
         
Section B3  
Scale Bar: 50 microns is 2.82 
    
Sample Length Diameter  
1 0.446 7.91  
2 0.412 7.30  
3 0.363 6.44  
4 0.389 6.90  
5 0.419 7.43  
6 0.448 7.94  
7 0.448 7.94  
8 0.374 6.63  
9 0.462 8.19  
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Section C1  
Scale Bar: 50 microns is 2.93 
    
Sample Length Diameter  
1 0.514 8.77  
2 0.488 8.33  
3 0.363 6.19  
4 0.493 8.41  
5 0.508 8.67  
6 0.427 7.29  
7 0.501 8.55  
8 0.471 8.04  
9 0.593 10.12  
    
 
         
         
         
Section C2  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.43 7.44  
2 0.193 3.34  
3 0.321 5.56  
4 0.388 6.72  
5 0.448 7.75  
6 0.437 7.56  
7 0.467 8.08  
8 0.451 7.81  
9 0.44 7.62  
    
 
         
         
         
Section C3  
Scale Bar: 50 microns is 2.944 
    
Sample Length Diameter  
1 0.358 6.08  
2 0.389 6.61  
3 0.478 8.12  
4 0.456 7.74  
5 0.399 6.78  
6 0.467 7.93  
7 0.432 7.34  
8 0.372 6.32  
9 0.5 8.49  
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Section D1  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.485 8.43  
2 0.505 8.78  
3 0.488 8.49  
4 0.478 8.31  
5 0.497 8.64  
6 0.479 8.33  
7 0.464 8.07  
8 0.437 7.60  
9 0.47 8.17  
    
 
         
         
         
Section D2  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.514 8.81  
2 0.414 7.10  
3 0.437 7.49  
4 0.456 7.82  
5 0.421 7.22  
6 0.418 7.16  
7 0.44 7.54  
8 0.453 7.76  
9 0.385 6.60  
    
 
         
         
         
Section D3  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.427 7.43  
2 0.457 7.95  
3 0.448 7.79  
4 0.493 8.57  
5 0.442 7.69  
6 0.523 9.10  
7 0.317 5.51  
8 0.409 7.11  
9 0.509 8.85  
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SPIN 5        
         
Section A1  
Scale Bar: 50 microns is 2.82 
    
Sample Length Diameter  
1 0.191 3.39  
2 0.397 7.04  
3 0.469 8.32  
4 0.351 6.22  
5 0.351 6.22  
6 0.467 8.28  
7 0.393 6.97  
8 0.418 7.41  
9 0.205 3.63  
    
 
         
         
         
Section A2  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.218 3.75  
2 0.366 6.30  
3 0.203 3.50  
4 0.451 7.77  
5 0.468 8.06  
6 0.413 7.11  
7 0.54 9.30  
8 0.468 8.06  
9 0.499 8.59  
    
 
         
         
         
Section A3  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.111 1.92  
2 0.447 7.74  
3 0.358 6.20  
4 0.195 3.37  
5 0.389 6.73  
6 0.364 6.30  
7 0.358 6.20  
8 0.348 6.02  
9 0.389 6.73  
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Section B1  
Scale Bar: 50 microns is 2.862 
    
Sample Length Diameter  
1 0.467 8.16  
2 0.224 3.91  
3 0.431 7.53  
4 0.44 7.69  
5 0.314 5.49  
6 0.191 3.34  
7 0.37 6.46  
8 0.265 4.63  
9 0.359 6.27  
    
 
         
         
         
Section B2  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.382 6.61  
2 0.309 5.35  
3 0.118 2.04  
4 0.399 6.91  
5 0.364 6.30  
6 0.358 6.20  
7 0.36 6.23  
8 0.24 4.15  
9 0.2 3.46  
    
 
         
         
Section B3  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.393 6.77  
2 0.097 1.67  
3 0.416 7.17  
4 0.326 5.61  
5 0.444 7.65  
6 0.265 4.56  
7 0.193 3.32  
8 0.396 6.82  
9 0.408 7.03  
    
 
         
         
         
 197 
Section C1  
Scale Bar: 50 microns is 2.848 
    
Sample Length Diameter  
1 0.131 2.30  
2 0.166 2.91  
3 0.403 7.08  
4 0.24 4.21  
5 0.382 6.71  
6 0.258 4.53  
7 0.197 3.46  
8 0.246 4.32  
9 0.401 7.04  
    
 
         
         
         
Section C2  
Scale Bar: 50 microns is 2.848 
    
Sample Length Diameter  
1 0.432 7.58  
2 0.428 7.51  
3 0.37 6.50  
4 0.405 7.11  
5 0.387 6.79  
6 0.207 3.63  
7 0.358 6.29  
8 0.176 3.09  
9 0.414 7.27  
    
 
         
         
Section C3  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.418 7.27  
2 0.394 6.85  
3 0.197 3.43  
4 0.34 5.91  
5 0.424 7.37  
6 0.215 3.74  
7 0.36 6.26  
8 0.432 7.51  
9 0.333 5.79  
    
 
         
         
         
 198 
Section D1  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.413 7.15  
2 0.344 5.95  
3 0.399 6.91  
4 0.514 8.90  
5 0.214 3.70  
6 0.45 7.79  
7 0.39 6.75  
8 0.118 2.04  
9 0.382 6.61  
    
 
         
         
         
Section D2  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.36 6.23  
2 0.39 6.75  
3 0.278 4.81  
4 0.415 7.18  
5 0.451 7.81  
6 0.234 4.05  
7 0.527 9.12  
8 0.382 6.61  
9 0.401 6.94  
    
 
         
         
Section D3  
Scale Bar: 50 microns is 2.793 
    
Sample Length Diameter  
1 0.402 7.20  
2 0.469 8.40  
3 0.397 7.11  
4 0.409 7.32  
5 0.684 12.24  
6 0.275 4.92  
7 0.447 8.00  
8 0.443 7.93  
9 0.318 5.69  
    
 
 
 
 
         
 199 
SPIN 6        
         
Section A1  
Scale Bar: 50 microns is 2.834 
    
Sample Length Diameter  
1 0.638 11.26  
2 0.469 8.27  
3 0.488 8.61  
4 0.489 8.63  
5 0.419 7.39  
6 0.486 8.57  
7 0.384 6.77  
8 0.361 6.37  
9 0.37 6.53  
    
 
         
         
         
Section A2  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.587 10.11  
2 0.529 9.11  
3 0.641 11.04  
4 0.318 5.48  
5 0.138 2.38  
6 0.456 7.85  
7 0.477 8.22  
8 0.486 8.37  
9 0.462 7.96  
    
 
         
         
Section A3  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.254 4.35  
2 0.544 9.32  
3 0.609 10.44  
4 0.44 7.54  
5 0.486 8.33  
6 0.502 8.60  
7 0.432 7.40  
8 0.523 8.96  
9 0.482 8.26  
    
 
         
 200 
Section B1  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.083 1.42  
2 1.016 17.42  
3 0.475 8.14  
4 0.461 7.90  
5 0.448 7.68  
6 0.399 6.84  
7 0.443 7.59  
8 0.273 4.68  
9 0.357 6.12  
    
 
         
         
         
Section B2  
Scale Bar: 50 microns is 2.82 
    
Sample Length Diameter  
1 1.014 17.98  
2 0.511 9.06  
3 0.47 8.33  
4 0.448 7.94  
5 0.328 5.82  
6 0.508 9.01  
7 0.449 7.96  
8 0.432 7.66  
9 0.512 9.08  
    
 
         
         
Section B3  
Scale Bar: 50 microns is 2.807 
    
Sample Length Diameter  
1 0.406 7.23  
2 0.455 8.10  
3 0.289 5.15  
4 0.394 7.02  
5 0.451 8.03  
6 0.382 6.80  
7 0.317 5.65  
8 0.449 8.00  
9 0.512 9.12  
    
 
         
         
         
 201 
Section C1  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.5 8.65  
2 0.234 4.05  
3 0.446 7.72  
4 0.418 7.23  
5 0.449 7.77  
6 0.427 7.39  
7 0.473 8.19  
8 0.418 7.23  
9 0.485 8.39  
    
 
         
         
         
Section C2  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.446 7.68  
2 0.641 11.04  
3 0.402 6.92  
4 0.448 7.72  
5 0.435 7.49  
6 0.292 5.03  
7 0.418 7.20  
8 0.451 7.77  
9 0.254 4.37  
    
 
         
         
Section C3  
Scale Bar: 50 microns is 2.848 
    
Sample Length Diameter  
1 0.419 7.36  
2 0.413 7.25  
3 0.296 5.20  
4 0.275 4.83  
5 0.474 8.32  
6 0.409 7.18  
7 0.57 10.01  
8 0.597 10.48  
9 0.314 5.51  
    
 
         
         
         
 202 
Section D1  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.447 7.66  
2 0.149 2.55  
3 0.495 8.48  
4 0.457 7.83  
5 0.466 7.99  
6 0.457 7.83  
7 0.376 6.44  
8 0.45 7.71  
9 0.41 7.03  
    
 
         
         
         
Section D2  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.548 9.53  
2 0.45 7.83  
3 0.37 6.43  
4 0.432 7.51  
5 0.374 6.50  
6 0.439 7.63  
7 0.41 7.13  
8 0.399 6.94  
9 0.524 9.11  
    
 
         
         
Section D3  
Scale Bar: 50 microns is 2.807 
    
Sample Length Diameter  
1 0.351 6.25  
2 0.253 4.51  
3 0.539 9.60  
4 0.462 8.23  
5 0.405 7.21  
6 0.426 7.59  
7 0.468 8.34  
8 0.418 7.45  
9 0.431 7.68  
    
 
 
 
 
         
 203 
SPIN 7        
         
Section A1  
Scale Bar: 50 microns is 2.944 
    
Sample Length Diameter  
1 0.328 5.57  
2 0.361 6.13  
3 0.439 7.46  
4 0.335 5.69  
5 0.401 6.81  
6 0.413 7.01  
7 0.35 5.94  
8 0.462 7.85  
9 0.399 6.78  
    
 
         
         
         
Section A2  
Scale Bar: 50 microns is 2.862 
    
Sample Length Diameter  
1 0.427 7.46  
2 0.344 6.01  
3 0.501 8.75  
4 0.154 2.69  
5 0.44 7.69  
6 0.361 6.31  
7 0.496 8.67  
8 0.35 6.11  
9 0.292 5.10  
    
 
         
         
Section A3  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.087 1.51  
2 0.627 10.90  
3 0.498 8.66  
4 0.437 7.60  
5 0.894 15.55  
6 0.385 6.70  
7 0.34 5.91  
8 0.205 3.57  
9 0.341 5.93  
    
 
         
 204 
Section B1  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.406 6.99  
2 0.415 7.15  
3 0.37 6.37  
4 0.419 7.22  
5 0.351 6.05  
6 0.424 7.30  
7 0.419 7.22  
8 0.382 6.58  
9 0.383 6.60  
    
 
         
         
         
Section B2  
Scale Bar: 50 microns is 2.944 
    
Sample Length Diameter  
1 0.361 6.13  
2 0.432 7.34  
3 0.405 6.88  
4 0.235 3.99  
5 0.401 6.81  
6 0.42 7.13  
7 0.409 6.95  
8 0.418 7.10  
9 0.413 7.01  
    
 
         
         
Section B3  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.428 7.44  
2 0.36 6.26  
3 0.401 6.97  
4 0.351 6.10  
5 0.366 6.37  
6 0.35 6.09  
7 0.435 7.57  
8 0.412 7.17  
9 0.322 5.60  
    
 
         
         
         
 205 
Section C1  
Scale Bar: 50 microns is 2.848 
    
Sample Length Diameter  
1 0.405 7.11  
2 0.367 6.44  
3 0.439 7.71  
4 0.427 7.50  
5 0.401 7.04  
6 0.351 6.16  
7 0.419 7.36  
8 0.407 7.15  
9 0.378 6.64  
    
 
         
         
         
Section C2  
Scale Bar: 50 microns is 2.862 
    
Sample Length Diameter  
1 0.469 8.19  
2 0.432 7.55  
3 0.355 6.20  
4 0.437 7.63  
5 0.481 8.40  
6 0.431 7.53  
7 0.437 7.63  
8 0.418 7.30  
9 0.353 6.17  
    
 
         
         
Section C3  
Scale Bar: 50 microns is 2.958 
    
Sample Length Diameter  
1 0.413 6.98  
2 0.413 6.98  
3 0.389 6.58  
4 0.248 4.19  
5 0.45 7.61  
6 0.443 7.49  
7 0.451 7.62  
8 0.444 7.51  
9 0.461 7.79  
    
 
         
         
         
 206 
Section D1  
Scale Bar: 50 microns is 2.848 
    
Sample Length Diameter  
1 0.419 7.36  
2 0.376 6.60  
3 0.44 7.72  
4 0.297 5.21  
5 0.47 8.25  
6 0.446 7.83  
7 0.353 6.20  
8 0.35 6.14  
9 0.351 6.16  
    
 
         
         
         
Section D2  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.567 9.81  
2 0.469 8.12  
3 0.385 6.66  
4 0.536 9.28  
5 0.372 6.44  
6 0.405 7.01  
7 0.394 6.82  
8 0.515 8.91  
9 0.405 7.01  
    
 
         
         
Section D3  
Scale Bar: 50 microns is 2.82 
    
Sample Length Diameter  
1 0.467 8.28  
2 0.431 7.64  
3 0.316 5.60  
4 0.332 5.89  
5 0.522 9.26  
6 0.482 8.55  
7 0.418 7.41  
8 0.389 6.90  
9 0.457 8.10  
    
 
 
 
 
         
 207 
SPIN 8        
         
Section A1  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.426 7.37  
2 0.344 5.95  
3 0.415 7.18  
4 0.687 11.89  
5 0.489 8.46  
6 0.471 8.15  
7 0.418 7.23  
8 0.425 7.36  
9 0.56 9.69  
    
 
         
         
         
Section A2  
Scale Bar: 50 microns is 2.986 
    
Sample Length Diameter  
1 0.279 4.67  
2 0.418 7.00  
3 0.444 7.43  
4 0.254 4.25  
5 0.414 6.93  
6 0.335 5.61  
7 0.248 4.15  
8 0.432 7.23  
9 0.409 6.85  
    
 
         
         
Section A3  
Scale Bar: 50 microns is 2.985 
    
Sample Length Diameter  
1 0.127 2.13  
2 0.488 8.17  
3 0.511 8.56  
4 0.388 6.50  
5 0.5 8.38  
6 0.37 6.20  
7 0.303 5.08  
8 0.418 7.00  
9 0.345 5.78  
    
 
         
 208 
Section B1  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.42 7.20  
2 0.458 7.85  
3 0.535 9.17  
4 0.461 7.90  
5 0.485 8.31  
6 0.492 8.43  
7 0.441 7.56  
8 0.519 8.90  
9 0.43 7.37  
    
 
         
         
         
Section B2  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.428 7.34  
2 0.418 7.16  
3 0.231 3.96  
4 0.449 7.70  
5 0.491 8.42  
6 0.464 7.95  
7 0.408 6.99  
8 0.443 7.59  
9 0.46 7.88  
    
 
         
         
Section B3  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.244 4.24  
2 0.728 12.66  
3 0.444 7.72  
4 0.462 8.03  
5 0.47 8.17  
6 0.29 5.04  
7 0.475 8.26  
8 0.409 7.11  
9 0.374 6.50  
    
 
         
         
         
 209 
Section C1  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.456 7.82  
2 0.519 8.90  
3 0.497 8.52  
4 0.486 8.33  
5 0.289 4.95  
6 0.401 6.87  
7 0.372 6.38  
8 0.537 9.20  
9 0.409 7.01  
    
 
         
         
         
Section C2  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.425 7.39  
2 0.416 7.23  
3 0.387 6.73  
4 0.457 7.95  
5 0.414 7.20  
6 0.401 6.97  
7 0.372 6.47  
8 0.481 8.37  
9 0.473 8.23  
    
 
         
         
Section C3  
Scale Bar: 50 microns is 2.834 
    
Sample Length Diameter  
1 0.467 8.24  
2 0.184 3.25  
3 0.496 8.75  
4 0.426 7.52  
5 0.224 3.95  
6 0.357 6.30  
7 0.477 8.42  
8 0.366 6.46  
9 0.43 7.59  
    
 
         
         
         
 210 
Section D1  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.469 8.08  
2 0.573 9.87  
3 0.407 7.01  
4 0.378 6.51  
5 0.305 5.25  
6 0.401 6.91  
7 0.42 7.23  
8 0.437 7.53  
9 0.587 10.11  
    
 
         
         
         
Section D2  
Scale Bar: 50 microns is 2.93 
    
Sample Length Diameter  
1 0.459 7.83  
2 0.488 8.33  
3 0.517 8.82  
4 0.409 6.98  
5 0.443 7.56  
6 0.37 6.31  
7 0.387 6.60  
8 0.284 4.85  
9 0.261 4.45  
    
 
         
         
Section D3  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.459 7.87  
2 0.529 9.07  
3 0.534 9.15  
4 0.47 8.06  
5 0.448 7.68  
6 0.441 7.56  
7 0.555 9.51  
8 0.475 8.14  
9 0.393 6.74  
    
 
 
 
 
         
 211 
SPIN 9        
    
Section A1  
Scale Bar: 50 microns is 2.944 
    
Sample Length Diameter  
1 0.531 9.02  
2 0.554 9.41  
3 0.514 8.73  
4 0.595 10.11  
5 0.479 8.14  
6 0.469 7.97  
7 0.524 8.90  
8 0.501 8.51  
9 0.499 8.47  
    
 
         
         
    
Section A2  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.413 7.18  
2 0.427 7.43  
3 0.512 8.90  
4 0.488 8.49  
5 0.524 9.11  
6 0.363 6.31  
7 0.497 8.64  
8 0.233 4.05  
9 0.466 8.10  
    
 
         
         
    
Section A3  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.52 9.04  
2 0.562 9.77  
3 0.531 9.23  
4 0.516 8.97  
5 0.524 9.11  
6 0.462 8.03  
7 0.545 9.48  
8 0.52 9.04  
9 0.565 9.83  
    
 
 212 
    
Section B1  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.361 6.28  
2 0.474 8.24  
3 0.555 9.65  
4 0.506 8.80  
5 0.428 7.44  
6 0.506 8.80  
7 0.357 6.21  
8 0.531 9.23  
9 0.401 6.97  
    
 
         
         
    
Section B2  
Scale Bar: 50 microns is 2.862 
    
Sample Length Diameter  
1 0.572 9.99  
2 0.335 5.85  
3 0.511 8.93  
4 0.506 8.84  
5 0.535 9.35  
6 0.386 6.74  
7 0.485 8.47  
8 0.502 8.77  
9 0.454 7.93  
    
 
         
    
Section B3  
Scale Bar: 50 microns is 2.958 
    
Sample Length Diameter  
1 0.552 9.33  
2 0.541 9.14  
3 0.42 7.10  
4 0.567 9.58  
5 0.565 9.55  
6 0.321 5.43  
7 0.508 8.59  
8 0.557 9.42  
9 0.555 9.38  
    
 
         
         
 213 
    
Section C1  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.482 8.34  
2 0.446 7.72  
3 0.488 8.45  
4 0.529 9.16  
5 0.506 8.76  
6 0.467 8.08  
7 0.427 7.39  
8 0.36 6.23  
9 0.321 5.56  
    
 
         
         
    
Section C2  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.444 7.65  
2 0.427 7.35  
3 0.378 6.51  
4 0.511 8.80  
5 0.511 8.80  
6 0.499 8.59  
7 0.497 8.56  
8 0.457 7.87  
9 0.555 9.56  
    
 
         
    
Section C3  
Scale Bar: 50 microns is 2.958 
    
Sample Length Diameter  
1 0.449 7.59  
2 0.518 8.76  
3 0.382 6.46  
4 0.56 9.47  
5 0.46 7.78  
6 0.536 9.06  
7 0.431 7.29  
8 0.512 8.65  
9 0.405 6.85  
    
 
         
         
 214 
    
Section D1  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.474 8.16  
2 0.508 8.75  
3 0.561 9.66  
4 0.237 4.08  
5 0.509 8.77  
6 0.543 9.35  
7 0.507 8.73  
8 0.488 8.41  
9 0.52 8.96  
    
 
         
         
    
Section D2  
Scale Bar: 50 microns is 2.972 
    
Sample Length Diameter  
1 0.492 8.28  
2 0.532 8.95  
3 0.449 7.55  
4 0.518 8.71  
5 0.541 9.10  
6 0.516 8.68  
7 0.52 8.75  
8 0.566 9.52  
9 0.484 8.14  
    
 
         
    
Section D3  
Scale Bar: 50 microns is 2.972 
    
Sample Length Diameter  
1 0.519 8.73  
2 0.461 7.76  
3 0.166 2.79  
4 0.548 9.22  
5 0.522 8.78  
6 0.477 8.02  
7 0.567 9.54  
8 0.308 5.18  
9 0.492 8.28  
    
 
 
 
         
 215 
SPIN 10       
         
Section A1  
Scale Bar: 50 microns is 2.944 
    
Sample Length Diameter  
1 0.541 9.19  
2 0.454 7.71  
3 0.174 2.96  
4 0.174 2.96  
5 0.481 8.17  
6 0.161 2.73  
7 0.636 10.80  
8 0.466 7.91  
9 0.388 6.59  
    
 
         
         
         
Section A2  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.456 7.89  
2 0.467 8.08  
3 0.496 8.58  
4 0.152 2.63  
5 0.537 9.29  
6 0.517 8.95  
7 0.517 8.95  
8 0.545 9.43  
9 0.486 8.41  
    
 
         
         
Section A3  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.443 7.63  
2 1.033 17.79  
3 0.523 9.01  
4 0.499 8.59  
5 0.437 7.53  
6 0.511 8.80  
7 0.459 7.91  
8 0.284 4.89  
9 0.468 8.06  
    
 
         
 216 
Section B1  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.466 8.03  
2 0.254 4.37  
3 0.499 8.59  
4 0.185 3.19  
5 0.526 9.06  
6 0.401 6.91  
7 0.466 8.03  
8 0.245 4.22  
9 0.243 4.19  
    
 
         
         
         
Section B2  
Scale Bar: 50 microns is 2.93 
    
Sample Length Diameter  
1 0.458 7.82  
2 0.154 2.63  
3 0.414 7.06  
4 0.456 7.78  
5 0.428 7.30  
6 0.486 8.29  
7 0.437 7.46  
8 0.154 2.63  
9 0.302 5.15  
    
 
         
         
Section B3  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.388 6.68  
2 0.512 8.82  
3 0.474 8.16  
4 0.58 9.99  
5 0.511 8.80  
6 0.421 7.25  
7 0.478 8.23  
8 0.37 6.37  
9 0.244 4.20  
    
 
         
         
         
 217 
Section C1  
Scale Bar: 50 microns is 2.972 
    
Sample Length Diameter  
1 0.527 8.87  
2 0.161 2.71  
3 0.691 11.63  
4 0.728 12.25  
5 0.21 3.53  
6 0.431 7.25  
7 0.511 8.60  
8 0.422 7.10  
9 0.488 8.21  
    
 
         
         
         
Section C2  
Scale Bar: 50 microns is 2.972 
    
Sample Length Diameter  
1 0.442 7.44  
2 0.1 1.68  
3 0.466 7.84  
4 0.566 9.52  
5 0.192 3.23  
6 0.487 8.19  
7 0.501 8.43  
8 0.448 7.54  
9 0.416 7.00  
    
 
         
         
Section C3  
Scale Bar: 50 microns is 3.027 
    
Sample Length Diameter  
1 0.92 15.20  
2 0.493 8.14  
3 0.506 8.36  
4 1.129 18.65  
5 0.142 2.35  
6 0.565 9.33  
7 0.409 6.76  
8 0.519 8.57  
9 0.29 4.79  
    
 
         
         
         
 218 
Section D1  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.378 6.48  
2 0.243 4.17  
3 0.168 2.88  
4 0.304 5.21  
5 0.866 14.84  
6 0.445 7.63  
7 0.305 5.23  
8 0.76 13.03  
9 0.36 6.17  
    
 
         
         
         
Section D2  
Scale Bar: 50 microns is 2.903 
    
Sample Length Diameter  
1 0.21 3.62  
2 0.179 3.08  
3 0.195 3.36  
4 0.321 5.53  
5 0.286 4.93  
6 0.24 4.13  
7 0.518 8.92  
8 0.798 13.74  
9 0.443 7.63  
    
 
         
         
Section D3  
Scale Bar: 50 microns is 2.958 
    
Sample Length Diameter  
1 0.287 4.85  
2 0.936 15.82  
3 0.647 10.94  
4 0.117 1.98  
5 0.591 9.99  
6 0.358 6.05  
7 0.666 11.26  
8 0.193 3.26  
9 0.253 4.28  
    
 
 
 
 
         
 219 
SPIN 11       
         
Section A1  
Scale Bar: 50 microns is 2.972 
    
Sample Length Diameter  
1 0.586 9.86  
2 0.198 3.33  
3 0.069 1.16  
4 0.142 2.39  
5 0.898 15.11  
6 0.391 6.58  
7 0.363 6.11  
8 0.481 8.09  
9 0.044 0.74  
    
 
         
         
         
Section A2  
Scale Bar: 50 microns is 2.917 
    
Sample Length Diameter  
1 0.305 5.23  
2 1.027 17.60  
3 0.348 5.97  
4 0.473 8.11  
5 0.435 7.46  
6 0.087 1.49  
7 0.445 7.63  
8 0.461 7.90  
9 0.125 2.14  
    
 
         
Section A3  
Scale Bar: 50 microns is 2.985 
    
Sample Length Diameter  
1 0.618 10.35  
2 0.421 7.05  
3 0.237 3.97  
4 0.088 1.47  
5 0.22 3.69  
6 0.321 5.38  
7 0.363 6.08  
8 0.482 8.07  
9 0.123 2.06  
    
 
         
         
 220 
Section B1  
Scale Bar: 50 microns is 2.738 
    
Sample Length Diameter  
1 0.394 7.20  
2 0.467 8.53  
3 0.458 8.36  
4 0.487 8.89  
5 0.46 8.40  
6 0.374 6.83  
7 0.477 8.71  
8 0.406 7.41  
9 0.457 8.35  
    
 
         
         
         
Section B2  
Scale Bar: 50 microns is 2.944 
    
Sample Length Diameter  
1 0.505 8.58  
2 0.454 7.71  
3 0.473 8.03  
4 0.462 7.85  
5 0.493 8.37  
6 0.506 8.59  
7 0.557 9.46  
8 0.457 7.76  
9 0.413 7.01  
    
 
         
         
Section B3  
Scale Bar: 50 microns is 2.958 
    
Sample Length Diameter  
1 0.446 7.54  
2 0.571 9.65  
3 0.509 8.60  
4 0.421 7.12  
5 0.434 7.34  
6 0.44 7.44  
7 0.511 8.64  
8 0.44 7.44  
9 0.499 8.43  
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Section C1  
Scale Bar: 50 microns is 2.875 
    
Sample Length Diameter  
1 0.222 3.86  
2 0.486 8.45  
3 0.427 7.43  
4 0.496 8.63  
5 0.474 8.24  
6 0.305 5.30  
7 0.168 2.92  
8 0.512 8.90  
9 0.451 7.84  
    
 
         
         
         
Section C2  
Scale Bar: 50 microns is 2.862 
    
Sample Length Diameter  
1 0.414 7.23  
2 0.248 4.33  
3 0.493 8.61  
4 0.448 7.83  
5 0.341 5.96  
6 0.41 7.16  
7 0.419 7.32  
8 0.489 8.54  
9 0.478 8.35  
    
 
         
         
Section C3  
Scale Bar: 50 microns is 2.779 
    
Sample Length Diameter  
1 0.283 5.09  
2 0.193 3.47  
3 0.354 6.37  
4 0.481 8.65  
5 0.466 8.38  
6 0.393 7.07  
7 0.451 8.11  
8 0.396 7.12  
9 0.314 5.65  
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Section D1  
Scale Bar: 50 microns is 2.82 
    
Sample Length Diameter  
1 0.266 4.72  
2 0.366 6.49  
3 0.418 7.41  
4 0.573 10.16  
5 0.505 8.95  
6 0.446 7.91  
7 0.412 7.30  
8 0.281 4.98  
9 0.279 4.95  
    
 
         
         
         
Section D2  
Scale Bar: 50 microns is 2.807 
    
Sample Length Diameter  
1 0.428 7.62  
2 0.322 5.74  
3 0.312 5.56  
4 0.435 7.75  
5 0.172 3.06  
6 0.478 8.51  
7 0.469 8.35  
8 0.437 7.78  
9 0.409 7.29  
    
 
         
         
Section D3  
Scale Bar: 50 microns is 2.889 
    
Sample Length Diameter  
1 0.399 6.91  
2 0.428 7.41  
3 0.475 8.22  
4 0.47 8.13  
5 0.492 8.52  
6 0.462 8.00  
7 0.466 8.07  
8 0.514 8.90  
9 0.305 5.28  
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APPENDIX F: THICKNESS MEASUREMENTS 
 
 
Introduction 
 
 
 Scaffold wall thicknesses were measured using a combination of SEM  images and 
the Image J software.  Using the program?s line length measurement tool (ANALYZE > 
MEASURE), the scale bar on all images was measured.  This length corresponded to 2 
millimeters on all images.  Twelve measurements corresponding to the numbers on a 
clock were made on each image, unless the sample had a corrupted section.  In the case 
of corrupted sections or entire samples, no measurements were made.  A simple 
calculation was then used in Microsoft Excel to convert the collected wall thickness into 
wall thickness in millimeters.  In the data shown below, entries under Thickness are in 
millimeters.  All other values are unitless.  Below the thickness column, the mean and 
standard deviation of the data is given. 
 
mm
S
tD 2•


=  
  Where:  D is scaffold thickness in millimeters 
    t is scaffold thickness measured on Image J 
    S is length of the scale bar measured on Image J 
 
 
 
 
 
 
 
     
 224 
SPIN 1 
        
A1        
Scale Bar: 2mm is 365  
 
     
        
Sample Length Thickness      
Top 1 138 0.758      
Top 2 157 0.863      
Top 3 142 0.778      
Right 1 139 0.762      
Right 2 140 0.769      
Right 3 132 0.724      
Bottom 1 122 0.670      
Bottom 2 129 0.705      
Bottom 3 126 0.694      
Left 1 133 0.731      
Left 2 145 0.797      
Left 3 138 0.759      
  0.751 + 0.051    
        
        
        
        
B1        
Scale Bar: 2mm is 343  
 
     
        
Sample Length Size      
Top 1 126.411 0.736      
Top 2 119.195 0.694      
Top 3 121.88 0.710      
Right 1 113.036 0.658      
Right 2 109.628 0.639      
Right 3 97.125 0.566      
Bottom 1 109.429 0.637      
Bottom 2 113.859 0.663      
Bottom 3 93.39 0.544      
Left 1 115.214 0.671      
Left 2 131.557 0.766      
Left 3 123.515 0.719      
  0.667 + 0.065    
        
        
        
        
        
        
        
        
        
 225 
        
        
B2        
BAD SAMPLE   
 
     
        
Sample Length Size      
Top 1 - -      
Top 2 - -      
Top 3 - -      
Right 1 - -      
Right 2 - -      
Right 3 - -      
Bottom 1 - -      
Bottom 2 - -      
Bottom 3 - -      
Left 1 - -      
Left 2 - -      
Left 3 - -      
        
        
        
        
        
C1        
Scale Bar: 2mm is 332  
 
     
        
Sample Length Size      
Top 1 101 0.611      
Top 2 101 0.610      
Top 3 110 0.665      
Right 1 103 0.622      
Right 2 102 0.615      
Right 3 103 0.620      
Bottom 1 89 0.537      
Bottom 2 97 0.586      
Bottom 3 104 0.625      
Left 1 116 0.698      
Left 2 115 0.693      
Left 3 118 0.714      
  0.633 + 0.051    
        
        
        
        
        
        
        
        
        
 226 
        
        
        
        
C2        
Scale Bar: 2mm is 330  
 
     
        
Sample Length Size      
Top 1 108 0.657      
Top 2 101 0.609      
Top 3 115 0.696      
Right 1 90 0.544      
Right 2 99 0.602      
Right 3 100 0.605      
Bottom 1 104 0.628      
Bottom 2 108 0.652      
Bottom 3 122 0.737      
Left 1 108 0.654      
Left 2 114 0.691      
Left 3 108 0.653      
  0.644 + 0.051    
        
        
        
        
D1        
Scale Bar: 2mm is 352.6  
 
     
        
Sample Length Size      
Top 1 137.1 0.778      
Top 2 127.8 0.725      
Top 3 142.7 0.809      
Right 1 127.2 0.721      
Right 2 129.4 0.734      
Right 3 123.7 0.701      
Bottom 1 109.9 0.624      
Bottom 2 112.0 0.635      
Bottom 3 123.8 0.702      
Left 1 125.4 0.711      
Left 2 109.3 0.620      
Left 3 118.2 0.670      
  0.703 + 0.059    
        
        
TOTAL AVERAGE: 0.679 + 0.069024    
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SPIN 2 Thickness Measurement Table     
        
A1        
Scale Bar: 2mm is 322  
 
     
        
Sample Length Thickness      
Top 1 80 0.498      
Top 2 67 0.417      
Top 3 88 0.545      
Right 1 97 0.600      
Right 2 89 0.550      
Right 3 101 0.627      
Bottom 1 89 0.554      
Bottom 2 83 0.515      
Bottom 3 87 0.542      
Left 1 90 0.560      
Left 2 85 0.528      
Left 3 91 0.563      
  0.542 + 0.052    
        
        
        
        
B1        
Scale Bar: 2mm is 305  
 
     
        
Sample Length Size      
Top 1 134 0.879      
Top 2 122 0.798      
Top 3 135 0.882      
Right 1 112 0.735      
Right 2 111 0.730      
Right 3 128 0.836      
Bottom 1 95 0.621      
Bottom 2 92 0.606      
Bottom 3 102 0.669      
Left 1 108 0.709      
Left 2 103 0.677      
Left 3 113 0.738      
  0.740 + 0.093    
        
        
        
        
        
        
        
        
        
 228 
        
        
B2        
Scale Bar: 2mm is 306  
 
     
        
Sample Length Size      
Top 1 100 0.652      
Top 2 95 0.619      
Top 3 96 0.629      
Right 1 83 0.540      
Right 2 81 0.529      
Right 3 93 0.608      
Bottom 1 99 0.650      
Bottom 2 93 0.606      
Bottom 3 97 0.636      
Left 1 94 0.617      
Left 2 92 0.603      
Left 3 87 0.565      
  0.604 + 0.040    
        
        
        
        
C1        
Scale Bar: 2mm is 313  
 
     
        
Sample Length Size      
Top 1 121 0.775      
Top 2 110 0.706      
Top 3 108 0.692      
Right 1 103 0.659      
Right 2 109 0.694      
Right 3 126 0.807      
Bottom 1 110 0.705      
Bottom 2 112 0.719      
Bottom 3 118 0.754      
Left 1 108 0.691      
Left 2 134 0.858      
Left 3 141 0.903      
  0.747 + 0.075    
        
        
        
        
        
        
        
        
        
 229 
        
        
        
        
C2        
Scale Bar: 2mm is 313  
 
     
        
Sample Length Size      
Top 1 119 0.76042      
Top 2 108 0.687573      
Top 3 122 0.776395      
Right 1 119 0.757225      
Right 2 126 0.807067      
Right 3 136 0.869051      
Bottom 1 113 0.722079      
Bottom 2 114 0.728469      
Bottom 3 106 0.675432      
Left 1 125 0.796843      
Left 2 126 0.803872      
Left 3 114 0.729747      
  0.760 + 0.055    
        
        
        
        
D1        
Scale Bar: 2mm is 313  
 
     
        
Sample Length Size      
Top 1 107 0.682      
Top 2 126 0.805      
Top 3 108 0.686      
Right 1 95 0.607      
Right 2 115 0.737      
Right 3 113 0.723      
Bottom 1 95 0.606      
Bottom 2 117 0.746      
Bottom 3 96 0.615      
Left 1 113 0.719      
Left 2 109 0.695      
Left 3 100 0.638      
  0.688 + 0.062    
        
        
TOTAL AVERAGE: 0.680 + 0.102964    
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SPIN 3     
        
A1        
Scale Bar: 2mm is 321  
 
     
        
Sample Length Thickness      
Top 1 113 0.705      
Top 2 129 0.802      
Top 3 123 0.769      
Right 1 109 0.681      
Right 2 112 0.699      
Right 3 122 0.759      
Bottom 1 105 0.652      
Bottom 2 110 0.686      
Bottom 3 108 0.674      
Left 1 110 0.688      
Left 2 119 0.739      
Left 3 123 0.765      
  0.718 + 0.047    
        
        
        
        
B1        
Scale Bar: 2mm is 320  
 
     
        
Sample Length Size      
Top 1 108 0.678      
Top 2 113 0.706      
Top 3 104 0.651      
Right 1 108 0.678      
Right 2 120 0.752      
Right 3 123 0.770      
Bottom 1 113 0.706      
Bottom 2 108 0.677      
Bottom 3 99 0.619      
Left 1 107 0.672      
Left 2 110 0.691      
Left 3 119 0.745      
  0.695 + 0.043    
        
        
        
        
        
        
        
        
        
 231 
        
        
B2        
Scale Bar: 2mm is 314  
 
     
        
Sample Length Size      
Top 1 103 0.656      
Top 2 110 0.702      
Top 3 109 0.696      
Right 1 92 0.582      
Right 2 99 0.630      
Right 3 80 0.508      
Bottom 1 105 0.666      
Bottom 2 111 0.707      
Bottom 3 112 0.713      
Left 1 100 0.639      
Left 2 104 0.661      
Left 3 104 0.660      
  0.652 + 0.059    
        
        
        
        
C1        
Scale Bar: 2mm is 324  
 
     
        
Sample Length Size      
Top 1 106 0.657      
Top 2 111 0.687      
Top 3 124 0.766      
Right 1 106 0.654      
Right 2 116 0.720      
Right 3 132 0.817      
Bottom 1 128 0.793      
Bottom 2 119 0.735      
Bottom 3 128 0.791      
Left 1 129 0.795      
Left 2 118 0.729      
Left 3 144 0.891      
  0.753 + 0.070    
        
        
        
        
        
        
        
        
        
 232 
        
        
        
        
C2        
Scale Bar: 2mm is 329  
 
     
        
Sample Length Size      
Top 1 110 0.668404      
Top 2 128 0.780439      
Top 3 125 0.760048      
Right 1 121 0.733039      
Right 2 115 0.697456      
Right 3 115 0.699536      
Bottom 1 96 0.58331      
Bottom 2 109 0.664536      
Bottom 3 112 0.682404      
Left 1 124 0.75528      
Left 2 129 0.781595      
Left 3 137 0.832017      
  0.720 + 0.067    
        
        
        
        
D1        
Scale Bar: 2mm is 320  
 
     
        
Sample Length Size      
Top 1 100 0.625      
Top 2 106 0.665      
Top 3 110 0.690      
Right 1 116 0.725      
Right 2 113 0.706      
Right 3 126 0.786      
Bottom 1 117 0.732      
Bottom 2 111 0.694      
Bottom 3 106 0.666      
Left 1 101 0.632      
Left 2 96 0.602      
Left 3 102 0.638      
  0.680 + 0.053    
        
        
TOTAL AVERAGE: 0.703 + 0.064068    
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SPIN 4     
        
A1        
Scale Bar: 2mm is 330  
 
     
        
Sample Length Thickness      
Top 1 123 0.746      
Top 2 134 0.814      
Top 3 108 0.655      
Right 1 103 0.626      
Right 2 96 0.580      
Right 3 108 0.652      
Bottom 1 112 0.681      
Bottom 2 111 0.673      
Bottom 3 114 0.689      
Left 1 110 0.666      
Left 2 102 0.620      
Left 3 127 0.768      
  0.681 + 0.066    
        
        
        
        
B1        
Scale Bar: 2mm is 335  
 
     
        
Sample Length Size      
Top 1 125 0.747      
Top 2 119 0.711      
Top 3 134 0.800      
Right 1 125 0.743      
Right 2 120 0.714      
Right 3 131 0.782      
Bottom 1 131 0.782      
Bottom 2 119 0.708      
Bottom 3 113 0.675      
Left 1 116 0.694      
Left 2 130 0.775      
Left 3 137 0.814      
  0.745 + 0.045    
        
        
        
        
        
        
        
        
        
 234 
        
        
B2        
Scale Bar: 2mm is 335  
 
     
        
Sample Length Size      
Top 1 116 0.693      
Top 2 132 0.790      
Top 3 126 0.751      
Right 1 116 0.694      
Right 2 112 0.667      
Right 3 131 0.783      
Bottom 1 111 0.664      
Bottom 2 116 0.693      
Bottom 3 110 0.655      
Left 1 111 0.664      
Left 2 127 0.760      
Left 3 112 0.668      
  0.707 + 0.050    
        
        
        
        
C1        
Scale Bar: 2mm is 330  
 
     
        
Sample Length Size      
Top 1 108 0.655      
Top 2 123 0.745      
Top 3 120 0.725      
Right 1 110 0.669      
Right 2 115 0.697      
Right 3 119 0.718      
Bottom 1 109 0.657      
Bottom 2 111 0.672      
Bottom 3 120 0.725      
Left 1 128 0.778      
Left 2 127 0.769      
Left 3 118 0.715      
  0.710 + 0.042    
        
        
        
        
        
        
        
        
        
 235 
        
        
        
        
C2        
Scale Bar: 2mm is 330  
 
     
        
Sample Length Size      
Top 1 100 0.605727      
Top 2 112 0.680182      
Top 3 119 0.720214      
Right 1 108 0.654869      
Right 2 112 0.675839      
Right 3 110 0.667601      
Bottom 1 108 0.655505      
Bottom 2 115 0.69604      
Bottom 3 106 0.641695      
Left 1 109 0.657213      
Left 2 107 0.64522      
Left 3 117 0.708797      
  0.667 + 0.032    
        
        
        
        
D1        
Scale Bar: 2mm is 317  
 
     
        
Sample Length Size      
Top 1 104 0.657      
Top 2 102 0.644      
Top 3 100 0.632      
Right 1 102 0.645      
Right 2 104 0.654      
Right 3 103 0.652      
Bottom 1 106 0.670      
Bottom 2 116 0.734      
Bottom 3 104 0.657      
Left 1 101 0.640      
Left 2 113 0.715      
Left 3 106 0.669      
  0.664 + 0.031    
        
        
TOTAL AVERAGE: 0.696 + 0.05261    
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SPIN 5     
        
A1        
Scale Bar: 2mm is 309.1  
 
     
        
Sample Length Thickness      
Top 1 131 0.845      
Top 2 144 0.933      
Top 3 148 0.961      
Right 1 145 0.937      
Right 2 157 1.017      
Right 3 161 1.040      
Bottom 1 129 0.837      
Bottom 2 137 0.885      
Bottom 3 150 0.974      
Left 1 158 1.025      
Left 2 163 1.055      
Left 3 146 0.944      
  0.954 + 0.073    
        
        
        
        
B1        
Scale Bar: 2mm is 313.0  
 
     
        
Sample Length Size      
Top 1 - -      
Top 2 - -      
Top 3 - -      
Right 1 153 0.975      
Right 2 141 0.898      
Right 3 140 0.892      
Bottom 1 153 0.977      
Bottom 2 151 0.963      
Bottom 3 139 0.891      
Left 1 136 0.868      
Left 2 147 0.940      
Left 3 125 0.800      
  0.912 + 0.058    
        
        
        
        
        
        
        
        
        
 237 
        
        
B2        
Scale Bar: 2mm is 311.7  
 
     
        
Sample Length Size      
Top 1 150 0.960      
Top 2 173 1.108      
Top 3 148 0.952      
Right 1 159 1.019      
Right 2 164 1.052      
Right 3 158 1.015      
Bottom 1 145 0.929      
Bottom 2 145 0.932      
Bottom 3 139 0.894      
Left 1 147 0.941      
Left 2 145 0.928      
Left 3 147 0.941      
  0.973 + 0.062    
        
        
        
        
C1        
Scale Bar: 2mm is 313.0  
 
     
        
Sample Length Size      
Top 1 134 0.856      
Top 2 145 0.925      
Top 3 149 0.950      
Right 1 143 0.915      
Right 2 146 0.932      
Right 3 141 0.899      
Bottom 1 132 0.846      
Bottom 2 130 0.833      
Bottom 3 143 0.913      
Left 1 150 0.959      
Left 2 161 1.030      
Left 3 142 0.905      
  0.913 + 0.054    
        
        
        
        
        
        
        
        
        
 238 
        
        
        
        
C2        
Scale Bar: 2mm is 314.3  
 
     
        
Sample Length Size      
Top 1 145 0.921      
Top 2 165 1.050      
Top 3 137 0.870      
Right 1 130 0.827      
Right 2 135 0.857      
Right 3 144 0.917      
Bottom 1 139 0.883      
Bottom 2 132 0.839      
Bottom 3 136 0.868      
Left 1 135 0.856      
Left 2 144 0.914      
Left 3 135 0.861      
  0.889 + 0.059    
        
        
        
        
D1        
Scale Bar: 2mm is 328.9  
 
     
        
Sample Length Size      
Top 1 145 0.884      
Top 2 151 0.920      
Top 3 143 0.869      
Right 1 132 0.803      
Right 2 151 0.917      
Right 3 137 0.833      
Bottom 1 140 0.852      
Bottom 2 149 0.909      
Bottom 3 144 0.875      
Left 1 154 0.936      
Left 2 160 0.975      
Left 3 147 0.892      
  0.889 + 0.047    
        
        
TOTAL AVERAGE: 0.922 + 0.066    
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SPIN 6     
        
A1        
Scale Bar: 2mm is 328.9  
 
     
        
Sample Length Thickness      
Top 1 143 0.870      
Top 2 123 0.751      
Top 3 121 0.738      
Right 1 110 0.672      
Right 2 112 0.682      
Right 3 113 0.686      
Bottom 1 112 0.684      
Bottom 2 110 0.667      
Bottom 3 113 0.689      
Left 1 118 0.716      
Left 2 135 0.819      
Left 3 134 0.813      
  0.732 + 0.068    
        
        
        
        
B1        
Scale Bar: 2mm is 324.9  
 
     
        
Sample Length Size      
Top 1 114 0.702      
Top 2 123 0.758      
Top 3 112 0.692      
Right 1 111 0.686      
Right 2 109 0.669      
Right 3 108 0.662      
Bottom 1 109 0.673      
Bottom 2 110 0.675      
Bottom 3 118 0.726      
Left 1 107 0.660      
Left 2 114 0.703      
Left 3 119 0.733      
  0.695 + 0.031    
        
        
        
        
        
        
        
        
        
 240 
        
        
B2        
Scale Bar: 2mm is 324.9  
 
     
        
Sample Length Size      
Top 1 122 0.752      
Top 2 130 0.797      
Top 3 126 0.776      
Right 1 122 0.753      
Right 2 131 0.805      
Right 3 114 0.701      
Bottom 1 111 0.686      
Bottom 2 113 0.695      
Bottom 3 119 0.731      
Left 1 119 0.731      
Left 2 120 0.740      
Left 3 124 0.761      
  0.744 + 0.038    
        
        
        
        
C1        
Scale Bar: 2mm is 320.9  
 
     
        
Sample Length Size      
Top 1 128 0.797      
Top 2 122 0.763      
Top 3 120 0.746      
Right 1 118 0.736      
Right 2 130 0.813      
Right 3 120 0.749      
Bottom 1 115 0.717      
Bottom 2 119 0.744      
Bottom 3 116 0.723      
Left 1 121 0.755      
Left 2 128 0.796      
Left 3 111 0.695      
  0.753 + 0.035    
        
        
        
        
        
        
        
        
        
 241 
        
        
        
        
C2        
BAD SAMPLE       
        
Sample Length Size      
Top 1 - -      
Top 2 - -      
Top 3 - -      
Right 1 - -      
Right 2 - -      
Right 3 - -      
Bottom 1 - -      
Bottom 2 - -      
Bottom 3 - -      
Left 1 - -      
Left 2 - -      
Left 3 - -      
        
        
        
        
        
D1        
Scale Bar: 2mm is 328.9  
 
     
        
Sample Length Size      
Top 1 115 0.702      
Top 2 133 0.808      
Top 3 107 0.653      
Right 1 113 0.690      
Right 2 125 0.758      
Right 3 111 0.678      
Bottom 1 106 0.646      
Bottom 2 114 0.696      
Bottom 3 111 0.678      
Left 1 114 0.694      
Left 2 114 0.696      
Left 3 112 0.680      
  0.698 + 0.044    
        
        
TOTAL AVERAGE: 0.724 + 0.049668    
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SPIN 7     
        
A1        
Scale Bar: 2mm is 324.0  
 
     
        
Sample Length Thickness      
Top 1 129 0.798      
Top 2 151 0.933      
Top 3 130 0.803      
Right 1 132 0.815      
Right 2 129 0.798      
Right 3 107 0.663      
Bottom 1 107 0.660      
Bottom 2 114 0.702      
Bottom 3 120 0.738      
Left 1 131 0.810      
Left 2 137 0.846      
Left 3 136 0.840      
  0.784 + 0.080    
        
        
        
        
B1        
Scale Bar: 2mm is 336.8  
 
     
        
Sample Length Size      
Top 1 145 0.862      
Top 2 151 0.899      
Top 3 157 0.931      
Right 1 142 0.843      
Right 2 139 0.828      
Right 3 138 0.821      
Bottom 1 130 0.772      
Bottom 2 128 0.762      
Bottom 3 139 0.823      
Left 1 133 0.790      
Left 2 154 0.913      
Left 3 145 0.861      
  0.842 + 0.054    
        
        
        
        
        
        
        
        
        
 243 
        
        
B2        
Scale Bar: 2mm is 331.5  
 
     
        
Sample Length Size      
Top 1 - -      
Top 2 - -      
Top 3 - -      
Right 1 - -      
Right 2 - -      
Right 3 - -      
Bottom 1 147 0.885      
Bottom 2 139 0.837      
Bottom 3 140 0.843      
Left 1 156 0.942      
Left 2 143 0.865      
Left 3 121 0.727      
  0.850 + 0.071    
        
        
        
        
C1        
Scale Bar: 2mm is 332.8  
 
     
        
Sample Length Size      
Top 1 123 0.740      
Top 2 132 0.795      
Top 3 113 0.678      
Right 1 123 0.740      
Right 2 135 0.809      
Right 3 129 0.772      
Bottom 1 116 0.696      
Bottom 2 115 0.690      
Bottom 3 122 0.735      
Left 1 125 0.752      
Left 2 141 0.847      
Left 3 119 0.713      
  0.747 + 0.051    
        
        
        
        
        
        
        
        
        
 244 
        
        
        
        
C2        
Scale Bar: 2mm is 332.8  
 
     
        
Sample Length Size      
Top 1 127 0.763961      
Top 2 139 0.835403      
Top 3 125 0.752748      
Right 1 132 0.794992      
Right 2 141 0.844291      
Right 3 126 0.757255      
Bottom 1 129 0.773756      
Bottom 2 131 0.786068      
Bottom 3 129 0.773425      
Left 1 114 0.68479      
Left 2 126 0.754256      
Left 3 135 0.808507      
  0.777 + 0.042    
        
        
        
        
D1        
Scale Bar: 2mm is 336.8  
 
     
        
Sample Length Size      
Top 1 132 0.782      
Top 2 152 0.901      
Top 3 137 0.815      
Right 1 126 0.751      
Right 2 140 0.833      
Right 3 147 0.875      
Bottom 1 139 0.827      
Bottom 2 122 0.727      
Bottom 3 126 0.747      
Left 1 125 0.740      
Left 2 140 0.832      
Left 3 127 0.752      
  0.799 + 0.057    
        
        
TOTAL AVERAGE: 0.795 + 0.066627    
 
 
 
 245 
SPIN 8     
        
A1        
Scale Bar: 2mm is 328.9  
 
     
        
Sample Length Thickness      
Top 1 - -      
Top 2 - -      
Top 3 - -      
Right 1 121 0.738      
Right 2 114 0.691      
Right 3 116 0.708      
Bottom 1 112 0.681      
Bottom 2 115 0.702      
Bottom 3 112 0.682      
Left 1 116 0.704      
Left 2 128 0.780      
Left 3 126 0.765      
  0.717 + 0.036    
        
        
        
        
B1        
Scale Bar: 2mm is 317.0  
 
     
        
Sample Length Size      
Top 1 157 0.988      
Top 2 159 1.003      
Top 3 144 0.908      
Right 1 147 0.926      
Right 2 134 0.844      
Right 3 136 0.860      
Bottom 1 129 0.817      
Bottom 2 116 0.734      
Bottom 3 131 0.823      
Left 1 155 0.978      
Left 2 151 0.951      
Left 3 156 0.984      
  0.901 + 0.085    
        
        
        
        
        
        
        
        
        
 246 
        
        
B2        
Scale Bar: 2mm is 315.7  
 
     
        
Sample Length Size      
Top 1 132 0.838      
Top 2 128 0.811      
Top 3 129 0.819      
Right 1 126 0.795      
Right 2 140 0.889      
Right 3 124 0.788      
Bottom 1 127 0.804      
Bottom 2 140 0.887      
Bottom 3 130 0.824      
Left 1 135 0.857      
Left 2 130 0.824      
Left 3 124 0.789      
  0.827 + 0.035    
        
        
        
        
C1        
Scale Bar: 2mm is 323.6  
 
     
        
Sample Length Size      
Top 1 145 0.899      
Top 2 149 0.920      
Top 3 141 0.873      
Right 1 146 0.901      
Right 2 147 0.909      
Right 3 155 0.958      
Bottom 1 148 0.913      
Bottom 2 144 0.890      
Bottom 3 143 0.885      
Left 1 146 0.903      
Left 2 153 0.949      
Left 3 151 0.932      
  0.911 + 0.025    
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C2        
Scale Bar: 2mm is 323.6  
 
     
        
Sample Length Size      
Top 1 187 1.155184      
Top 2 194 1.201775      
Top 3 154 0.951993      
Right 1 146 0.904981      
Right 2 153 0.948414      
Right 3 152 0.942215      
Bottom 1 - -      
Bottom 2 - -      
Bottom 3 - -      
Left 1 173 1.066519      
Left 2 166 1.026955      
Left 3 164 1.016515      
  1.024 + 0.102    
        
        
        
        
D1        
Scale Bar: 2mm is 314.3  
 
     
        
Sample Length Size      
Top 1 137 0.875      
Top 2 139 0.886      
Top 3 123 0.786      
Right 1 142 0.902      
Right 2 145 0.926      
Right 3 145 0.923      
Bottom 1 137 0.872      
Bottom 2 144 0.916      
Bottom 3 141 0.898      
Left 1 142 0.906      
Left 2 139 0.882      
Left 3 131 0.832      
  0.884 + 0.040    
        
        
TOTAL AVERAGE: 0.878 + 0.102846    
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SPIN 9     
        
A1        
Scale Bar: 2mm is 317.0  
 
     
        
Sample Length Thickness      
Top 1 143 0.902      
Top 2 138 0.872      
Top 3 138 0.871      
Right 1 123 0.778      
Right 2 129 0.813      
Right 3 124 0.784      
Bottom 1 123 0.778      
Bottom 2 123 0.775      
Bottom 3 131 0.825      
Left 1 146 0.921      
Left 2 145 0.917      
Left 3 140 0.882      
  0.843 + 0.057    
        
        
        
        
B1        
Scale Bar: 2mm is 326.2  
 
     
        
Sample Length Size      
Top 1 138 0.848      
Top 2 143 0.878      
Top 3 129 0.792      
Right 1 - -      
Right 2 - -      
Right 3 - -      
Bottom 1 130 0.794      
Bottom 2 131 0.805      
Bottom 3 130 0.798      
Left 1 138 0.844      
Left 2 144 0.884      
Left 3 139 0.855      
  0.833 + 0.036    
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B2        
Scale Bar: 2mm is 318.3  
 
     
        
Sample Length Size      
Top 1 137 0.860      
Top 2 145 0.913      
Top 3 155 0.976      
Right 1 150 0.941      
Right 2 149 0.937      
Right 3 126 0.794      
Bottom 1 127 0.798      
Bottom 2 123 0.772      
Bottom 3 131 0.822      
Left 1 132 0.832      
Left 2 139 0.876      
Left 3 143 0.898      
  0.868 + 0.066    
        
        
        
        
C1        
Scale Bar: 2mm is 320.9  
 
     
        
Sample Length Size      
Top 1 141 0.881      
Top 2 143 0.890      
Top 3 128 0.795      
Right 1 122 0.760      
Right 2 135 0.843      
Right 3 126 0.785      
Bottom 1 131 0.818      
Bottom 2 129 0.807      
Bottom 3 121 0.756      
Left 1 127 0.794      
Left 2 146 0.909      
Left 3 137 0.852      
  0.824 + 0.051    
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C2        
Scale Bar: 2mm is 319.6  
 
     
        
Sample Length Size      
Top 1 127 0.797      
Top 2 145 0.905      
Top 3 129 0.807      
Right 1 132 0.826      
Right 2 132 0.826      
Right 3 134 0.836      
Bottom 1 127 0.795      
Bottom 2 129 0.809      
Bottom 3 128 0.798      
Left 1 125 0.780      
Left 2 146 0.916      
Left 3 147 0.920      
  0.835 + 0.050    
        
        
        
        
D1        
Scale Bar: 2mm is 319.6  
 
     
        
Sample Length Size      
Top 1 126 0.787      
Top 2 124 0.777      
Top 3 122 0.761      
Right 1 119 0.748      
Right 2 124 0.777      
Right 3 127 0.793      
Bottom 1 111 0.693      
Bottom 2 111 0.694      
Bottom 3 114 0.713      
Left 1 120 0.748      
Left 2 127 0.795      
Left 3 123 0.771      
  0.755 + 0.037    
        
        
TOTAL AVERAGE: 0.826 + 0.06094    
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SPIN 10     
        
A1        
Scale Bar: 2mm is 332.8  
 
     
        
Sample Length Thickness      
Top 1 140 0.839      
Top 2 165 0.993      
Top 3 134 0.808      
Right 1 130 0.779      
Right 2 136 0.818      
Right 3 134 0.803      
Bottom 1 134 0.806      
Bottom 2 140 0.839      
Bottom 3 141 0.845      
Left 1 126 0.760      
Left 2 136 0.818      
Left 3 132 0.792      
  0.825 + 0.059    
        
        
        
        
B1        
Bad Sample       
        
Sample Length Size      
Top 1 - -      
Top 2 - -      
Top 3 - -      
Right 1 - -      
Right 2 - -      
Right 3 - -      
Bottom 1 - -      
Bottom 2 - -      
Bottom 3 - -      
Left 1 - -      
Left 2 - -      
Left 3 - -      
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B2        
Scale Bar: 2mm is 319.6  
 
     
        
Sample Length Size      
Top 1 125 0.780      
Top 2 138 0.862      
Top 3 125 0.780      
Right 1 151 0.942      
Right 2 158 0.987      
Right 3 127 0.796      
Bottom 1 118 0.737      
Bottom 2 132 0.827      
Bottom 3 131 0.818      
Left 1 133 0.830      
Left 2 125 0.780      
Left 3 120 0.752      
  0.824 + 0.075    
        
        
        
        
C1        
Scale Bar: 2mm is 319.6  
 
     
        
Sample Length Size      
Top 1 127 0.794      
Top 2 147 0.919      
Top 3 138 0.864      
Right 1 136 0.850      
Right 2 148 0.926      
Right 3 133 0.830      
Bottom 1 115 0.721      
Bottom 2 135 0.843      
Bottom 3 130 0.812      
Left 1 133 0.832      
Left 2 142 0.886      
Left 3 149 0.931      
  0.851 + 0.061    
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C2        
Scale Bar: 2mm is 319.6  
 
     
        
Sample Length Size      
Top 1 129 0.808      
Top 2 142 0.886      
Top 3 144 0.900      
Right 1 135 0.844      
Right 2 154 0.965      
Right 3 146 0.915      
Bottom 1 135 0.845      
Bottom 2 136 0.850      
Bottom 3 138 0.865      
Left 1 136 0.854      
Left 2 151 0.943      
Left 3 135 0.842      
  0.876 + 0.046    
        
        
        
        
D1        
Scale Bar: 2mm is 320.9  
 
     
        
Sample Length Size      
Top 1 118 0.735      
Top 2 137 0.856      
Top 3 134 0.835      
Right 1 135 0.841      
Right 2 149 0.926      
Right 3 140 0.874      
Bottom 1 118 0.737      
Bottom 2 117 0.727      
Bottom 3 133 0.832      
Left 1 135 0.840      
Left 2 140 0.875      
Left 3 126 0.784      
  0.822 + 0.063    
        
        
TOTAL AVERAGE: 0.840 + 0.062941    
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SPIN 11     
        
A1        
Scale Bar: 2mm is 335.5  
 
     
        
Sample Length Thickness      
Top 1 134 0.800      
Top 2 133 0.793      
Top 3 139 0.827      
Right 1 133 0.791      
Right 2 133 0.793      
Right 3 132 0.786      
Bottom 1 128 0.762      
Bottom 2 108 0.646      
Bottom 3 104 0.618      
Left 1 127 0.757      
Left 2 137 0.814      
Left 3 125 0.743      
  0.761 + 0.065    
        
        
        
        
B1        
Scale Bar: 2mm is 319.6  
 
     
        
Sample Length Size      
Top 1 103 0.646      
Top 2 123 0.768      
Top 3 121 0.755      
Right 1 125 0.782      
Right 2 123 0.770      
Right 3 121 0.758      
Bottom 1 120 0.750      
Bottom 2 121 0.757      
Bottom 3 122 0.765      
Left 1 115 0.719      
Left 2 114 0.714      
Left 3 119 0.747      
 132 0.744 + 0.037    
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B2        
Scale Bar: 2mm is 320.9  
 
     
        
Sample Length Size      
Top 1 - -      
Top 2 - -      
Top 3 - -      
Right 1 154 0.957      
Right 2 145 0.904      
Right 3 145 0.903      
Bottom 1 118 0.734      
Bottom 2 106 0.661      
Bottom 3 99 0.617      
Left 1 103 0.639      
Left 2 116 0.721      
Left 3 139 0.865      
  0.778 + 0.130    
        
        
        
        
C1        
Scale Bar: 2mm is 320.9  
 
     
        
Sample Length Size      
Top 1 152 0.950      
Top 2 149 0.931      
Top 3 144 0.896      
Right 1 146 0.909      
Right 2 135 0.843      
Right 3 126 0.787      
Bottom 1 119 0.741      
Bottom 2 132 0.820      
Bottom 3 131 0.814      
Left 1 132 0.825      
Left 2 143 0.890      
Left 3 150 0.933      
  0.862 + 0.066    
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C2        
Bad Sample       
        
Sample Length Size      
Top 1 - -      
Top 2 - -      
Top 3 - -      
Right 1 - -      
Right 2 - -      
Right 3 - -      
Bottom 1 - -      
Bottom 2 - -      
Bottom 3 - -      
Left 1 - -      
Left 2 - -      
Left 3 - -      
        
        
        
        
        
D1        
Scale Bar: 2mm is 328.9  
 
     
        
Sample Length Size      
Top 1 124 0.755      
Top 2 139 0.847      
Top 3 124 0.754      
Right 1 124 0.757      
Right 2 140 0.852      
Right 3 142 0.865      
Bottom 1 136 0.827      
Bottom 2 135 0.822      
Bottom 3 129 0.783      
Left 1 143 0.869      
Left 2 160 0.974      
Left 3 138 0.839      
  0.829 + 0.063    
        
        
TOTAL AVERAGE: 0.796 + 0.084699    
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APPENDIX G: TENSILE TESTING FIGURES 
 
 
Introduction 
 
 
 In this appendix, tensile testing results for all consistency constructs are included.  
For an explanation of how each construct was sectioned and tested, see Chapter 4.  The 
first graph presented for individual sections shows stress versus strain behavior for the 
entire tensile test.  Y-axis stress values are all in units of MPa, while x-axis strain values 
are unitless (mm/mm).  The second graph shows linear stress behavior, in which the slope 
of the best-fit linear line represents Young?s modulus according to Hooke?s Law.  
Microsoft Excel was used to generate all figures and equations. 
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Spin 1 
 
Section AB: Longitudinal Test 
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Spin 1 
 
Section AB: Radial Test 
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Spin 1 
 
Section BC: Longitudinal Test 
 
Stress-Strain Curve
0
0.2
0.4
0.6
0.8
1
1.2
0 0.5 1 1.5 2 2.5 3 3.5
Strain
St
re
ss
 
 
 
Linear Stress y = 8.1919x - 0.2209
R2 = 0.9739
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 0.02 0.04 0.06 0.08 0.1 0.12
Strain
St
re
ss
 
 
 
 
 
 
 
 
 
 
 
 
 261 
Spin 1 
 
Section BC: Radial Test 
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Spin 1 
 
Section CD: Longitudinal Test 
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Spin 1 
 
Section CD: Radial Test 
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Spin 2 
 
Section AB: Longitudinal Test 
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Spin 2 
 
Section AB: Radial Test 
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Spin 2 
 
Section BC: Longitudinal Test 
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Spin 2 
 
Section BC: Radial Test 
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Spin 2 
 
Section CD: Longitudinal Test 
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Spin 2 
 
Section CD: Radial Test 
 
Stress-Strain Curve
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0 0.5 1 1.5 2 2.5
Strain
St
re
ss
 
 
 
Chart Title
y = 5.7769x + 0.005
R2 = 0.9928
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 0.02 0.04 0.06 0.08 0.1 0.12 0.14
Stress vs. Strain
Linear (Stress vs. Strain)
 
 
 
 
 
 
 
 
 
 
 
 
 270 
Spin 3 
 
Section AB: Longitudinal Test 
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Spin 3 
 
Section AB: Radial Test 
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Spin 3 
 
Section BC: Longitudinal Test 
 
Stress-Strain Curve
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
-1 0 1 2 3 4 5 6 7 8 9
Strain
St
re
ss
 
 
 
Linear Stress y = 12.884x - 0.3264
R2 = 0.9699
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16
Strain
St
re
ss
 
 
 
 
 
 
 
 
 
 
 
 
 273 
Spin 3 
 
Section BC: Radial Test 
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Spin 3 
 
Section CD: Longitudinal Test 
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Spin 3 
 
Section CD: Radial Test 
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Spin 4 
 
Section AB: Longitudinal Test 
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Spin 4 
 
Section AB: Radial Test 
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Spin 4 
 
Section BC: Longitudinal Test 
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Spin 4 
 
Section BC: Radial Test 
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Spin 4 
 
Section CD: Longitudinal Test 
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Spin 4 
 
Section CD: Radial Test 
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Spin 5 
 
Section AB: Longitudinal Test 
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Spin 5 
 
Section AB: Radial Test 
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Spin 5 
 
Section BC: Longitudinal Test 
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APPENDIX H: INTRASCAFFOLD FIBER DIAMETER COMPARISON 
 
 
Introduction 
 
 
This appendix contains ANOVA test results comparing the statistical similarity of 
fiber diameter data between sections of the same scaffold.  Each test has four levels 
corresponding to the four sections imaged for fiber diameter from each scaffold (A, B, C, 
and D).  Tukey?s method of comparison was used to generate 95% confidence intervals 
for each ANOVA test and the intervals are presented below the ANOVA results.  The 
confidence intervals show how the data from each section compares to the others based 
on individual means and a pooled standard deviation. 
The key to understanding the intrascaffold fiber diameter ANOVA tests is the P-
value.  The P-value tells whether the null hypothesis (fiber diameter of all sections are 
equal) should be rejected or not.  A small P-value indicates that there is a small chance of 
committing a type I error, which means rejecting the null hypothesis and being incorrect.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 325 
 
One-way ANOVA: Spin 1  
 
Source   DF      SS    MS     F      P 
Section   3    7.52  2.51  0.42  0.741 
Error   104  624.94  6.01 
Total   107  632.46 
 
S = 2.451   R-Sq = 1.19%   R-Sq(adj) = 0.00% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev  ---+---------+---------+---------+------ 
A      27  7.013  1.809            (------------*-------------) 
B      27  6.414  2.325   (-------------*------------) 
C      27  6.574  2.401      (------------*------------) 
D      27  6.329  3.097  (------------*-------------) 
                         ---+---------+---------+---------+------ 
                          5.60      6.30      7.00      7.70 
 
 
One-way ANOVA: Spin 2  
 
Source   DF      SS    MS     F      P 
Section   3   17.79  5.93  1.50  0.219 
Error   104  410.78  3.95 
Total   107  428.57 
 
S = 1.987   R-Sq = 4.15%   R-Sq(adj) = 1.39% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev  -----+---------+---------+---------+---- 
A      27  6.584  1.635          (----------*----------) 
B      27  6.004  2.022  (----------*----------) 
C      27  7.011  2.456                (----------*----------) 
D      27  6.088  1.734   (----------*----------) 
                         -----+---------+---------+---------+---- 
                            5.60      6.30      7.00      7.70 
 
 
One-way ANOVA: Spin 3  
 
Source   DF      SS    MS     F      P 
Section   3   16.48  5.49  1.14  0.336 
Error   104  500.99  4.82 
Total   107  517.47 
 
S = 2.195   R-Sq = 3.19%   R-Sq(adj) = 0.39% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev    +---------+---------+---------+--------- 
A      27  7.067  0.884             (-----------*-----------) 
B      27  7.365  0.725                 (-----------*-----------) 
C      27  6.407  1.531    (-----------*-----------) 
D      27  6.530  3.952     (-----------*-----------) 
                           +---------+---------+---------+--------- 
                         5.60      6.30      7.00      7.70 
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One-way ANOVA: Spin 4  
 
Source   DF      SS    MS     F      P 
Section   3    3.98  1.33  0.91  0.439 
Error   104  151.91  1.46 
Total   107  155.89 
 
S = 1.209   R-Sq = 2.56%   R-Sq(adj) = 0.00% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev    +---------+---------+---------+--------- 
A      27  7.922  0.822                 (------------*-------------) 
B      27  7.566  1.697       (------------*------------) 
C      27  7.468  1.287    (------------*-------------) 
D      27  7.864  0.793                (------------*------------) 
                           +---------+---------+---------+--------- 
                         7.00      7.35      7.70      8.05 
  
 
One-way ANOVA: Spin 5 
 
Source   DF      SS    MS     F      P 
Section   3   27.66  9.22  2.74  0.047 
Error   104  350.36  3.37 
Total   107  378.02 
 
S = 1.835   R-Sq = 7.32%   R-Sq(adj) = 4.64% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev    +---------+---------+---------+--------- 
A      27  6.339  1.898               (---------*---------) 
B      27  5.605  1.769    (---------*---------) 
C      27  5.647  1.735     (---------*---------) 
D      27  6.819  1.933                     (---------*---------) 
                           +---------+---------+---------+--------- 
                         4.90      5.60      6.30      7.00 
 
 
One-way ANOVA: Spin 6  
 
Source   DF      SS    MS     F      P 
Section   3   11.28  3.76  0.79  0.503 
Error   104  496.54  4.77 
Total   107  507.82 
 
S = 2.185   R-Sq = 2.22%   R-Sq(adj) = 0.00% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev  --+---------+---------+---------+------- 
A      27  8.005  1.908              (------------*-------------) 
B      27  7.990  3.246             (-------------*-------------) 
C      27  7.333  1.703  (-------------*-------------) 
D      27  7.371  1.422   (-------------*-------------) 
                         --+---------+---------+---------+------- 
                         6.60      7.20      7.80      8.40 
 
 
 327 
One-way ANOVA: Spin 7  
 
Source   DF      SS    MS     F      P 
Section   3    7.82  2.61  1.12  0.344 
Error   104  241.58  2.32 
Total   107  249.40 
 
S = 1.524   R-Sq = 3.14%   R-Sq(adj) = 0.34% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev  --------+---------+---------+---------+- 
A      27  6.828  2.576     (-----------*----------) 
B      27  6.681  0.739  (-----------*----------) 
C      27  7.128  0.826           (-----------*----------) 
D      27  7.376  1.194                (-----------*----------) 
                         --------+---------+---------+---------+- 
                               6.50      7.00      7.50      8.00 
 
 
One-way ANOVA: Spin 8 
 
Source   DF      SS    MS     F      P 
Section   3    9.73  3.24  1.27  0.287 
Error   104  264.81  2.55 
Total   107  274.54 
 
S = 1.596   R-Sq = 3.54%   R-Sq(adj) = 0.76% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev  -----+---------+---------+---------+---- 
A      27  6.860  1.905  (-----------*-----------) 
B      27  7.609  1.597                 (-----------*-----------) 
C      27  7.222  1.424         (-----------*------------) 
D      27  7.556  1.406                (-----------*-----------) 
                         -----+---------+---------+---------+---- 
                            6.50      7.00      7.50      8.00 
 
 
 
One-way ANOVA: Spin 9  
 
Source   DF      SS    MS     F      P 
Section   3    4.20  1.40  0.81  0.490 
Error   104  179.50  1.73 
Total   107  183.71 
 
S = 1.314   R-Sq = 2.29%   R-Sq(adj) = 0.00% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev  ---+---------+---------+---------+------ 
A      27  8.518  1.221               (------------*-----------) 
B      27  8.297  1.313          (-----------*------------) 
C      27  7.973  1.031  (-----------*------------) 
D      27  8.180  1.621       (------------*-----------) 
                         ---+---------+---------+---------+------ 
                          7.60      8.00      8.40      8.80 
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One-way ANOVA: Spin 10 
 
Source   DF      SS    MS     F      P 
Section   3    28.6   9.5  0.89  0.450 
Error   104  1114.2  10.7 
Total   107  1142.7 
 
S = 3.273   R-Sq = 2.50%   R-Sq(adj) = 0.00% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev  -----+---------+---------+---------+---- 
A      27  7.832  2.987             (-----------*------------) 
B      27  6.712  2.107  (-----------*------------) 
C      27  7.894  3.718             (------------*-----------) 
D      27  7.000  3.958     (-----------*-----------) 
                         -----+---------+---------+---------+---- 
                            6.0       7.0       8.0       9.0  
 
 
 
One-way ANOVA: Spin 11  
 
Source   DF      SS     MS     F      P 
Section   3   53.46  17.82  3.15  0.028 
Error   104  587.72   5.65 
Total   107  641.18 
 
S = 2.377   R-Sq = 8.34%   R-Sq(adj) = 5.69% 
 
 
                         Individual 95% CIs For Mean Based on Pooled StDev 
Level   N   Mean  StDev  --------+---------+---------+---------+- 
A      27  6.112  4.052  (--------*--------) 
B      27  8.083  0.734                      (--------*--------) 
C      27  6.920  1.755          (--------*--------) 
D      27  7.184  1.601             (--------*--------) 
                         --------+---------+---------+---------+- 
                               6.0       7.0       8.0       9.0 
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APPENDIX I: INTRASCAFFOLD THICKNESS COMPARISON 
 
  
Introduction 
 
 
This appendix contains ANOVA test results comparing the statistical similarity of 
wall thickness data between sections of the same scaffold.  Each test has six levels 
corresponding to the six sections imaged for scaffold thickness from each scaffold (A1, 
B1, B2, C1, C2, and D1).  Tukey?s method of comparison was used to generate 95% 
confidence intervals for each ANOVA test and the intervals are presented below the 
ANOVA results.  The confidence intervals show how the data from each section 
compares to the others based on individual means and a pooled standard deviation. 
The key to understanding the intrascaffold wall thickness ANOVA tests is the P-
value.  The P-value tells whether the null hypothesis (wall thickness of all sections are 
equal) should be rejected or not.  A small P-value indicates that there is a small chance of 
committing a type I error, which means rejecting the null hypothesis and being incorrect.   
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One-way ANOVA: Spin 1  
 
Source  DF       SS       MS     F      P 
Section  4  0.11022  0.02756  8.87  0.000 
Error   55  0.17087  0.00311 
Total   59  0.28109 
 
S = 0.05574   R-Sq = 39.21%   R-Sq(adj) = 34.79% 
 
 
                             Individual 95% CIs For Mean Based on Pooled StDev 
Level   N     Mean    StDev    +---------+---------+---------+--------- 
A1     12  0.75074  0.05132                            (-----*------) 
B1     12  0.66700  0.06549           (-----*------) 
C1     12  0.63301  0.05081    (------*-----) 
C2     12  0.64397  0.05106      (------*-----) 
D1     12  0.70252  0.05850                  (------*-----) 
                               +---------+---------+---------+--------- 
                             0.600     0.650     0.700     0.750 
 
 
 
 
 
 
 
 
One-way ANOVA: Spin 2  
 
Source  DF       SS       MS      F      P 
Section  5  0.47235  0.09447  22.24  0.000 
Error   66  0.28036  0.00425 
Total   71  0.75272 
 
S = 0.06518   R-Sq = 62.75%   R-Sq(adj) = 59.93% 
 
 
                             Individual 95% CIs For Mean Based on Pooled StDev 
Level   N     Mean    StDev  -------+---------+---------+---------+-- 
A1     12  0.54162  0.05226  (----*---) 
B1     12  0.74021  0.09268                           (----*---) 
B2     12  0.60447  0.04004          (----*---) 
C1     12  0.74703  0.07511                            (---*----) 
C2     12  0.75951  0.05511                             (----*----) 
D1     12  0.68822  0.06233                    (----*----) 
                             -------+---------+---------+---------+-- 
                                  0.560     0.640     0.720     0.800 
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One-way ANOVA: Spin 3  
 
Source  DF       SS       MS     F      P 
Section  5  0.07469  0.01494  4.55  0.001 
Error   66  0.21675  0.00328 
Total   71  0.29144 
 
S = 0.05731   R-Sq = 25.63%   R-Sq(adj) = 19.99% 
 
 
                             Individual 95% CIs For Mean Based on Pooled StDev 
Level   N     Mean    StDev  ------+---------+---------+---------+--- 
A1     12  0.71825  0.04689               (------*-----) 
B1     12  0.69528  0.04350          (------*------) 
B2     12  0.65162  0.05864  (-----*------) 
C1     12  0.75282  0.06983                      (------*-----) 
C2     12  0.71984  0.06727               (------*------) 
D1     12  0.68007  0.05267       (------*------) 
                             ------+---------+---------+---------+--- 
                                 0.650     0.700     0.750     0.800 
 
 
 
 
 
 
 
 
One-way ANOVA: Spin 4  
 
Source  DF       SS       MS     F      P 
Section  5  0.05803  0.01161  5.53  0.000 
Error   66  0.13848  0.00210 
Total   71  0.19652 
 
S = 0.04581   R-Sq = 29.53%   R-Sq(adj) = 24.19% 
 
 
                             Individual 95% CIs For Mean Based on Pooled StDev 
Level   N     Mean    StDev  --------+---------+---------+---------+- 
A1     12  0.68083  0.06633       (-------*------) 
B1     12  0.74538  0.04526                         (-------*-------) 
B2     12  0.70692  0.04982              (-------*-------) 
C1     12  0.71049  0.04167               (-------*-------) 
C2     12  0.66741  0.03150   (-------*------) 
D1     12  0.66404  0.03051  (-------*------) 
                             --------+---------+---------+---------+- 
                                   0.665     0.700     0.735     0.770 
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One-way ANOVA: Spin 5  
 
Source  DF       SS       MS     F      P 
Section  5  0.07181  0.01436  4.06  0.003 
Error   63  0.22298  0.00354 
Total   68  0.29479 
 
S = 0.05949   R-Sq = 24.36%   R-Sq(adj) = 18.36% 
 
 
                           Individual 95% CIs For Mean Based on Pooled StDev 
Level   N    Mean   StDev  ------+---------+---------+---------+--- 
A1     12  0.9544  0.0728                  (--------*-------) 
B1      9  0.9115  0.0582      (---------*---------) 
B2     12  0.9726  0.0624                       (-------*--------) 
C1     12  0.9135  0.0541        (-------*--------) 
C2     12  0.8887  0.0591  (-------*--------) 
D1     12  0.8886  0.0469  (-------*--------) 
                           ------+---------+---------+---------+--- 
                               0.880     0.920     0.960     1.000 
 
 
 
 
 
 
 
 
 
One-way ANOVA: Spin 6  
 
Source  DF       SS       MS     F      P 
Section  4  0.03360  0.00840  4.13  0.005 
Error   55  0.11195  0.00204 
Total   59  0.14555 
 
S = 0.04512   R-Sq = 23.09%   R-Sq(adj) = 17.49% 
 
 
                             Individual 95% CIs For Mean Based on Pooled StDev 
Level   N     Mean    StDev  -------+---------+---------+---------+-- 
A1     12  0.73226  0.06770              (--------*--------) 
B1     12  0.69497  0.03083  (--------*-------) 
B2     12  0.74391  0.03800                  (--------*--------) 
C1     12  0.75277  0.03505                     (--------*--------) 
D1     12  0.69819  0.04439   (--------*-------) 
                             -------+---------+---------+---------+-- 
                                  0.690     0.720     0.750     0.780 
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One-way ANOVA: Spin 7  
 
Source  DF       SS       MS     F      P 
Section  5  0.07702  0.01540  4.37  0.002 
Error   60  0.21152  0.00353 
Total   65  0.28854 
 
S = 0.05937   R-Sq = 26.69%   R-Sq(adj) = 20.59% 
 
 
                             Individual 95% CIs For Mean Based on Pooled StDev 
Level   N     Mean    StDev  -------+---------+---------+---------+-- 
A1     12  0.78389  0.07996         (------*------) 
B1     12  0.84202  0.05397                     (-----*------) 
B2      6  0.84966  0.07087                   (---------*---------) 
C1     12  0.74736  0.05113  (-----*------) 
C2     12  0.77745  0.04213        (-----*------) 
D1     12  0.79861  0.05700            (------*------) 
                             -------+---------+---------+---------+-- 
                                  0.750     0.800     0.850     0.900 
 
 
 
 
 
 
 
 
One-way ANOVA: Spin 8  
 
Source  DF       SS       MS      F      P 
Section  5  0.47638  0.09528  27.07  0.000 
Error   60  0.21115  0.00352 
Total   65  0.68752 
 
S = 0.05932   R-Sq = 69.29%   R-Sq(adj) = 66.73% 
 
 
                           Individual 95% CIs For Mean Based on Pooled StDev 
Level   N    Mean   StDev  --+---------+---------+---------+------- 
A1      9  0.7168  0.0361  (---*---) 
B1     12  0.9013  0.0852                     (--*---) 
B2     12  0.8271  0.0348             (---*--) 
C1     12  0.9109  0.0254                      (--*---) 
C2      9  1.0238  0.1015                                (---*---) 
D1     12  0.8835  0.0403                   (--*---) 
                           --+---------+---------+---------+------- 
                           0.70      0.80      0.90      1.00 
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One-way ANOVA: Spin 9  
 
Source  DF       SS       MS     F      P 
Section  5  0.08720  0.01744  6.65  0.000 
Error   63  0.16534  0.00262 
Total   68  0.25253 
 
S = 0.05123   R-Sq = 34.53%   R-Sq(adj) = 29.33% 
 
 
                             Individual 95% CIs For Mean Based on Pooled StDev 
Level   N     Mean    StDev  -----+---------+---------+---------+---- 
A1     12  0.84316  0.05721                    (-----*-----) 
B1      9  0.83320  0.03641                 (------*-----) 
B2     12  0.86820  0.06601                         (-----*-----) 
C1     12  0.82419  0.05072                (-----*-----) 
C2     12  0.83462  0.05027                  (-----*-----) 
D1     12  0.75476  0.03657  (-----*-----) 
                             -----+---------+---------+---------+---- 
                                0.750     0.800     0.850     0.900 
 
 
 
 
 
 
 
 
 
 
One-way ANOVA: Spin 10  
 
Source  DF       SS       MS     F      P 
Section  4  0.02685  0.00671  1.78  0.145 
Error   55  0.20688  0.00376 
Total   59  0.23373 
 
S = 0.06133   R-Sq = 11.49%   R-Sq(adj) = 5.05% 
 
 
                             Individual 95% CIs For Mean Based on Pooled StDev 
Level   N     Mean    StDev  -----+---------+---------+---------+---- 
A1     12  0.82513  0.05864   (---------*---------) 
B2     12  0.82430  0.07461  (----------*---------) 
C1     12  0.85058  0.06071          (---------*---------) 
C2     12  0.87635  0.04642                 (---------*----------) 
D1     12  0.82163  0.06295  (---------*---------) 
                             -----+---------+---------+---------+---- 
                                0.805     0.840     0.875     0.910 
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One-way ANOVA: Spin 11  
 
Source  DF       SS       MS     F      P 
Section  4  0.11431  0.02858  5.17  0.001 
Error   52  0.28742  0.00553 
Total   56  0.40174 
 
S = 0.07435   R-Sq = 28.45%   R-Sq(adj) = 22.95% 
 
 
                             Individual 95% CIs For Mean Based on 
                             Pooled StDev 
Level   N     Mean    StDev  ---+---------+---------+---------+------ 
A1     12  0.76086  0.06483     (------*------) 
B1     12  0.74420  0.03681  (------*------) 
B2      9  0.77799  0.13009      (--------*-------) 
C1     12  0.86154  0.06589                     (-------*------) 
D1     12  0.82872  0.06262                (------*------) 
                             ---+---------+---------+---------+------ 
                              0.720     0.780     0.840     0.900 
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APPENDIX J: PRELIMINARY CELLULAR RESPONSE TO ELECTROSPUN 
P(LLA-CL) SCAFFOLDING 
 
 
Introduction 
 
 
 For electrospun scaffolding to be effective in the BVM, fiber diameter should be 
decreased to sub-micron levels.  The process used in this thesis failed to produce fibers 
with diameters this small.  Despite their large fiber diameter, the electropsun P(LLA-CL) 
constructs were implemented in the BVM as a preliminary cell viability test.  Full 
confluency was not the anticipated outcome; rather, this experiment tested the hypothesis 
that the electrospun P(LLA-CL) would not have a cytotoxic effect in the BVM system. 
 
 
Methods and Materials 
 
 
Scaffold Fabrication and Preparation 
 
 
 All electrospinning parameters were the same as those used in the consistency 
study.  Upon completion of the electrospinning process, the construct was allowed to dry 
in a dessicator for 24 hours.  Two 2.5 cm long scaffolds were cut from the center of the 
construct, as well as four 0.2 cm long samples used to measure average fiber diameter ().  
Fiber diameter was measured using SEM micrographs in the same manner as the 
consistency study (Image J), but the fiber selection mask was not used.  Instead, 15 fibers 
were randomly selected and measured.  The two scaffolds were sterilized using ethylene 
oxide gas (EtOH) prior to implementation in the BVM. 
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Cell Sodding and Implentation Into the BVM  
 
 
 The sterilized scaffolds were sutured into the BVM system in the same manner as 
ePTFE scaffolding.  Nutrient supplemented media was supplied to the system and the 
scaffolds were allowed to soak prior to cell sodding.  The scaffolds were sodded at a 
density of 1x106 cells/cm2 with p7 HUVECs and allowed to sit for 1 hour, then the 8-
roller peristaltic pump was turned on at a speed of 15 rpm, corresponding to a flow rate of 
approximately 1 ml/min.  After two hours, one scaffold was removed from a BVM 
system and placed in histochoice to halt cellular activity and fix cells to the scaffold.  The 
second scaffold was allowed to stay in the BVM for 24 hours before it was removed and 
placed in histochoice. 
 
 
Imaging of Scaffolds 
 
 
 Scaffolds were placed in a bis benzene sulphonylimide (BBI) staining solution 
overnight for histological examination.  Scaffolds were cut in half lengthwise, and then 
imaged using a fluorescent light microscope.  Following histological examination, 
scaffolds were placed in a desiccator to dry overnight.  Once dry, the scaffolds were 
prepared for SEM imaging in the same manner as the samples were prepared in the 
consistency study.  SEM images were then taken for high resolution topographical 
examination of the scaffolds. 
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Results 
 
 
 Qualitative analysis of fluorescent microscope images revealed cell presence on 
the lumen of electrospun P(LLA-CL) scaffolds at both 2 (Figure J1) and 24 hours (Figure 
Figure J2).  The fluorescent microscope images suggest that discrete sections of the 
scaffold lumens were confluent with ECs, while other sections were void of cells. 
 
 
 
 
 
Figure J1 ? Histological examination of electrospun P(LLA-CL) scaffolding sodded with 
HMVECs indicated that the in-house fabricated scaffolds did not have a cytotoxic effect 
after 2 hours in the BVM. (100x) 
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Figure J2 ? Histological examination of an electrospun P(LLA-CL) scaffold sodded with 
HMVECs after 24 hours of flow conditions in the BVM. (100x) 
 
 
 
 
 Analysis of SEM images showing the lumen of the sodded electrospun scaffolds 
after 2 hours (Figure J3) and 24 hours (Figure J4) of flow conditions confirmed that 
discrete areas of the scaffolds were void of cells.  In areas with ECs, cells stretched from 
one fiber to adjacent fibers.  
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Figure J3 ? SEM image of the lumen of an electrospun P(LLA-CL) scaffold sodded with 
ECs and cultured under flow conditions for 2 hours. (825x) 
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Figure J4 ? SEM image after 24 hours of flow condition culturing for the sodded 
electrospun P(LLA-CL) scaffold. (418x) 
 
 
 
 
Discussion 
 
 
 These preliminary results suggest that electrospun P(LLA-CL) scaffolds do not 
have a cytotoxic effect.  A long term study is necessary to ascertain the true potential of 
these scaffolds to support ECs in the BVM.  This may include looking over time at the 
migration, proliferation, and % confluency of ECs, as well as the effect of local pH 
fluctuation due to scaffold degradation.   
In addition, a confluent layer of ECs did not form on the lumen of the scaffolds.  
This outcome was anticipated, as some of the pore sizes were large enough to permit cells 
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to pass through into the interior of the scaffold.  For cells that did attach, stretching from 
fiber to fiber was characteristic. 
 Another possible use for these scaffolds is support for a dual-sodded BVM 
developed within our lab group.  The dual-sodding procedure incorporates a base layer of 
SMCs in addition to a top layer of ECs.  The large pores in the electrospun P(LLA-CL) 
may allow for infiltration of SMCs that would later provide support for a confluent 
luminal layer of ECs.  
 
 
 
